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History of Medicine
Ageism and London’s Hospitals: A long-overdue and insufficient remedy
Bryan Young, MD, FRCPC,
Professor, Division of Neurology,
Department of Clinical Neurological Sciences, University of Western Ontario
Member of Active Staff, Neurology and Critical Care, London Health Sciences Centre

The term “ageism” was coined in 1969 by
Robert Butler, who likened it to other forms of
bigotry such as racism and sexism, defining it as
a process of systematic stereotyping and
discrimination against people because they are at
or beyond a certain age.1 Ageist attitudes are
perpetuated in many ways. Institutions
perpetuate ageism and reinforce ageist
stereotypes by not hiring or promoting older
workers and through mandatory retirement.
Ultimately, stereotypes are dehumanizing and
promote one-dimensional thinking about others.
Elders are not seen as human beings but as
depersonalized objects who, therefore, can be
more easily denied opportunities and rights,
leading to cruel and inhumane treatment. Ageism,
as manifested by mandatory retirement, is based
on fallacious thinking and untenable policies.
Chronological age is a poor predictor of the
competence of the older adult.2 Furthermore
there is far more variation of productivity, ability
and intelligence within than across age groups.3
The Ontario Government’s Bill 211, which is
now in effect,, should force London Health
Science Centre’s (LHSC) and St. Joseph’s
Health Centre’s (SJHC) to amend their by-laws
that gave an absolute cut-off for hospital-based,
OHIP or LHSC/SJHC-funded remunerative work
to individuals over 70 years of age. However, the
plan not to reinstate those recently terminated
before December 2007/January 2008 will
unjustly curtail the careers of several capable,
internationally renowned academic clinicians.
Thus, this arbitrary decision perpetuates the
injustice that existed here before Bill 211.
Why should we persist in discriminating
against individuals who are otherwise well
qualified? If we cut off physicians’ livelihood,

i.e., the ability to be remunerated for clinical
work, they cannot viably continue their academic
pursuits, even if the university position remains.
Mandatory, age-dependent retirement has been
abolished in most Canadian universities and
hospitals. The policy is, above all, inhumane:
“The deprivation of the opportunity to work has
been the most widespread disadvantage imposed
on people because of old age.”4 At a time of
physician shortages, we are losing good people
who could still make valuable contributions in
research, teaching and patient care. Within the
academic medical centre the academic milieu is
damaged. There are aspects of collegiality, best
demonstrated in academic rounds and
collaborative research projects, that would be
compromised if these individuals were forced to
retire.
We need not look far for examples of the
damaging effects of mandatory retirement. We
have lost a number of internationally famous
individuals, who have moved to other
institutions, e.g., Mayo Clinic, when they could
no longer work at LHSC and SJHC. In the past
two years several prominent, active, productive
faculty members have lost even their outpatient
privileges and their ability to carry on their
needed activities in established units at the
LHSC and SJHC, because of ageist bylaws of
convenience. This makes no sense if they want to
work and if they are needed.
Why must this persist, when LHSC and
SJHC are otherwise so progressive and
prominent in research, teaching and patient care?
Within medical and surgical departments,
mandatory retirement was a convenient means
for department heads to be freed from the
responsibility of passing judgment on the
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competence of senior departmental members,
some of whom were the mentors or professors of
current department heads or service chiefs. It
also allows the system to eventually free itself of
incompetent and non-productive members.
Mandatory retirement is one of the few methods
by which positions are created to hire new
departmental members. However, if the senior
member is still active and capable (often such
individuals are in their prime at age 65, 70 years
or beyond), this cannot be justified. Why should
they be sacrificed? From an ethical perspective it
is wrong: the ends do not justify the means.5
Also, at a time of physician shortages in almost
all branches of medicine, forcing out our most
productive, competent and prestigious colleagues
is both wasteful and unwise.
Reform is the best approach to counteracting
ageism within institutions. The object is to have
quality members in the department, regardless of
age.6 To do this we need a better model.
Although it will be a challenge to design and
implement a workable, fair system, it is the right
thing to do. Departments have Appointments and
Promotion Committees that have the duty of
assessing the performance of departmental
members and recommending their continuation,
promotion, demotion or discontinuation. Surely
these committees should function as they were
intended and allow for yearly, fair, merit-based
assessments of each Departmental member. The
committee should be empowered to make
decisions about appointments, promotion as well
as the dismissal of individuals based upon
agreed-upon qualifications and record of
research, teaching and service in the “stream”
appropriate for each member. This would take
the onus off the divisional chairs to make such
decisions in isolation. Other models for the
operation of hospital and university departments
can be formulated that allow continuation of the
best and hiring of the brightest: the Faculty could

derive another system for physician assessment
with appropriate oversight, principles of function,
accountability and authority with checks and
balances. Individuals should be maintained on
our staff while they continue to make meaningful
contributions to the missions of the university,
hospital and departments. Mandatory retirement
from LHSC/SJHC, with respect to admitting,
consultation and billing privileges should be
abolished. It is shameful at a time when we need
capable and knowledgeable academic clinicians
for them to be effectively dismissed.
This would be a very good time for LHSC
and SJHC to abolish mandatory retirement as
well as the “no re-entry” policy for the unjustly
retired. We need to develop other models for
dealing with competence and productivity, so
that the incompetent and non-productive can be
jettisoned from and the good retained in
academic medical centres.
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Zebra Files
A Royal Pain: The Porphyria Disorders
Badrinath Narayan, BSc, Medicine 2009
Stephen Chihrin, BSc, Medicine 2008
One of the first and most popular examples of historical diagnosis is provided by an examination of King George III
and the records of his significant illness. Plagued with acute attacks of intense abdominal pain, curiously-coloured
urine, and a constellation of neuropsychiatric symptoms, historians were at a loss for an explanation for nearly two
centuries. It is now generally accepted that King George suffered from some form of porphyria, likely acute
intermittent porphyria (AIP) or variegate porphyria (VP). Porphyria diseases are at their root a variety of disorders of
heme synthesis. Symptoms are believed to result from the accumulation of biosynthetic intermediates. It is the intent
of this paper to outline AIP and VP and their association with many influential people from the past. Maintaining a
high index of suspicion for these entities you will not only undoubtedly impress your senior resident – you may also
find yourself in royal company for your efforts.

Introduction
One cannot discuss the history of rare diseases
without mention of King George III. Ruler of the
British Empire from 1760 to 1820, he presided
over a considerable time span marked by great
achievements and questionable decisions alike.
Britain’s navy had proven itself as the
undisputed world leader, defeating Napoleonic
France and strengthening King George’s
influence across the world. On the other hand,
mismanagement of the American colonies led to
the Boston Tea Party, and ultimately, the
Declaration of Independence. The establishment
of Australia as a penal colony, also controversial,
was also conducted during his reign.1 These
events left somewhat of a shadow over the
legacy of King George III, “The King Who Lost
America”.2 Subtle and not-so-subtle indications
of Parliament’s hesitancy with King George’s
rule stemmed from his periodic bouts of madness
– bouts that while well documented would not
receive a diagnosis for nearly 200 years.
While evidence suggests minor episodes
began much earlier, it was in October of 1788
that King George experienced his most
prolonged bout of intense, totally debilitating
madness, leaving England largely without a ruler
until February of 1789 – a period often now
referred to as The Regency Crisis.1 Royal
physicians Dr. Richard Warren and Sir George
Baker meticulously recorded symptoms of

tachycardia, fever, periodic jaundice or
bloodshot eyes, abdominal colic, constipation,
lower leg cramps, pain, and weakness. They also
noted bullous eruptions along the arms,
hoarseness, and port-wine coloured urine, as well
as a variety of psychiatric manifestations
including bouts of vivid multi-sensory
hallucinations, delusions, and rambling which
often degenerated into incoherent strings of
obscenities.3
Initially assumed to be a chiefly psychiatric
disease, intriguing reports by royal attendants of
urine that “leaves a pale blue ring upon the glass
near the upper surface” left historians and
physicians alike looking for a better answer.4 In
the 1960’s Ida Macalpine and Richard Hunter
first proposed that King George III was afflicted
with acute intermittent porphyria (AIP), and with
the permission of the royal family collected urine
samples from his descendants, many of whom
displayed elevated porphyrin levels.5 The
subsequent discussion they sparked is perhaps
unmatched in the field of medical history, and
the mystery has spawned countless books and
even an Oscar winning feature film.6 More
recent proposals have integrated the observation
of vesicular lesions to suggest instead a
diagnosis of variegate porphyria (VP)3, though
VP does not as commonly present with
psychiatric manifestations, and rarely ever has it
produced symptomology as severe as observed
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in King George III.7 As this topic remains
controversial, it is the intent of this article to
address both AIP and VP.
Epidemiology and Pathogenesis
AIP results from an autosomal dominant
mutation in the Porphobilinogen (PBG)
deaminase gene.8 While mutation rates for this
gene are relatively high, and more than 400
mutants have been identified, gene penetrance is
low resulting in a disease prevalence of 1-2 per
100,000.9 VP, resulting from an autosomal
dominant mutation in protoporphyrinogen
oxidase (PPOX) 8, is just as heterogeneous in its
mutations, and while one subtype occurs at a
frequency of 1 per 300 in South Africa, global
frequency is considerably lower. Furthermore,
incidence of subtypes displaying associated
psychiatric disease is rarer still leaving estimates
as simply “less than AIP”.10
Both genes are involved in the biochemical
cascade required for the synthesis of
protoporphyrin,
the
integral
iron-bound
component of hemoglobin. Defects in either of
these two genes results in accumulation of both
PBG and delta-aminolaevulinic acid (ALA).9

Interestingly, both of these compounds are
colourless in the isolated state but develop a
yellow, red, or purple pigment when left to react
non-enzymatically in the urine.4
Under normal circumstances the accumulation of
biosynthetic intermediates is insufficient to
produce symptoms of porphyria. However, under
conditions of hematologic stress, most notably
infection, blood loss, or Cytochrome P450
induction resulting from smoking, excess alcohol
intake, fasting, fever, or pharmacologic
interactions, porphyrin precursors accumulate to
dangerous levels.9 While both ALA and PBG are
implicated in triggering the neuropsychiatric
aspects of porphyria, research has indicated that
it is predominantly ALA that is responsible, by
competitively inhibiting normal GABA receptor
binding.9
It has also been proposed that the extreme
symptoms experienced by King George III may
have been magnified by accidental, or perhaps
iatrogenic arsenic exposure.1 It is well
established that arsenic in its trivalent state can
disrupt a number of the enzymes responsible for
hemoglobin synthesis. Analysis of hair samples
from King George III found arsenic traces

Table 1: Signs and Symptoms of Acute Intermittent Porphyria and Variegate Porphyria7,11
Stage
Early through late
(Abdominal)

Signs and Symptoms
Severe colicky abdominal pain (often epigastric lasting days)
Constipation
Nausea and vomiting

Mid through late
(Psychiatric)*

Depression common
Mania
Psychosis

Late only
(Neurologic)

Areflexia common
Motor weakness, usually in lower limb
Diffuse pain, usually in upper limb
Autonomic neuropathy (hypertension, postural hypotension,
tachycardia are common)
Delirium, coma, cortical blindness also reported

Skin**

Photosensitive lesions, bulla or furrowing (most severe in
children)
Lesions often friable
Hypertrichosis
Sclerodermoid changes
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* Much debate exists as to whether these symptoms have a pathogenic mechanism in VP. Observation
of the South African cohort, where roughly 1 in 300 people have the gene for VP, suggests not.
** Skin manifestations only present in VP.

throughout the length of each hair, suggesting
chronic exposure to low dose arsenic. It has been
proposed that this exposure may have resulted
from contamination of his antimonial emetic
tartar, which at one point he was receiving at a
rate of 120mg q6h. Treatments involving
elemental compounds were quite popular at the
time, and Dr. John Willis, head of Dunston
House, London’s premier asylum of the time,
was quite found of arsenic therapies. However,
direct therapy using arsenic is not recorded in the
logs of King George’s physicians.1
The observation of a bluish layer
precipitating to the surface of collected urine has
also recently been explained.4 It has been
observed that prolonged constipation can affect
levels of bacterial sulphatase in the
gastrointestinal tract, and in the presence of
excess tryptophan, can lead to excessive
production of indoxyl sulphate (indican). This
substance is then processed in the liver and
excreted via the kidneys. Barely soluble, it falls
out of solution as urine temperature drops
outside of the body. While this mechanism is
largely believed, what is not understood is why
this phenomenon is observed with greater
frequency in patients suffering from an acute
episode of porphyria.4

Urine levels of ALA and PBG may be
misleading if urine samples are left too long
before analysis, particularly if exposed to light,
or if collected from a patient with chronic renal
failure. In this circumstance measuring direct
ALA and PBG serum levels is indicated.7
Measurement
of
protoporphyrin
and
coproporphyrin in the stool may also assist in
these circumstances, but is of low sensitivity.5
Recently, experts have also suggested that
directly assessing PBG deaminase activity may
be warranted as it unequivocally detects the
defect associated with AIP.9

Diagnosis
Diagnosis relies on a high index of suspicion
given the signs and symptoms of both AIP and
VP (see Table 1).7,11 It should be noted that
symptom groups generally progress as
overlapping groups, with initial manifestation
limited to the abdomen, followed by psychiatric
symptoms, and finally peripheral neuropathy.
Ultimately, early morning or 24-hour urine
collection should be conducted, ideally during an
acute attack of the disease, and assessed for ALA
and PBG accumulation.8 While levels will be
substantially elevated during an acute attack,
levels of both ALA and PBG, particularly PBG,
remain elevated, often for years following the
last acute attack.11

Management
Successful management of acute attacks of
porphyria rest on decreasing heme synthesis, in
turn decreasing production and accumulation of
heme precursors.9 Administration of high-dose
glucose has been observed moderately curtail
heme synthesis, if given in doses of at least 400g
per day.11 More severe attacks have been well
managed with the use of hematin, a heme
derivative, at a dosing of 4mg/kg/day for at least
4 days.11
Just as important as treating acute attacks,
prevention of further attacks is a critical aspect
of management, and one that is complicated by
significant pharmacologic interactions. Well over
200 drugs have been found to exhibit properties
that may predispose an individual to more

Differential
The differential diagnosis of acute porphyria is
potentially enormous, thus diagnosis rests on
successful
identification
of
hemoglobin
precursors in the urine, blood, or stool. The
abdominal symptoms present in AIP are similar
to
many
acute
GI
disorders.7-9,11
Neuropsychiatric manifestations are most closely
approximated by heavy metal poisoning. The
skin lesions observed in cases of VP share
similarities with a number of dermatological
conditions, the most important to rule out include
drug-induced photosensitivity reactions and
porphyria cutanea tarda.7,9
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frequent bouts of porphyria.7,11 The classes felt
to be most harmful include androgens, estrogens,
progesterones,
barbiturates,
sulfonamides,
hydantoins, griseofulvin, as well as ethanol.12
Due to the sheer volume of potential interactions,
it is important to consult up to date,
comprehensive lists when treating patients with
AIP or any other porphyria.
Appropriate management must also include
education and screening of family members. In
asymptomatic individuals an assay for
erythrocyte PGB deaminase has been found to be
most sensitive in families with AIP.11 Similarly,
assays for protoporphyrinogen oxidase have been
used in assessing families with VP.7
Conclusion
The acute porphyria diseases, despite being
exceeding rare have captured a large portion of
medical historians’ attention. In fact, it was King
George and his regency crisis that many cite as
one of the first and finest examples of ‘historical
diagnosis’ to be discussed in the literature. Since
the early papers on this topic a number of other
historical figures have also been suggested to
suffer from acute intermittent porphyria. As one
would expect, many other British Royalty of
King George’s bloodline have been afflicted,
including Queen Anne, King James I, Queen
Mary I of Scotland, and Frederic the Great of
Germany. Other notable individuals often
suggested to have had porphyria include Vincent
van Gogh and King Nebuchadnezzar of Babylon.
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Diagnostic Review
A Historical Perspective of the Diagnosis of Diabetes
Mark Kirchhof, BSc (Hons), Meds 2009
Nooreen Popat, BSc (Hons), Meds 2008
Janet Malowany, BHSc (Hons), Meds 2008
Diabetes is a disease whose symptoms have been recorded in the annals of history ever since the earliest reports of
polyuria in 1500 BC. However, it was only in the last hundred years that adequate treatment methods have been
developed, initiated by Banting and Best’s discovery of insulin. Tracing the historical methods used to diagnose
diabetes provides a perspective for current diagnostic and treatment strategies. Diagnostic tests have become
increasingly quantitative evolving from the earliest diagnostic tests where urine was tasted to modern methods
assaying the percentage of glycosylated hemoglobin. The basis of future diagnostic tools for diabetes will most
certainly be based on past research findings and experiences.

The signs and symptoms of diabetes have been
observed and recorded since the beginnings of
civilization.
The earliest descriptions were
limited to changes in urine output and the fatal
outcome of those inflicted with diabetes.
Polyuria, as we now know, has many different
etiologies, thus it is impossible to discern today
whether the symptoms and treatments were
correctly directed at diabetes mellitus. However,
the early recognition of diabetes began with the
examination of urine.
While the term “diabetes” was first
introduced in the 1st or 2nd century BC by
Demetrius of Apameia,1 descriptions of
abnormal polyuria were recorded as early as
1500 BC in the Egyptian Papyrus Ebers, an
ancient
written
document
of
medical
1-3
knowledge.
The term “diabetes” was based
from the Ionic and Latin terms that meant to pass
through or to siphon.1 It was coined by Areteus
of Cappadocia (AD 30-90) “because the fluid
does not remain in the body but uses the man’s
body as a ladder whereby to leave it”.3 It was
the prevailing belief that diabetics had large
volumes of urine due to large volumes of
ingested fluids, unchanged as it passes through
the body, as if the patient was a siphon.1 In
addition to coining the term diabetes, Areteus is
credited with the first accurate clinical
description of diabetes, likening it to “an
affliction… melting down of the flesh and limbs
into the urine”.1

The first test for diabetes was the urine taste
test. While the Greek physician Claudius Galen
(AD 129-200) believed diabetics’ urine was
“unchanged drink” which may have accounted
for a different aroma, early Egyptians, Indians,
and Asians noted the sweet taste of urine.3
Chang Chung-Ching (AD 229) noted that the
urine was so sweet that that dogs liked it.3
Indeed, animals and insects alike were attracted
to the sweet urine.3,4 The Hindu medical
textbooks from the 5th century described sweet,
honey and sugarcane urine amongst 20 varieties
of diseased flow of urine.1,3 Both Avicenna (AD
980-1037) and Paracelsus (AD 1493-1541) later
recommended tasting the urine of diabetics.1,3
The source, however, of the sweet taste of
diabetics’ urine remained unknown. Avicenna
noted a sticky residue as sweet as honey
remained after urine was left to stand in ambient
air.1 Theophilos Protospatharios (630 AD) was
the first to mention applying heat to urine as a
diagnostic test.3 Paracelsus reported that boiling
diabetic urine recovered “4 ounces of salt”.3
However, it was Thomas Willis (1621-1675) that
first described the saccharine nature of urine,
describing the sweet taste after evaporation “as if
imbued with honey (quasi melle) and sugar”.1
In 1776, Matthew Dobson performed a
diagnostics experiment that lead to the belief that
diabetes was not just a disease of the kidneys,
but rather a system disorder.1,5
Dobson
evaporated the urine of diabetic patients to
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discover the presence of a substance like brown
sugar in taste and appearance, he also went on to
observe that diabetic patients had the sweetish
taste of sugar in their blood.1,5 This confirmed
the relationship between the sugars present in the
blood and those excreted in the urine.
John Rollo established the link between the
food consumed by diabetics and the amount of
sugar in the urine.6 Rollo recorded the amount
and kind of food eaten by his diabetic patients,
and then weighed the "sugar cake" which
remained after evaporating their urine.6 He
observed that carbohydrates increased sugar
levels, and animal product consumption resulted
in less sugar.1,5,6 He promoted the idea that the
treatment for diabetes should be a diet low in
carbohydrates and high in fat and protein. This
modification of diet became the recommended
treatment for diabetes until the discovery of
insulin.7
The first clinical tests for glycosuria were
developed in the nineteenth century. In 1841,
Karl Trommer, developed a qualitative test for
sugar which involves treating a urine sample
with a strong acid which results in the acid
hydrolysis
of
disaccharides
into
monosaccharides.5,6
The solution is then
neutralized and a solution of copper sulphate is
added, then excess of alkali, followed by boiling,
a brick-red cuprous oxide precipitate forms if
glucose is present.5,6 In 1850, Hermann von
Fehling developed a quantitative test based on
Trommer’s work to measure sugar content.6
Frederick Pavy (1829-1911) established a
quantitative relationship between the degree of
hyperglycemia and glycosuria based on
Fehling’s test.5 Pavy also improved upon the
Fehling’s test for quantitative sugar urinalysis by
substituting ammonia for caustic potash and
thereby facilitating production of the first
urinalysis tablets.5
In the twentieth century, easier methods to
determine urine sugar content and tests for blood
glucose were developed. In 1907, Stanley
Benedict developed a milder test for glycosuria
using a copper reagent with a carbonate base
rather than the hydroxide base of Fehling’s test.8
In 1913, Ivar Bang pioneered a method to test

blood glucose levels whereby blood proteins
were fixed to filter paper and the filtrate was
used to measure glucose using copper sulfate and
KCl.9 However, the use of glucose-dependent
copper reagent reduction reactions became
increasingly analytically problematic as they
underestimated the amount of glucose present.8
In 1941, the Ames company introduced the first
“stick” or “strip” tests (Clinitest) which was still
based on the old methodology involving copper
sulfate reduction.10 Shortly thereafter, the Ames
company produced the far more accurate
Clinistix which is based on the enzymatic
reaction of glucose oxidase.10 This enzyme
generates hydrogen peroxide as it interacts with
glucose, which in turn reacts with horseradish
peroxidase to produce oxygen which oxidizes
orthotoluidine to produce a blue or purple
colour.10
In more recent times, the diagnosis of
diabetes has taken on a more quantified approach.
The emphasis over that last forty years has been
on measuring blood glucose levels and response
to oral glucose challenges. Debate, however, has
ensued over the determination of cut-off values
for diagnosis, and the accepted values have
changed a number of times, reflecting changes in
trends and attitudes.
In 1979, the National Diabetes Data Group
and the World Health Organization developed
diagnostic criteria for the diagnosis of diabetes
that involved measuring glucose tolerance using
an oral glucose tolerance test (OGTT).11 An
OGTT involves giving a patient 75 gm of
glucose by mouth and then measuring their
blood sugars two hours later. If a patient’s blood
sugars are elevated more than they would be in a
normal individual, then that patient has impaired
glucose tolerance. Using this test, the following
criterion was established for the diagnosis of
diabetes: fasting blood glucose 7.8 mmol/L or
higher, or an OGTT two-hour blood glucose
value of 11.1 mmol/L or higher.11
These guidelines were updated in 1997 by
the American Diabetes Association (ADA), and
then revised in 2003. The new guidelines require
meeting one of three criteria in order to diagnose
diabetes: a) a fasting blood glucose concentration
UWOMJ 78(1)2008 P8

of 7.0 mmol/L or higher with symptoms of
hyperglycemia, which include polydipsia,
polyuria, and weight loss; b) a random blood
glucose of 11.1 mmol/L or higher; c) a two hour
value in an OGTT of 11.1 mmol/L or higher.12
The diagnosis must then be confirmed on a
different day with any of the three criteria.12 The
ADA cautions use of the OGTT as a tool for
diagnosis, and stresses the use of fasting blood
glucose measurements instead, because the
results of the OGTT are not always reproducible
and so the test is not reliable.13
There has been recent interest in using
hemoglobin A1c values to aid in the diagnosis of
type 2 diabetes in conjunction with random
blood glucose levels.14,15 Hemoglobin A1c is the
glycosylated form of hemoglobin A, the major
adult hemoglobin type. The utility in measuring
hemoglobin A1c comes from the fact that its
concentration is proportional to blood glucose
levels. In non-diabetics, the normal hemoglobin
A1c level is less than 5% of the total
hemoglobin.16
In patients with diabetes,
chronically elevated blood sugars will lead to a
higher than normal percentage of hemoglobin
A1c. It has been proposed that to avoid the
inconvenience of measuring fasting blood
glucose as a means of diagnosis, an abnormal
random blood glucose value (11.1 mmol/L or
higher) in addition to a hemoglobin A1c value
greater than 2 standard deviations above normal
could be used.14,15 Before the incorporation of
hemoglobin A1c measurements into diagnostic
criteria, a number of issues need to be addressed
including erroneous levels due to diseases that
falsely elevate or depress A1c values.17 Despite
these potential sources of error, since 1999 Japan
has been using HbA1c levels over 6.5 % as a
diagnostic marker for diabetes.18,19 It seems
clear that there still remains work to be done to
standardize the diagnostic tools in the
determination of diabetes.
From the initial reports of sweet tasting urine
to the biochemical analysis of glycosylated
hemoglobin, the tests employed to diagnose
diabetes have become more sophisticated over
the past centuries as our knowledge of the
disease grows. The future promises to have ever

more specific tests to diagnose the different
varieties of diabetes, some of which may enter
the
realm
of
genetic
screening
or
pharmacogenetics.
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Profiles
Chasing Hippocrates: Dr. Paul Potter’s Journey through the History of Medicine
Renata Villela, Meds 2009
Dr. Paul Potter received his medical degree from McGill University in 1968 and subsequently completed his graduate
classical training in Hamilton and in Kiel, Germany. One year after obtaining his Ph.D. in 1973, Dr. Potter became a
member of the Faculty of Medicine at the University of Western Ontario. He currently holds the post of Jason A.
Hannah Professor and the Chairman of the Department of the History of Medicine. Dr. Potter provides insight into his
experiences as a medical historian and the future of the history of medicine.

The classical world opened its doors to Dr. Paul
Potter in Hamilton, Ontario amidst a sumptuous
chocolate cake and grape juice at a high school
Greek club meeting. In spite of its enticing siren
call, however, Dr. Potter’s love for the classical
world was counterbalanced by his interest
in science. Following his graduation from
secondary school, he began a seven-year medical
degree program at McGill University in 1961.
Fortunately, the program’s structure allowed him
to pursue a range of subjects, thereby enabling
him to take several Greek courses in addition to
his basic science requirements. By the end of his
medical degree, Dr. Potter’s fascination with
languages steered him towards the path of
devoting himself full-time to the Greek language.
He returned to Hamilton to complete a Masters
of Arts degree in Greek at McMaster University
and next departed for Kiel, Germany. There, he
received his Ph.D. in 1973 for a dissertation on
the Hippocratic text Diseases III. A subsequent
sinecure provided him with ample time to study
medical history. By 1974, he returned to Canada
to begin teaching at the University of Western
Ontario in London. Dr. Potter currently teaches
undergraduate and graduate students and is
cross-appointed
between
the
Classics
Department and the Faculty of Medicine.
Dr. Potter’s travels and medical training have
provided him with a strong foundation for
understanding the physician within various
historical contexts. His research on Greek
medicine has afforded him the opportunity to
visit ancient healing temples and hospitals along
the Mediterranean coasts of Greece, Italy, and
France. In addition, his medical degree has

proven valuable in ways that he had not
originally foreseen. For example, several of his
medical school laboratory sessions involved the
use of frogs and other animals as subjects for
physiology experiments.
These experiences
enabled him to relate to the work of past
physicians who used animals as models to
understand better the inner workings of the body.
Thus, Dr. Potter views himself as an “insider” in
medicine.
When not teaching students in the classroom,
Dr. Potter explores topics in the history of
medicine through the Osler Society. The group
was originally founded in 1922 by Dr. J.W.
Crane in memory of Sir William Osler, who died
in 1919. Although the group began as an honor
society, its focus moved towards the history of
medicine after World War II. By the time Dr.
Potter arrived at the University of Western
Ontario, however, the society was barely active.
In the late 1980s, Dr. Potter was informed of a
potential removal of funds for the club, which
served as a catalyst for renewing medical
students’ interest. Since then, the club has
enjoyed a solid membership increase. Using his
former Greek club as a model, Dr. Potter offers
his home as a meeting place for the Osler Society
each month and serves a delectable selection of
hors d’oeuvres and desserts.
Throughout his career, Dr. Potter has noticed
some interesting developments within the study
of the history of medicine. Prior to the 1950s,
several medical historians were doctors
interested in exploring the roots of their
profession. Between 1950 and 1960, social and
institutional historians began to enter the field.
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Their view tended to be more critical of
medicine than their physician counterparts.
Whereas the latter focused more on medical
achievements, the social historians were
interested in how physicians exerted their power
and influence in various cultures. Fortunately,
these differing perspectives came together to
form the Canadian Society for the History of
Medicine. Dr. Potter foresees that important

future topics in the history of medicine will
include the limits of medicine, especially with
regards to the amount of money society is
willing to invest in health care and to how
society will deal with technological advances
such as genetic engineering. Ultimately, history
will provide a template to guide physicians in
confronting the future challenges of medicine.
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History of Medicine
Light in the Dark Ages
Raza Naqvi, Meds 2009
Urszula Zurawska, Meds 2008
While the Dark Ages were a time of intellectual and societal stagnation throughout much of Europe, the torch of
academia continued to burn brightly in the Islamic world. The intellectual progress made during this time includes
numerous medical breakthroughs which physicians, historians, and students should strive to understand not only for
academic interest but also to learn and improve medicine today. The use of secular hospitals originated in this era and
there were significant developments in a variety of medical fields including anesthesia, ophthalmology, pharmacology,
neurology and psychiatry. A strong emphasis on patient-centered and interdisciplinary care was evident in many of the
areas of Islamic medicine during the Dark Ages. The achievements of Islamic physicians during the Dark Ages also
demonstrates the importance of strong communication within the global medical field, as the presence of avenues for
global academic communication could have eliminated much of the disparity in medical care in different parts of the
world over subsequent centuries. The need for improved international communication applies to medicine even today.

Introduction
The Dark Ages are known to be a time of
intellectual and societal stagnation throughout
much of Europe1 and as learners in the Western
world we rarely hear about the academic
achievements during this time. This is clearly
seen in the medical field where historians often
move from the work of the Greco-Romans
before the Dark Ages to the discoveries of the
Europeans afterwards.2-4 However from the
seventh to thirteenth centuries the Islamic empire
spread from Spain to China and was the centre
for trading of goods, knowledge, and ideas.5-8
The Islamic civilization was thriving
intellectually at this time yet many historians
regard the role of the Muslims during the Dark
Ages as merely translators and transmitters of the
Greco-Roman medical knowledge.4
There are three important stages in the
development of medicine in Islam.7 The first is
the compilation and translation of the medical
works of previous eras which occurred in the
seventh and eighth centuries. The second stage
was that of significant and genuine contribution
by Islamic physicians to the current medical and
scientific knowledge base. The third stage,
occurring after the thirteenth century, was that of
intellectual stagnation and decline within the
Islamic world.7
This article will briefly review the above
described second stage, discussing the unique

contributions of Islam to medicine during the
Dark Ages and their relevance to modern- day
medicine.
Hospitals
One significant contribution of Islam to medicine
was the introduction of hospitals as we are
familiar with them today.7-11 Although hospitals
had existed prior to the seventh century, it was
the Islamic era that transformed hospitals into
secular institutions for the first time in history.9
All ill individuals were treated irrespective of
financial status, gender, age, and faith.9,12 Since
Muslims required clean water to prepare for their
daily prayers, all hospitals were also supplied
with ample clean water12 and for the sake of
modesty between genders separate wards were
created for male and female patients in which the
nurses and patients were of the same gender.8,13
The nature of this hospital care is a clear
example of making the patient’s needs and
preferences a priority – a concept towards which
medicine is returning today.
The contributions of Islamic medicine to the
development of hospitals also included allowing
only qualified physicians to practice medicine7,14,
originating an extensive teaching system within
hospitals in which medical students became
active learners7,9,14-15, the advent of patient
records for the first time in history7,8, and the use
of hospitals to care for lepers, the mentally ill,
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and other groups that were ostracized for
centuries to come in other areas of the world.8,9,16
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Ophthalmology
These centuries were also a time of tremendous
growth in the field of ophthalmology. Not only
did most medical manuals published during this
time in the Islamic world include a chapter
devoted to the eye, but a variety of compendiums
were also written solely for diseases and
conditions of the eye.17 Hunain ibn Ishaq’s
influential “Ten Treatises of the Eye” was a
work that demonstrated significant advancement
from the previous knowledge of the GrecoRomans,17-18 while al-Haytham’s “Optical
Thesaurus” inspired the theories of future
notables including Roger Bacon, Leonardo da
Vinci, and Johannes Kepler.8,19
Furthermore, it was Al-Razi (Rhazes) who
discovered the light-reaction of the pupil, Ibn
Sina (Avicenna) who first described the six
intrinsic muscles of the eye, and Ammar bin Ali
who was the first to describe cataract extraction
using suction.8 This again reinforces the idea that
the Islamic era was not merely one of translation
but rather one of medical breakthroughs.
Anesthesia
Ali ibn Isa was the first in history to propose the
use of anesthesia.20 The soporific sponge, which
was a sponge soaked with aromatics and
narcotics and then held to the patient’s nostrils,
was also invented by Islamic physicians.4,7-8,21
This implementation of anesthesia was one of
the causes of the “rise of Arab surgery to the
level of an honorable specialty” while it
remained a less cultivated profession in Europe
until the formula for the soporific sponge was
received from Muslim sources in the thirteenth
century.22 In 1886, Burton reiterated the
precedence of Islamic physicians in the field of
anesthesia by stating that “anesthetics have been
used in surgery throughout the East for centuries
before ether and chloroform became the fashion
in the civilized West”23 thereby reminding that
communication of medical research and
discovery is integral to global health and wellbeing.
In addition, it was Avicenna who introduced
the concept of oral anesthetics.7-8 He described
numerous recipes for anesthetics and analgesics

in his Canon of Medicine and was the first to
propose the pharmacological effects of opium as
well as various other drugs.7-8,24 Avicenna was
also the first to describe the effect of pain on
one’s ability to ventilate.24-25
Pharmacology
The field of pharmacology saw tremendous
growth during the Dark Ages within the Islamic
world. Indeed it was during this era that
pharmacology was first established as a separate
discipline from alchemy and medicine. For the
first time, licensing for pharmacists was
introduced.8 These changes were also
accompanied by refinement of the methods of
drug production as drug preparation and
extraction became a high art.8,26 Furthermore,
pharmacies were introduced adjacent to
numerous hospitals for the first time in history7 –
this is yet another example of the precociously
progressive approach of early Islamic medicine
towards multi-disciplinary care.
Islamic physicians of the time also
introduced a variety of new drugs, including
camphor, musk, and senna.8,26 The use of alcohol
as a pharmaceutical, anesthetic, and anti-septic
also originated during this era.22
The various medical texts published during
this time consistently included chapters devoted
solely to pharmacology26 and it was Ibn alBaytar whose compendium described more than
five hundred drugs discovered by Islamic
scientists in addition to over one thousand
classical drugs derived from previous
knowledge.27
Neurology and Psychiatry
Several significant developments occurred in the
field of neurology and psychiatry in the Islamic
world as well. Contrary to the common practices
in Europe, Islamic medicine attributed
psychological problems to neurological deficits
and not to demonic possession or supernatural
forces.15 The importance of sharing knowledge
globally is evident as this could have prevented
much of the social stigmatization that
accompanied psychiatric disorders throughout
the world in subsequent centuries.
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Some modern-day history-taking techniques
were also evident during this time. For example,
in his 11th century practice, Ibn Ridwan would
ask questions to determine a patient’s state of
mind and note both their responses and
behaviour. He also noted whether the affliction
was of recent or long-term origin and treated
accordingly. Ibn Ridwan’s exam tested the acuity
of vision and hearing and articulation of speech.
Furthermore, he evaluated muscle strength by
asking patients to lift weights and grasp objects.
He also recommended that physicians observe a
patient’s gait both forwards and backwards
during their clinical assessments.29 Physicians
such as Ibn Ridwan exemplify the truly advanced
state of medical sciences in the Islamic world
over one millennium ago.
Physicians in the Islamic world at this time
were also responsible for discovering
hydrocephalus and various brain tumours, as
well as differentiating between delirium,
meningitis, and meningismus.22 They were also
the first to describe post-traumatic epilepsy and
the notion of epilepsy as a manifestation of brain
disease.22
Numerous other developments in neurology
were made, including Rhazes’ description of the
pupillary light reaction and his original
description of the laryngeal branch of the
recurrent laryngeal nerve.4 Avicenna elucidated
the differences between vertigo and epilepsy30
and also gave the first account of a trigeminal
neuralgia.31 This era also brought the first
description of a brain abscess following otitis32
as well as the association between headaches and
temporal arteritis.33

and Ibn al-Quff who presented novel works on
embryology.35
Conclusion
The era between the seventh and thirteenth
centuries was one of tremendous development
and growth in the Islamic world, playing host to
many physicians who made profound
contributions to the world of medicine. Their
compendiums and texts were commonly used
throughout Europe during the subsequent
centuries, illustrating that throughout time, the
torch of knowledge was passed from one
civilization to the next. It is important for
physicians, students, researchers and historians
today to realize that this torch continued to burn
brightly even during the Dark Ages.
It is also important that we apply the lessons
learnt from early Islamic physicians, such as the
value of interdisciplinary and patient-centered
care, as well as recognize that global sharing of
information in medical care today is essential to
ensure the success of medical care tomorrow.
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History of Medicine
Medicine’s Role in Decoding Ancient Egypt
Raza Naqvi, Meds 2009
Recent medical investigations have worked to decode some of the great mysteries surrounding the life of various
Ancient Egyptians. The research has sparked debate over this mysterious civilization; debates that range from the
genetic makeup of the Pharaohs to whether or not they were murdered. The scientific and historical knowledge gained
from such research has opened the doors for medicine to unravel some of the great mysteries of Ancient Egypt and
other past civilizations. Tutankhamun, better known as King Tut, became Pharaoh at the tender age of nine and died
after ten years of reign when he was only nineteen. It had long been suspected that he had been murdered, as
evidenced by X-ray images from the late 1960s indicating a blow to the lower base of his skull. However, a series of
CT scans in 2005 have shown no evidence of this suspected blow but do implicate a large fracture in the Pharaoh’s left
femur as the cause of death. Thus the most recent theory is that this Ancient Egyptian ruler was not murdered for his
throne, but rather likely died due to an infection secondary to his broken leg.

Ancient Egypt – Mummification and Beyond
For over three millennia, ancient Egyptian
civilizations have awed society with their
unparalleled development and innovation. From
the complex hieroglyphics found etched
intricately into stone walls, the fine art of
mummification, and the mysteries that remain
regarding pyramid development and architecture,
this era was replete with scientific and historical
masterpieces.
With the infamous discovery of Tutankhamun’s
tomb in 1922 by English archaeologist Howard
Carter, the first tomb to be discovered
completely intact, came rejuvenated excitement
in academic circles as to the potential that these
relics had in deciphering many mysteries from
the Egyptian era.1 The discovery provided new
insight into the process of mummification, the
lives of the pharaohs of the 18th Dynasty, artistic
practices of the time, and many other areas of
history. It turns out that medicine has played an
enormous role in deciphering this complex story.
Tutankhamun – King Tut
The ancient boy king Tutankhamun has
captivated the interest of the entire world since
the discovery of his intact tomb by Howard
Carter in 1922.2 Ascending the thrown as a mere
nine year old boy in 1334 BC, Tutankhamun is
possibly a son of the heretical Akhenaten and has
been given credit for the reversion of Egypt back

to its ancient polytheistic beliefs and traditions.
His reign lasted just over nine years as
Tutankhamun died as a young nineteen year old
in1325 BC.3 His premature death as a nineteen
year-old has led many Egyptologists to speculate
as to the cause and numerous theories involve a
murder in their explanation.
Tutankhamun rests in piece(s)
Carter and his staff, which included Derry and
Saleh, two forensic specialists, began their
investigations of Tutankhamun’s body in
November of 1925.4 The mummy had been stuck
to the inside of the coffin by the unguent that had
been used to preserve Tutankhamun’s body. His
body adhered to the base of the coffin and his
skull remained fitted inside a golden helmet.4
Carter’s team removed Tutankhamun from his
coffin in pieces. They chose to cut the head off at
the neck, used heated knives to remove the skull
from the mask, detached the arms and legs,
separated the pelvis and trunk, and effectively
dismembered the body to facilitate their analysis.
Derry and Saleh predicted an age of death
between 18 to 22 based on Tutankhamun’s bony
epiphyses and partially erupted molars.
X-ray Vision
Tutankhamun’s body was left untouched until
1968 when a team led by anatomy professor R.G.
Harrison of the University of Liverpool began
their investigations. The first thing that was
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discovered was that rather than leaving
Tutankhamun to rest in peace, Carter and his
team had left him resting in pieces, a fact that
was omitted from Carter’s report and
documentation. Harrison’s goal was to image the
body of Tutankhamun but they found it to be in
poor and fragile condition. The team did manage
to perform X-rays on the skull of Tutankhamun.
Their analysis showed two thick deposits of
opaque material, later determined to be solidified
embalming fluid, in the skull as well as a
fragment of bone near the occiput. Several
historians and Egyptologists have since
suggested that the bone chip is concrete evidence
in favour of the theory that Tutankhamun was
murdered by a deadly physical injury to his
head.5
The 1968 X-ray series also demonstrated that
the sternum and some of Tutankhamun’s frontal
ribs were missing6 which then led to various
medical and historical theories. Egyptologist
Dennis Forbes theorized that perhaps
Tutankhamun died in a chariot accident that
crushed his sternal area7 and the sternum and ribs
were subsequently removed by embalmers in
order to facilitate the embalming. Others claim
that Tutankhamun may have been pigeonchested, a birth defect, and note that his spine
shows pronounced scoliosis to support this
theory.8
Astounding Discoveries
The latest medical investigation of Tutankhamun
was followed closely by many historians and
gave rise to a strong sense of anticipation. World
renowned Egyptologist Zahi Hawass performed
a full-body CT scan of Tutankhamun on January
5, 2005. With a team of radiologists, anatomists,
and forensic specialists from the Faculty of
Medicine at Cairo University, Hawass and his
team spent the next two months analyzing the
1,700 images that were taken on that historical
night. Upon reaching their conclusions, the team
confirmed their results with a variety of foreign
consultants including paleopathologists and
radiologists from several European countries. In
March of 2005, the stunning results were

published to an anxiously awaiting community
of historians and Egyptologists.
Through a more detailed examination of
Tutankhamun’s epiphyses and partially erupted
third molars, Hawass and his team fixed the
king’s age of death at nineteen years. They
confirmed his height of 170cm and noted that
Tutankhamun showed no signs of malnutrition or
chronic disease. The team confirmed the
elongated nature Tutankhamun’s skull, as had
been noted previously6, but added that there was
no premature fusion of the cranial sutures, thus
confirming that the elongated skull was not a
developmental abnormality but rather a normal
anthropological variation.
The detailed analysis also indicates that
Tutankhamun did not suffer from scoliosis as
previously claimed by some historians.2 The
vertebra did not display any rotation or
deformation and thus the medical team
concluded that the curvature of the spine was
likely a result of the manner in which the
embalmers placed the body, and not scoliosis.
Another extraordinary finding involves the
suspicious missing ribs and sternum. The CT
scans reveal that the ends of the ribs have been
cut with a sharp instrument. Hawass and his
team believe that the removal may have been by
the embalmers, however evidence fails to show
any signs of serious chest trauma as has been
suggested by some historians7 as the vertebrae
remain undamaged. One cannot rule out a minor
chest injury, although there is an alternate theory
that is favoured by many. It seems difficult to
conceive that Derry and Saleh, the two forensic
pathologists who made detailed notes on their
observations in the 1925 uncovering of
Tutankhamun’s body, would fail to mention the
obvious missing ribs and sternum – and fail to
mention it they did. It would also make sense
that the ribs, if removed by embalmers, would
have been wrapped and kept within the
sarcophagus of Tutankhamun, as was the
Egyptian custom2. This indicates that the frontal
ribs and sternum may have been removed by
Carter’s team and simply never replaced. These
missing items would be in addition to the right
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thumb and other body parts which were reported
missing by Harrison’s team in 1968 but are
evident in images taken by Carter’s team in the
1925 investigations.6
The most striking conclusion that has
resulted from the CT scans involves the cause of
death of Tutankhamun. It turns out that the team
of investigators has been able to conclude that
Tutankhamum did not die from a blow to the
head, as previously theorized. The loose pieces
of cranium could not have come from an injury
prior to death as they remain outside of the
solidified embalming fluid. The team is
unanimous in their agreement that the cranial
injuries constitute postmortem damage however
there is some debate as to whether the injuries
were due to the embalmers over three millennia
ago or Carter’s team in the early twentieth
century.2
A fracture of the lower left femur, at
approximately the level of the epiphyseal plate,
was also found in the full-body CT results.
Although there are many fractures in the body
caused by the (mis)handling of Carter’s team,
this one is unique in several respects. Firstly, one
of Carter’s forensic specialists, Derry, actually
recorded this fracture in his notes as an
observation, something which is not seen for the
various additional fractures caused by the
handling at the time.9 As well, the break has
ragged, rather than sharp, edges and also has two
thin layers of embalming fluid that have entered
the injury site2. Furthermore, Derry had also
reported a loose left kneecap which may be used
as additional evidence for an injury to the left
lower limb.9
The theory that Hawass has proposed based
on these findings is that Tutankhamun died not
of a malicious attack to dethrone him but rather
due to a severe fracture in his left femur. A
fracture of this size could have easily led to
infection and even caused gangrene, thus
resulting in an infectious death secondary to the
injury.2 Critics argue that although the blow to
the head may not have been the cause of death,
this still does not rule out the possibility of
Tutankhamun’s murder by poisoning or other,
less conspicuous, methods of murder.10

Medicine in the future of Ancient Egypt
We can thus see how medicine has played a
variety of roles in the uncovering and decoding
of some of history’s great mysteries. Traditional
medical analyses may be used to analyze the life
and death of historical figures from a variety of
eras and medical technology may be used to
objectively analyze the physical remains of these
historical figures. Ancient Egypt lends itself
perfectly to this type of analysis due to the
unparalleled preservation of bodies attained due
to the process of mummification. The benefits
that the history of Ancient Egypt has already
seen due to medicine’s contribution will soon
carry over into various other ancient civilizations
as the investigative power of medicine continues
to expand. Advances in DNA analysis and
recovery, fields that are still in their infancy, as
well as the potential of future imaging techniques
as computers continue to improve, expand, and
surpass all previous expectations, will all
continue to demonstrate the unlimited potential
of the medicine to solve many of history’s great
mysteries.
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Medicine and the Law
The History of Health Information Privacy Legislation in Ontario
Andrea Anna Guerin, Meds 2008
Christian David Fortin, Meds 2009
Patient privacy is one of the fundamental tenants of the practice of medicine. Mutual trust and confidentiality form the
basis of the physician-patient relationship and have been recognized as sacred from the beginning of the medical
profession. In Canada, healthcare falls under the jurisdiction of the provinces, which are able to assess and
accommodate their own unique healthcare needs. Today, privacy of personal information is a top priority of
governments, as personal information gains more significance in the applications it can have. Health records are no
exception to this; information such as family history of congenital disorders, psychiatric conditions and financial
information are being included in patient records and the drive to protect this from being shared with undesirable
parties is escalating. This drive however must be balanced by the needs of healthcare professionals who require the
information to properly treat patients. After many recommendations and failed attempts to provide a comprehensive
legislation, on November 1, 2004, Ontario passed the Personal Health Information Privacy Act [PHIPA]. The
effectiveness of PHIPA will not be readily apparent for some time given its recent enactment, however the struggle to
provide the adequate balance between the protection of personal information and allowing healthcare professionals
ease of access to facilitate patient care will ultimately determine the effectiveness of this new Act.

Introduction
Patient privacy is one of the fundamental tenants
of the practice of medicine. Mutual trust and
confidentiality form the basis of the physicianpatient relationship and have been recognized as
sacred from the beginning of the medical
profession.1 The Hippocratic Oath addresses the
importance of protecting the health information
of patients: “What I may see or hear in the
course of the treatment or even outside of the
treatment in regard to the life of men, which on
no account one must spread abroad, I will keep
to myself, holding such things shameful to be
spoken about.”2
In Canada, healthcare falls under the
jurisdiction of the provinces, which are able to
assess and accommodate their own unique
healthcare needs. Today, privacy of personal
information is a top priority of governments, as
personal information gains more significance in
the applications it can have.3 Health records are
no exception to this; information such as family
history of congenital disorders, psychiatric
conditions and financial information are being
included in patient records and the drive to
protect this from being shared with undesirable
parties is escalating. This drive however must be
balanced by the needs of healthcare professionals

who require the information to properly treat
patients.
Who owns medical records?
The ability of physicians to share medical
records hinges upon the ownership of the
records. This question was addressed in the
1992 landmark Supreme Court decision of
McInerey v. MacDonald.4 The principle behind
this case is that the information contained within
the health record belongs to the patient, but the
record itself is property of the medical
institution.4 As such, legislation must then
provide a framework establishing the rights of
both the patient and healthcare professionals in
regards to the use, collection and distribution of
healthcare information.
The Development of Health Information
Privacy in Ontario
In 1977, the Royal Commission of Inquiry, lead
by Mr. Justice Krever was established to
investigate and make recommendations on the
privacy of health information.5 This commission
was created in response to allegations of police
access to patient records in OHIP and healthcare
facilities without obtaining prior consent.5 At
this time, no overarching legislation for the
protection of privacy and health information had
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been established and each healthcare facility was
subject to their own practices. After reviewing
the seventy-seven statutes and numerous
regulations that were in place, it concluded that
many aspects of health information were not
clearly covered under any legislation.6 The
Krever Report identified for the first time the
discrepancies in the practices of healthcare
institutions, healthcare professionals and the
ambiguity in the legislation governing privacy
and health information. It also recognized that
the implementation of legislation to provide a
universal provincial framework for privacy and
health information should not be so cumbersome
to impede the effective and timely delivery of
healthcare.
With these suggestions, the Ontario
government attempted to update and clarify the
existing legislation to provide clearer guidelines
for healthcare institutions and healthcare
professionals and reflected the growing role of
patient autonomy and privacy. However, no one
piece of legislation provided a comprehensive
approach. The Krever Report, recognized that
the many pieces of legislation were not sufficient
to encompass all the aspects of privacy and
health information, since each Act dealt with
separate issues, targeted to specific populations
and sectors of society.6 Many gaps in how
patient health information was handled
remained.
Two Failed Attempts
The Ontario Ministry of Health attempted to
create guidelines in June 1996 with the paper, A
Legal Framework for Health Information.7 If
this initiative was successful, Ontario would be
the only province to implement comprehensive
rules for personal health information. In
November of 1997, the Ministry of Health
created the Personal Health Information Protect
Act, 1997.8 The ambitious draft provided clear
guidelines on the collection, use and disclosure
of health information, the rights of patients to
access their information, the procedure for the
correction of health records. The scope of this
draft was large and encompassed territory that
had not been covered in previous legislation.

Therefore, much debate was generated and in the
end, the legislation was not made law.5
In the wake of the failed attempt of the
Personal Health Information Protection Act,
1997, Bill 159, An Act respecting personal
health information and related matters9 was
introduced to the legislature on December 7,
2000. The bill was not well received and found
to be lacking the adequate balance sought by
healthcare professionals and patients.
Federal Legislation and the Romanow Report
The provincial governments have the authority to
regulate the delivery of healthcare but must do so
in accordance with the Canadian Charter of
Rights and Freedoms.10 The Charter does not
explicitly protect privacy, but the Supreme Court
of Canada has established that privacy is a
constitutionally protected right.11
In 2001, The Committee of the Canada Privy
Council appointed the Honourable Roy
Romanow, Q.C, as Commissioner to review and
enquire to the future of Canada’s healthcare
system.12 The results of the review, released in
2002 and popularly referred to as the Romanow
Report, made many recommendations in regards
to health information privacy that were similar to
the Krever Report. Issues raised were the rights
of patients’ access to medical records, concern
over the misuse of information found in these
records, the critical needs for patients to have
access to their own information, and the need for
health information to provide adequate
treatment. Unlike the Krever Report, which
made recommendations for the province, the
Romanow Report called for clear and consistent
privacy rules across Canada.
In April 2000, the federal government passed
the Personal Information Protection and
Electronic Documents Act (PIPEDA),13 which
was limited to entities under federal jurisdiction,
such as banks. However, if by January 2004, a
province did not have its own privacy act that
was substantially similar, PIPEDA would apply
to all organizations within the province that
collect, use or disclose personal information,
including personal health information. PIPEDA
was intended for commercial activities, and its
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application to the health sector neither reflected
the needs of the healthcare system nor provided a
detailed framework for heath professionals to
use.5 This would be the catalyst for the
provincial government to draft comprehensive
privacy legislation for health information that
would better suit both the patients’ and
healthcare professionals’ requirements in
Ontario.
In December 2002, the Ministry of
Consumer and Business Services and Ministry of
Health and Long-Term Care, released a draft
called Privacy of Personal Information Act, 2002
(POPIA).14 The purpose of this legislation was to
meet the criteria of being substantially close to
PEPIDA and relieve the pressure of Ontario
health organizations from having to comply with
the federal legislation. Unfortunately, POPIA
was far from ideal; it contained two separate sets
of rules, one pertaining to personal health
information, and the other that regulated personal
information in the private sector.5 Although the
pressure to introduce POPIA was strong, with
the 2004 deadline of the PIPEDA approaching,
the bill failed.
Privacy Legislation Introduced at Last!
On November 1, 2004, Ontario passed the
Personal Health Information Privacy Act
(PHIPA).15 This legislation would provide an all
encompassing framework for the protection of
personal health information.
PHIPA creates a set of rights and obligations
relating to the collection, use, and disclosure of
personal health information within Ontario.16
One of the overarching goals of PHIPA is to
strike an appropriate balance between (a)
protecting privacy rights and (b) facilitating the
effective delivery of healthcare services. Other
objectives include providing individuals with the
right to: access health records and correct
erroneous information, request and independent
review and resolution of complaints relating to
the handling of health information, and obtain
remedies for contraventions of the Act.
PHIPA applies primarily to ‘health
information custodians’ (HICs), which include
professionals and organizations usually involved

with the provision of healthcare services. One of
the most salient features of PHIPA is its
treatment of an individual’s consent to the use of
disclosure of health information. A patient’s
consent can either be express or implied.
Typically, consent will be implied when a health
care provider discloses health information to
another party within the patient’s ‘circle of care’.
Express consent is necessary however when the
provider discloses information to a party not
classified as an HIC including, for example, a
personal trainer.17 It is important to note that a
request to hold health information confidential
nullifies any implied consent which was
presumed in the past.
Conclusion
The development of legislation to protect health
information privacy in Ontario has been a long
process, influenced by the federal and provincial
governments and many healthcare and patient
advocates. The effectiveness of PHIPA will not
be readily apparent for some time given its
recent enactment; however the struggle to
provide the adequate balance between the
protection of personal information and allowing
healthcare professionals ease of access to
facilitate patient care will ultimately determine
the effectiveness of this new Act.
(The website of the Information and Privacy
Commissioner includes basic information,
developments, and orders relating to the
interpretation of the Act and serves as an
invaluable resource to practitioners and
administrators concerned with health privacy.
For more information visit www.ipc.on.ca)
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Ethics
The Medical Oath: Honorable Tradition or Ancient Ritual?
Justin Morgenstern

When asked to contribute a commentary on
ethics in the history of medicine, it demonstrates
a distinct lack of imagination to write about the
Hippocratic Oath. While it may not be
imaginative, the Oath’s enduring role in modern
medicine makes it a topic of fundamental
importance. The Hippocratic Oath, or some
derivative thereof, plays a central role in the
graduation ceremony of nearly every medical
school in North America.1 However, whether
this is symbolic of one’s entrance into the
medical profession, a tribute to the great tradition
of medicine, or a solemn ethical commitment is
rarely indicated. What exactly is an oath and
what are its implications for the practice of
medicine? What impact should it have? Why the
Hippocratic Oath in particular? Why any oath at
all?
These questions have concerned me since I
first read the Oath, upon matriculation at medical
school. Since, I have repeatedly reviewed the
Oath, both in its original form and the “updated”
form we used on the first day of class. I searched
for meaning in the document I had always
believed to epitomize the grandeur of medicine,
but instead became incredulous that the archaic
text was still read at all.
Perhaps it is understandable that the original
oath, written in an era far removed from our own,
would conflict with our understanding of ethics
today. The Oath strictly prohibits abortion and
euthanasia, takes a vague stance against all
surgery, and indicates that medicine is strictly
the domain of men.2,3 These positions so
blatantly conflict with modern thought that the
common, and convenient, solution is to simply
omit the difficult passages. (The document I first
read made no reference to these ideals.) Of
course, ignoring the original tenets of the Oath
does a great injustice to the field of medical
ethics. If we truly believe that the positions

articulated in the oath are in error, we must
acknowledge and justify an alternate position. It
is only through such acknowledgement that we
can fully understand our ethical obligations.
While revising outdated positions may be
seen by some as trivial, there is a more
compelling reason why the Hippocratic Oath
should no longer be sworn. There is a single
theme that underlies the Oath – the so called
“Hippocratic Principle.”4 By stating that all
treatment will be applied “… for the good of my
patients according to my ability and my
judgement…,”3 the Oath is both paternalistic and
individualistic. The Oath’s focus on the
individual patient is at odds with the modern
practice of medicine, where scarcity and
rationing are common. We now understand the
physician to fulfill multiple roles – with
responsibilities to society as well as to individual
patients. A Hippocratic understanding of
medicine cannot recognize these divergent
objectives, and is therefore a poor ethical guide
for modern medicine. Furthermore, the emphasis
that the Oath places on the physician’s “abilities
and judgement” is incompatible with the modern
understanding of the doctor-patient relationship.
The Hippocratic ethic assumes that a vulnerable
patient will place himself at the physician’s
mercy and defer to the physician’s ‘better
judgement.’4 The doctor-patient relationship as
described in the Hippocratic Oath is the
antithesis of modern medical thought, which
embraces the concept of patient autonomy.
Therefore, the time has come to abandon the
practise of swearing the oath.
However, if we abandon the Hippocratic
Oath what, if anything, should fill the void?
There are three related properties of oaths that
must be considered to answer this question.
Oaths, like promises, are properly described as
‘performative utterances’. That is, once sworn,
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an oath does not simply describe the world – it
changes the world.5 The motives, goals, and
actions of the professor are fundamentally
altered by the words of the oath. Consequently,
an oath is also a serious moral commitment. “To
make or go back on a promise [or oath] is a very
solemn matter precisely because a promise [or
oath] is world altering.”6 Finally, an oath is a
lifelong commitment. Unlike a promise, an oath
contains no qualifications as to time or place, and
so the professor is declaring a principle that he
will always uphold.7
The significance and permanence of an oath
might suggest that it has no place in medicine,
where it is a simple fact that ethical thought can
and has changed. While these changes are
relatively easy to accommodate within
professional codes of ethics – and even medical
practice – it is far more difficult for physicians to
learn that the solemn oath they have sworn, and
that has changed their lives, is no longer relevant.
Furthermore, the assumption that ethics
could be reduced to a set of rules is particularly
troubling. The swearing of an oath – particularly
an oath formulated like the Hippocratic Oath implies that in simply doing this and not doing
that, one is acting ethically. It is a thoroughly
robotic and thoughtless process. Ethics requires
more than this. In order to truly act ethically, one
must understand the grounds for one’s actions.
One must intend to act morally.6 Pragmatically,
doctors must understand and be able to apply
ethical principles, not just rules, because every
circumstance is unique and no single set of rules
could cover every scenario. Furthermore, with
new technologies and redefined professional
relationships, an oath cannot remain truly
inclusive. Thus, as a set of ethical rules, the
permanence of an oath makes it ineffectual and
undesirable.
Yet, perhaps these arguments against oath
taking can be resolved by examining the
distinction between an oath and a code of ethics.
It has been observed that “the Oath of
Hippocrates, while primarily an oath, also
contains elements of a code. While primarily a
commitment to become a certain kind of person,
working for the benefit of one’s patients, it also

contains a specific list of do’s and don’ts. [sic]”7
Such rules are properly established in a code of
ethics. Unlike oaths, there is little difficulty in
arguing, changing, or augmenting ethical codes.
Thus, the distinction between oath and code, if
observed, can resolve the perceived difficulties
with oath taking.
However, if an oath does not outline a
specific set of moral rules, does it perform any
function within the medical profession? Some
might suggest that the Hippocratic Oath, as a
medical oath, is a relic of an earlier time and
should be abandoned.3,4,8 I believe there in
another, more appropriate option. Although
medical ethics has been increasingly viewed as a
simple subsection of universal ethics, such an
approach is likely over simplistic. While medical
professionals certainly must adhere to all the
directives of general ethics, the obligations of a
physician may not be fully described by such
ethics. For example, it would be very difficult, if
not impossible, to describe the basis of medical
beneficence in the language of universal ethics.
Beneficence, as an ethical obligation, simply
does not seem to apply to other professions or to
society in general. While the ethical codes of
lawyers, engineers, and even politicians employ
the principles of justice and non-maleficence,
they certainly do not demand the altruistic
dedication obliged
by beneficence.
If
beneficence is not a consequence of normal
ethical responsibilities, how does it become an
obligation in medical ethics?
The answer, as I see it, is that the medical
oath has played a very important role all along.
As a performative utterance, an oath has the
power to alter the world, both for its professor
and for the public who bear witness. Just as one
who makes a promise creates a new ethical
obligation for himself that is not generally
applicable (to keep that promise), the medical
community has established the ethical principle
of beneficence through the solemn promise of its
oath. Importantly, the specifics that caused such
difficulty for the Hippocratic Oath – those
statements that are more correctly delineated in a
code – are not necessary to establish this general
ideal. If the specifics are omitted, an oath can
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easily accommodate new technologies and
ethical theories. General principles, such as
beneficence, can be applied in various ways
without altering the underlying ideal. Therefore,
a properly formulated medical oath could be both
essential and enduring.
The time has come for the medical profession
to do away with the tradition of swearing the
Hippocratic Oath at graduation ceremonies – and
to learn from its many short-comings. However,
a medical oath is very important in establishing
the altruistic ethic that is so central to medicine.
The distinction between an oath and a code of
ethics is important and must be recognised in
order to preserve the validity of any medical oath.
Professional codes of ethics are required to
outline the individual rules that govern the
practise of medicine, but these rules are too
specific to preserve the permanence and
incorruptibility necessary of an oath. Thus,
although I presently offer no substitute for the
Hippocratic Oath, I suggest that one be
developed that focuses exclusively on the
essential principles of medicine, including the
physician’s altruistic dedication to his patients.

8.
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Health Promotion
The Mediterranean Diet
Jennifer Clara Tang
Luke Harris
“Let thy food be thy medicine, and thy medicine be thy food”
-Hippocrates (460-377 B.C.) 1

Since the ancient times, nutrition has always
played an integral part in the pursuit of human
health. Early physicians and philosophers like
Hippocrates, Plato, and Galen recognized the
importance of diet in health and wrote
extensively on the subject. Ironically, while our
ancient predecessors fell prey to famine and the
plague2, North Americans are dying from
obesity-related diseases.
For most North
Americans, the 21st century has been an age of
decadence, where, to paraphrase Christopher
Marlowe, “quod me nutrit me destruit” 3, what
nourishes us is destroying us.
In the last 50 years, the public has been
bombarded with promises of good health from
myriad popular diets. Unlike many of the other
fad diets, the Mediterranean diet is rooted in
ancient tradition. “Mediterranean diet” is a
general term used to describe the dietary style of
ancient Crete and the majority of Greece.4 This
diet (fig 1) is characterized by copious
consumption of fruits, vegetables, whole-grains,
olive oil, cheese and yogurt. Consumption of
fish, poultry, red wine and eggs is moderate,
while consumption of meat is occasional.4 The
possible health benefits of the Mediterranean diet
came to public attention with the “Seven
Countries” study led by Ancel Keys. Keys et al.
demonstrated a correlation between dietary
patterns in 1960s Crete and low rates of coronary
heart disease.4 This article seeks to examine the
origins of the Mediterranean diet and discuss the
efficacy of the diet with respect to health
protectiveness.
Though the Mediterranean diet focuses on
the habits of ancient Greeks and Cretans, it
should be noted that the Mediterranean region is

comprised of more than 15 countries, including
Greece, Italy, Cyprus and Turkey. War and
political acquisitions helped to blend dietary
culture. For example, in 8th century B.C.,
southern Italy was colonized by Greeks and is
known as “Magna Graecia”. 5 Diet played a key
role in classical Greek society (500-323 B.C.) as
evidenced by numerous references to food and
nutrition in Plato’s Republic (360 B.C.). So
famed were the Greeks for their plant-based diet,
the satirical poet Antiphanes (407-343 B.C.)
dubbed them the “leaf chewers”. Olive oil was
commonly used for lighting, cooking and as a
therapeutic balm.6 Cereals played a central role
in Greek diet, so much so that the Greek goddess
of the Earth, Demeter played a central role in
classical culture.
Wheat was commonly
fashioned into cakes and eaten with olive oil.
Legumes were often boiled into soups and their
laxative properties were championed by
Pythagorus.7 Figs, pears, apples pomegranates,
sorb-apples, bulbs, onions, greens, acorns and
myrtle berries were also popularly consumed.6
Meat was rarely consumed, as it was expensive
and also considered unfit to eat in certain
regions.7 In classical Athens, fish (mackerel,
tuna, mullet, anchovy, octopus, sole, eels,
mussels and oysters) was more popular than
meat.6 When it was consumed, meat was boiled
with spices and salt or roasted. Milk was rarely
consumed, but cheese was a staple of classical
Greek diet. Red wine was very popular and was
often diluted for consumption. Honey was used
as a primary sweetener.
Moderation and balance were key parts of the
Mediterranean diet as evidenced by Hippocrates’
comment on diets: “a regimen carried to the
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extreme of restriction is perilous; and in fact
repletion too, carried to extremes is perilous” .6
Hippocrates also recognized the dangers of
obesity: “those who are constitutionally very fat
are more apt to die quickly than those who are
thin” .8 Perhaps there is something to be learned
from these two gems of ancient wisdom in our
time.
It is important to note that although the
Mediterranean diet has ancient beginnings, it can
serve as a healthy dietary template for present
day people – and adherence to the diet is easy.
The diet’s staple foods, namely olive oil, fish,
fruits, legumes, and vegetables, are widely
available at grocery stores. These foods, while
offering protection against cardiovascular
disease and cancer 8, are also inexpensive. The
majority of health benefits of the Mediterranean
diet stem from its rich content of healthy fatty
acids and antioxidants.8 Recently, the diet has
emerged as a solution to the triad of
cardiovascular disease, diabetes, and cancer;
these diseases account for the majority of
morbidity and mortality in the Western world.
In fact, a close inspection of the Harvard School
of Public Health’s “Healthy Eating Pyramid”
reveals that the majority of the pyramid’s food
choices consist of Mediterranean staples.9 The
food pyramids of the Mayo Clinic and the
University of Michigan are also inspired by the
Mediterranean diet.
Virgin olive oil, a staple of the
Mediterranean diet, is comprised mostly of
monounsaturated fatty acids (MUFAs). These
fats have been shown to lower blood pressure 10,
protect arterial endothelium, and decrease postprandial plasma glucose levels. The latter effect
is likely related to the substitution of simple and
complex carbohydrate consumption with MUFA
consumption.8 Fish, another vital component of
the Mediterranean diet, is rich in n-3
polyunsaturated fatty acids (n-3 PUFAs). This
group of fatty acids exerts anti-inflammatory and
anti-thrombotic effects. Eicosapentanoic acid
(EPA), a type of n-3 PUFA, is known to inhibit
the synthesis of thromboxane A2, a platelet
aggregator and vasoconstrictor.8 EPA also
enhances the vasodilator effect of nitrous oxide,

and reduces leukocyte adhesion to the
endothelium.11 Fish consumption is associated
with a decreased incidence of cardiovascular
diseases12, and weekly fish intake has been
shown to reduce the risk of sudden cardiac death
by half.13
Olive oil, while contributing beneficial fatty
acids, is also a potent source of phenols. These
compounds have strong anti-oxidant effects, and
are known to be protective against
cardiovascular disease, colon cancer, and
prostate cancer. Virgin olive oil, which has an
even greater concentration of phenols than
regular olive oil, is a source of 30 phenolic
compounds.8 Vegetables are another important
source of phenols. Vegetables that are especially
high in these antioxidants include artichokes,
cabbage, broccoli, garlic, and red chicory
lettuce.14 Wine is also especially high in these
antioxidants, and is another key part of the
Mediterranean diet.
As our knowledge of cardiovascular disease
and cancer pathophysiology evolves, modern
evidence increasingly supports the ancient menu
of the Greeks and Cretans. One of the greatest
challenges in public health today is trying to help
Canadians improve their diets. This is perhaps
more easily accomplished by providing them
with a template from which to select foods. The
Mediterranean diet provides such a template, and
is pleasing to the palate. By encouraging the
North American consumer to substitute
“Mediterranean for McDonald’s”, physicians can
arm patients with a health protective diet that is
easy to adhere to and ascribes to the Hippocratic
notion “Let thy medicine be thy food”.
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Medicine and the Internet
The Robots Are Coming:
The History – and Future Prospects – of Telerobotic Surgery
Samuel Krausz, Meds 2009
Joanna Zurawska, Meds 2008
Telerobotic surgery has come a long way in its brief history. While teleconsultation continues to be used today, the
advent of high speed communications and increased computational power is making long distance remote control of
operating instruments, termed telepresence surgery, a reality. Based on laparoscopic technology, telerobotic surgery
was tested first on animals and, more recently, on humans with success. The technology offers several advantages,
including improved accuracy and the ability to bring difficult procedures to rural and remote locations where trained
surgeons are not available. While various technical difficulties and ethical issues must still be worked out, the
advantages of remote surgery ensure that this technology will continue to be developed for widespread implementation
in the years to come.

Surgery, which is arguably as much art as
science, has evolved from the early crude days of
trepanation and battlefield amputations to
modern
procedures
such
as
complex
neurosurgeries
and
minimally
invasive
laparoscopic interventions. Just as the artist can
do little without his brushes, however, the
surgeon is virtually useless without his tools, and
it is perhaps the development of these tools,
which has directly driven the evolution of
surgery. While various tools such as scalpels,
loops, stitches, anesthesia and antiseptics have
each expanded the range of possibilities for
procedures, some of the newest tools to enter the
surgical arena are computers and robotic
instrumentation.
Teleconsultation and the dawn of remote
surgery
While the advantages of computer and robotic
assistance in surgery, in terms of enhanced
accuracy and control may seem obvious, one of
the most interesting and useful applications of
this technology is to perform surgeries remotely.
Patients in rural and remote locations often do
not have access to advanced surgical care due to
a lack of qualified personnel.1 This is not only
the case in both wartime battlefields and third
world countries,2 but is, unfortunately, a problem
in many remote areas of Canada as well. Surgical
care in these locations is either impossible or

requires transportation to an urban center over
long distances.
The first attempts at remote care were really
what would be termed teleconsultation. The
1960’s saw the beginning of electronic
transmission of radiological films, while the
1970’s brought the ability for practitioners to
consult
with
experts
remotely
over
video-conference systems.3
In a surgical
implementation of teleconsultation, a remote
videoconferencing system was set up in the
operating room and was linked to an expert
physician at an urban center.2 This ‘remote’
surgeon did not actively participate in the
procedure, but rather offered advice or guidance
to the attending surgeon at critical points. At best,
electronic remote control of the video camera
was available, but little else. While definite
benefits in terms of transmitting expertise and
training inexperienced surgeons could be
realized with this setup, true remote surgical
control was impossible.
Laparoscopic surgery: a catalyst for
advancement of telerobotic surgery
This changed with the advent of a robotic system
aimed at assisting in laparoscopic procedures.
Laparoscopic surgery utilizes a miniature camera
(i.e., laparoscope) and small surgical tools which
are inserted into the body via tiny incisions and
controlled via external manipulators. Minimally
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invasive surgery performed using laparoscopy
provided several advantages to the patient: less
pain, a shorter hospital stay, better cosmetic
outcome and faster recovery.4 Unfortunately, this
surgical technique, in its original conception, had
several shortcomings. The laparoscope produced
only a 2-dimensional view of the surgical area,
and hand-eye coordination was difficult due to
the need to look at a monitor instead of one’s
hands. Furthermore, the laparoscope was held by
an assistant, and therefore direct was taken out of
the hands of the surgeon. Perhaps most
importantly however, laparoscopy, by its very
nature, introduced amplification of tremor, loss
of degrees of freedom in manipulation, and the
brought the requirement for making non-intuitive
motions when performing a procedure.4
In an attempt to overcome the inherent
limitations of laparoscopic surgery, research
supported by the United States Defense
Department’s Star Wars program was undertaken
in the early 1990s at the Stanford Research
Institute
to
develop
a
‘master-slave
telemanipulator’ – a system wherein a computer
and robotic instrumentation intervened between
the surgeon and the patient.4 Ironically, the
original goal of this technology was to enable
actual manipulation of surgical instruments by
remote surgeons,5 a concept termed telepresence
surgery. It was hoped that this technology would
be useful in performing remote trauma surgeries
on the battlefield or outer space, where surgeons
could not venture.5 Unfortunately, while a
system was developed, it lacked the required
degrees of freedom necessary for efficient
surgery, and its large size precluded widespread
use. When this research program ended in 1994,
the patents were sold to a private company,
which continued development to produce what is
now called the da Vinci robot system. This
robotic system builds on traditional laparoscopic
technology, rectifying some of its flaws while
introducing the capacity for remote manipulation.
The first refinement is that the camera platform
is stable, and can be controlled by the surgeon’s
feet or voice commands, eliminating the need for
an assistant. Second, visualization is greatly
enhanced with a 3-dimensional magnified

system to simulate natural vision, or alternately
2-dimensional displays positioned near the hand
controls.6 Moreover, since physical manipulation
of the controls is processed by a computer,
tremors can be digitally filtered out preventing
undue error. Finally, the use of motion scaling,
which reduces large movements to fine ones,
allows surgeons to perform actions which were
previously impossible due to their delicacy.6
Telerobotic surgery matures
Early telepresence surgery research was
extremely limited, and being hampered by
technical limitations, was carried out only on
animal
models.
Advanced
manipulation
techniques were not possible due to lack of
adequate
computational
power
and
communication bandwidth. An early ‘procedure’
was performed in 1993 by issuing keyboard and
mouse commands to manipulate an echographic
probe, biopsy needle and scalpel over a
transatlantic fiber optic telephone link to remove
a cyst from a pig’s liver. Unfortunately, transfer
of real-time video over the wired network was
technologically impossible at the time due to
bandwidth constraints; consequently, relatively
expensive satellite links were required.2
One of the leading difficulties in developing
clinically viable telerobotic surgery has been the
requirement of minimal time lag between the
issuing of commands, actual surgical action, and
reception of visual confirmation on the screen.
This lag is influenced by multiple factors
including time required for converting video and
movements into the appropriate signals and the
inherent delay in the communication network
itself. Experiments have determined that the
acceptable limit for safe surgery is 330
milliseconds.7 Even with the satellite video link
in early experiments, overall delays of
approximately 2 seconds2 were inherent in the
technology – obviously far from acceptable for a
real-time surgical procedure. Accordingly, it was
estimated that feasible distances for remote
surgery could not exceed several hundred
kilometers.8 This was, however, disproved in
subsequent years.
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The first successful telerobotic procedure on
a human was performed in 1995 by Dr. Alberto
Rovetta in Italy -- a prostate biopsy was obtained
from a patient 5km away via a robotic
telemanipulator.9 While this experiment was
promising, the original dream of a true longdistance fully controlled remote surgery was not
realized until several years later when suitable
high speed, high bandwidth communications and
adequate computational power were available.
On September 7th 2001, the world’s first transAtlantic complete operation, termed the
“Lindberg operation”, took place. In this case, a
patient
in
Strasbourg
underwent
a
cholecystectomy with the controlling surgeons
located in New York.7 This surgery was
completed using a second commercially

available robotic surgery system, called ZeusT,
which featured a robotic endoscope positioning
system called AESOP (Automated Endoscope
System for Optimal Positioning). With a time
delay of 155 milliseconds, the surgery was
deemed
safe,
and
no
post-operative
7
complications were noted. While telerobotic
surgery is still far from mainstream, several
surgeries have already been successfully
completed including fundoplications, sigmoid
resections, hemicolectomies, inguinar hernia
repairs, colectomies, radical prostatectomies and
nephrectomies.6,7 Other surgeries, including the
first Canadian remote coronary bypass (1999)
and mitral valve replacements were performed at
London Health Sciences Center.13

Image 1: Robotic preclinical testing and training lab. Courtesy of CSTAR.

The challenges ahead
While remote surgery seems promising, several
issues remain to be worked out. For one, current
systems lack tactile feedback, although this is

actively being developed. Without the ability to
feel resistance in tissues, the surgeon must
carefully review visual information to avoid
making an accidental tear.10 Another problem
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stems from the compliance of certain tissues; for
instance, the robotic manipulators have difficulty
in grasping slippery surfaces11. However, these
obstacles will likely be surmounted in future
versions of the technology, and a testament to
the incredible functionality already achieved by
these robots can be made by observing the
actions of the surgeons . Almost without fail,
surgeons using the telepresence system
unwittingly find themselves removing their
hands from the manipulators to retract a piece of
tissue, the advanced technology making them
forget for a moment that they are not really at the
surgical site.12
While telepresence surgery holds much
potential for fulfilling many of today’s remote
surgery requirements, it also brings with it a
variety of unique challenges. First, the cost of
equipment and communication links is high.

Training surgeons with the technology is timeconsuming, as is setting up the equipment.
Second, it is essential that an adequately trained
surgical team be present at the surgical site,
ready for emergency intervention in case the
equipment malfunctions, or the communications
line is severed. This ties down surgeons who
might otherwise be performing their own
operation elsewhere. Similarly, significant time
is required to switch surgical instruments on the
machine between operations.9 Finally, there are
many legal and ethical questions that must be
answered before remote surgery can be widely
adopted. Medical licensing over provincial and
international borders is unclear, at best. Perhaps
more importantly, however, the traditional
patient-clinician relationship will have to be
redefined, as the patient may never meet his
surgeon face to face.10

Image 2: Hybrid operating room/angiosuite. Courtesy of CSTAR.

The prospects for telesurgery are exciting.
From remote surgeries in space to mobile

hospitals in war zones or developing countries,
the possibilities are endless. While we have
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already come a long way from the early surgeries
performed with nothing more than a blade, the
continuous
evolution
of
computers,
communications systems and mechanical
surgical equipment ensures that many exciting
developments in the field of telesurgery will take
place in the years to come.
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Feature Article
A Brief History of Physician Remuneration
Tom Warren
In the general prologue of The Canterbury Tales, Geoffrey Chaucer describes physicians as having a “special love for
gold.” Since well before Chaucer’s time, the issue of physician remuneration has been discussed, with the debate
continuing today. The earliest evidence of this issue is in the Code of Hammurabi from around 1750 BC. Hippocrates,
Plato, and Galen discussed remuneration, and it was an issue in Jewish and Islamic culture too. During the last few
centuries, issues around physician remuneration have continued to be discussed. Examples from Australia, the United
States and Canada show how remuneration was handled in these nations.

In the general prologue of the Canterbury Tales,
Geoffrey Chaucer describes physicians as having
a “special love for gold”.1 Rightly or wrongly,
physicians have been accused of extorting higher
than deserved fees for the services that they
provide and in this article I will briefly review
how physicians have been remunerated
throughout the history of medicine.
Probably the oldest extant primary source of
medical fees is the code of Hammurabi. Written
about 2000 B.C., the code is a set of laws
decreed by King Hammurabi of Babylon. There
are several references to physicians, including
how they should be paid for their services. For
example, sections 215-217 of the code read:
If a physician has treated a man with a
metal knife for a severe wound, and has
cured the man, or has opened a man’s
tumour with a metal knife, and cured a
man’s eye; then he shall receive ten
shekels of silver. If the son of a
plebeian, he shall receive five shekels of
silver. If a man’s slave, the owner of the
slave shall give two shekels of silver to
the physician.2
Ancient authors such as Hippocrates,
Aristophanes, Sophocles, Plato, Aristotle and
Galen debated whether physicians should be paid
at all. There was disagreement as to whether
medicine was an art or a “techne” (skill or craft).
If medicine was a craft like carpentry then
physicians should be paid similarly, for all
craftsmen practiced their craft for money to earn
a living. However, if medicine was a liberal art

such as philosophy, mathematics or poetry, then
a man would do it for the sake of virtue and
collecting fees would “be regarded as doing
something typical of a hireling or slave”
The Hippocratic
according to Aristotle.3
writings often refer to medicine as an art, and
mention fees in some places but in others advise
to practice medicine without payment.
Aristophanes says that medicine was an art and
not a mere skill or craft, while Sophocles called
physicians “craftsmen of medicine”.4 In Plato’s
Republic, Socrates discusses the question of
whether a physician is a “money-maker or
someone who treats the sick”.5 Galen believed
that physicians practiced medicine either because
they love humanity, or because they love honour,
or because they love glory, or because they love
money.6 According to Galen, it was preferable
to practice medicine because of the love of
humanity but those that practice because of other
reasons were not inferior physicians but inferior
philosophers. Galen says he never requested
payment but would accept it if offered, which he
believed was an important difference.4
Practically, there were many physicians in the
ancient world who did not come from wealthy
and noble families like Hippocrates and Galen,
so there were many poor physicians who did
request and even sued for payment.4
There are examples from medieval Islamic
writings of physicians who worked in other
businesses on the side or received a patronage
from wealthy individuals such as a caliph or
sultan, so they had the opportunity to provide
their services free of charge. Ishaq b. ‘Ali alRuhawi, a ninth-century Islamic writer says that
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because health is the prerequisite for the
performance of all other human activities,
medicine occupies the highest position of all
professions.7 Therefore, society should meet the
physician’s financial demands in order that he
does not have to do other work to support
himself and that “the rich should pay the
physician more than enough, because he cannot
charge the poor towards whom he must extend
his charity.”7
According to the Hebrew scriptures, human
physicians could practice medicine but
ultimately, healing came from God. The Talmud
quotes an adage “A physician for nothing is
worth nothing”, and includes the fees a physician
should receive.8
Nachmanides, a medieval
Jewish writer says that “a physician may accept
fees for the loss of time and for the trouble” of
leaving his home and traveling but he should not
be remunerated for simply giving instructions.8
There were contracts between Jewish physicians
and Jewish communities in European cities
during the 17th and 18th centuries.9
The
physician was appointed for several years, was
given a yearly salary or was to charge stipulated
fees, was to attend to the poor without taking
payment, and was to receive special payment for
night calls and treating children. The rich were
expected to pay for their treatment but usually
only a stipulated fee.
In medieval Europe, some physicians were
employed by royalty and attended to the health
of the royal court and perhaps some of its
subjects, others were paid by the church to treat
the sick of the parish and the poor. Some citystates such as Venice employed physicians to
give free treatment to the poor, treat the rich at
reduced rates and advise the state on medicolegal and public health matters.10
There are many sources from America which
record how physicians were paid and whether
fees were regulated or not. One example is the
regulation of fees in Boston starting in 1780.11 It
was the Boston Medical Society which
developed the fee bill in order to stop physicians
from undercutting each other. The fees on the
fee bills were minimums so physicians could
charge more, but no less. In addition, patients
only wanted to pay for services if it included

treatment such as a drug or a procedure. The fee
bill however stipulated that charges be made for
all visits.
Because the physicians were
controlling the fees, they made sure that they
were always very well compensated, their
general policy being to increase fees in good
economic times but not to lower them in hard
economic times. Between 1795 and 1806 the
cost of living changed very little but the fees
increased by 50-60%.
In Boston, we see an example were the
physicians controlled their own remuneration
and thus sometimes charged quite high amounts
for their services. In South Carolina in 1844, we
have an example of quite the opposite. The St.
Peter’s parish, like the whole state, was very
poor so the local officials decided to set a fee bill
to curb the “exorbitant, oppressive” physician
fees which “unjustly absorbs so large a portion
of [the farmers] hard earned incomes.”12
If we compare the fees in Boston and South
Carolina, we can see the vast difference in fees
when physicians or the community set them. In
Boston in 1806, a regular single visit was $1.50,
normal obstetrical delivery was $12.00, treating
gonorrhea was $10.00 and the fee for amputating
a leg was set at $40.00.11 In South Carolina,
almost three decades later in 1844, a regular
single visit was no charge, normal obstetrical
delivery was $3.00, treating gonorrhea was $2.00
and the fee for amputating a leg was set at
$5.00.12
The advancing settlement of America
westward necessitated innovative solutions for
physician remuneration due to low populations
and poor patients. For example, a physician only
agreed to move to Tucson, Arizona in 1871 after
twenty-five families agreed to pay him $100 a
year for his services.13 The frontier medical
practice also required novel ways of payment
such as poultry, cattle, tobacco, fruit, vegetables,
wood and clothes.
Barter was also a common payment method
in Australia. The very first physicians were
military and naval surgeons and so would have
been paid as salaried practitioners. As free
settlers came though, “civilian” physicians
would need to be paid and payment with goods
and services would have been acceptable
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because the early Australian physician would
have few places to spend his money. By the
middle of the nineteenth century there are
examples of fee regulation in Australia. The Port
Philip Medical Association set fees for three
different classes of patient with different fees for
different classes.14 The 1st class patients (i.e. rich
patients) had to pay two to five times as much as
3rd class (i.e. poor patients) for the same
treatment.
In Canada, the first known surgeon came to
Montreal in 1653 as a military surgeon earning
147 livres a year from his military salary.15 He
also treated 42 families for 5 livres annually each
and trained an apprentice for 150 livres per year
giving him an annual income of about 500 livres
which was about 17 times that of the lowest
salaried worker. The first physician came to
Quebec City early in the eighteenth century and
earned about 2400 livres which was about 60
times that of the lowest salaried worker.15 In
1851, Dr. James Lanstaff’s medical income was
only about $500, but climbed to $2000 in 1861
and $3000 in 1880. During the same period, a
labourer would make about $300 per year.16
Langstaff became a wealthy man, but only
because he had income other than medical fees.
In fact, several hundred families owed Langstaff
money during his active practice and he accepted
payment from some families in the form of food,
produce, lumber, animals and labour.
Sir
William Osler charged his rich patients very high
fees and his poor patients nothing at all.6
From the very earliest of recorded history in
the code of Hammurabi to the present day, we
can find records of physician remuneration. It
was an important matter of debate in medical
texts as well as non-medical writings from
Aristophanes’ and Sophocles’ plays as
mentioned above to Moliere’s “Le Malade
imaginare” and George Bernard Shaw’s “The
Doctor’s Dilemma”. For the subject to be found
throughout recorded history – medical and non-

medical – the issue must have been important, as
it is today. Perhaps, some ideas to help us fix
our current problems can be found in the past.
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Feature Article
A Foundation of Western Ophthalmology in Medieval Islamic Medicine
Daren Lin
The conquests of Muhammad starting in the 7th century led to the spread of Islam and the teachings of the Qur’an, a
theology believing that genuine health and happiness is the natural state of existence. While medieval Europe rejected
the medical knowledge of the pagan Greeks, the early Islamic world was eager to assimilate and expand the Hellenistic
medical teachings, emerging as the collector and preserver of Western medicine. For ophthalmology, an especially
extensive literature developed. The prevalence of eye diseases in the Islamic lands resulted in particular interest in
their skilful diagnosis and treatment. Using principles of clinical observation, many ocular diseases were described or
classified for the first time. Intricate surgical excision with an array of minute instruments was used in the treatment of
several external diseases of the eye such as pannus and pterygium. Suction removal of cataracts using a hollow needle
was also described. Their advances in the knowledge of optics, anatomy, and physiology of the eye became major
contributions to modern ophthalmology. Latin translations of the extensive Arabic literature on ophthalmology
influenced late medieval Europe, and many of these contributions of early Islamic empire remain today. Medieval
Islam made these advancements because it eagerly encouraged knowledge and physician thinkers from all cultures.

A Medium for Medieval Medicine
Three civilizations emerged from the fall of
Rome in 476: the Byzantine Empire, the Early
Medieval West, and Islam. The Islamic empire
emerged as the sole preserver of the classical
knowledge of ophthalmology and added
contributions that are still significant today. The
Islamic empire was able to achieve its great
contribution to ophthalmology because of unique
cultural conditions within its borders during its
establishment and its golden age.
When Arabia was split into many different
tribes in 622, Muhammad founded his ideal
community in Medina, where religion and state
became one.1
Muhammad gave specific
instructions on various aspects of health, treating
people himself, stressing that genuine health is
the natural state of existence.2
With the
prevalence of disease, medicine became a central
part of medieval Islamic culture.3
With Muhammad’s death in 632, Arabia was
at peace for the first time1, united under a new
and resourceful religion, which espoused sound
health amongst its followers. Inclusion of other
societies within its growing borders allowed the
young Islamic world to flourish, absorbing the
culture and scientific knowledge of other
civilizations.
While conversion to Islam outside Arabic
lands was gradual, linguistic conversion

proceeded more rapidly. After only a century,
Arabic was the official and working language,
often completely replacing older languages
within the empire. Islam not only inherited the
earlier scientific and medical traditions, but also
received contributions from its non-Arab, nonMuslim peoples who adopted Arabic as a
common language of scholarship4, facilitating
unprecedented scientific and medical exchange
and enabling significant expansion of past
knowledge.
Because copying the Qur'an was an act of
piety, Islamic culture also had an engrossing
tradition of book-making, including calligraphy,
illustration,
paper-making,
and
binding.
Illustration practices were adopted from the
Byzantine and Persian cultures, while Chinese
paper making was improved upon.3 Islamic
medical knowledge was recorded in textbooks
and transmitted across its lands and to future
generations.
The Royal Library of Baghdad
The knowledge of the earlier Greek medical
teachings came to Islam through Nestorian
Christians, driven out of Byzantine and settling
in Persia.6 Their translations and teachings were
valued by an emerging Islamic empire which
needed to find ways of dealing with common
medical problems: disease, pain, injuries, and
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successful child-bearing.7 Upheavals in the first
millennium of Christianity caused the loss of
many Greek medical works which are now only
known from Arabic translations.5
This heritage of medical theory and practice
was assimilated and elaborated by an
international community of scholars of many
different cultures and languages including Arabic,
Persian, Syriac, Hebrew, and Turkish.1,7 During
the Abbasid Dynasty (750-1258), Islam’s Golden
Age, translation of Greek, Hindu, Syriac, and
Persian texts accelerated. Caliphs of this age
promoted knowledge and curiosity4 and the
Royal Library in Baghdad became a centre
where countless precious manuscripts from all
corners of the empire were collected for
translation.5
Hunayn ibn Ishaq, a Syriac-speaking
Christian working in Baghdad at this time, made
Arabic translations of nearly all known Greek
medical books. He also wrote several medical
and ophthalmologic treatises that later circulated
in Latin in Europe.
His treatises were
fundamental in establishing the basic conceptual
framework of medicine in renaissance Europe.
These translations maintained a continuity of
ideas between Roman, Islamic and late Medieval
European practices.7
Islamic physicians like Hunayn produced a
vast medical literature of their own, combining
Greek doctrines and their own observations.5 By
the end of the ninth century, Arabic medicine
had fully integrated the Galenic humoral system,
and further developed the Galenic tendency to
systematize by writing medical treatises that
organized the vast body of medical knowledge
into one comprehensive and logical structure.
Hunayn’s original work, Ten Treatises on the
Eye, is an example of this new organisation and
an exhaustive work on the eye.4
As opposed to theoretical reflections on
illness, a new trend developed that focused on
expanding empirical knowledge and on practical
procedures for treatment. Abu Bakr al-Razi or
Rhazes, criticized the inherited medical
knowledge for inferences that did not always
correlate with clinical observations.
He
pioneered clinical medicine by conducting what

amounted to controlled experimentation. For
instance, he used bloodletting in one group of
patients while giving no treatment to another
group.4 He also wrote case histories, 900 of
which were included in his casebook, Kitab alTajarib. His casebook described 48 cases of eye
conditions, often differing from his theoretical
writings.
A third of the ophthalmologic
complaints in his casebook, with their complex
mixture of symptoms, do not appear in his
famous theoretical book, Kitab al-Mansuri.
Furthermore, several treatments used in the
casebook deviated from the theoretical work
because of adjustments to the particular needs of
the patient.8
Works of the late Islamic golden age reflect
the mature development of all these trends as
demonstrated by the Perfected Book on
Ophthalmology written by Ibn an-Nafis (b. ca.
1210).
The first part, on the theoretical
principles, deals with anatomy, physiology,
pathology, aetiology and symptomology. The
second, on the clinical treatment and surgery, is
systemically organized and provides an account
of the improvements made based on clinical
observation.9
Medieval Islam was responsible for
translating and preserving many medical works
into Arabic, allowing an international
community of scholars to improve on inherited
knowledge in two broad themes: the
systematization of contemporary medical and
ophthalmologic knowledge in manuals for easy
transmission; and the development of clinical
medicine through rigorous research and
observation, challenging pre-existing theoretical
frameworks. These frameworks allowed the
Arabic advancement of classical ophthalmology.
A Specialty is Written
Blindness was a major cause of disability
throughout the Islamic lands. As a result,
Islamic physicians displayed particular concern
and ability in the diagnosis and treatment of eye
diseases3 and nearly every medical compendium
had chapters on ophthalmology. Rhazes’ work,
Kitab al-Mansuri, included a large section on the
specialty.10 It was one of the most widely read
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on the eye were written, thirteen of them
medieval medical manuals in Europe and often
surviving and ten written by ophthalmologists.
reprinted with commentaries by prominent
7
These doctors had thorough specialty training
Renaissance physicians such as Vesalius.
and were honoured by the public.13
There were a large number of
3
monographs devoted solely to ophthalmology.
The early work of Hunayn’s ninth-century
New Insights
manual, Ten Treatises on the Eye, and Ibn anAnatomy
The Islamic scholars based their anatomic
Nafis’ thirteenth-century manual, Perfected Book
on Ophthalmology, are two examples. Ali ibn
knowledge upon Galen’s works and as a result
Isa’s tenth-century Memorandum Book for
made similar errors: the posterior chamber was
too deep, the optic nerve had a canal and there
Oculists was the classical Arabic textbook of
was an extra extrinsic muscle.13 Nonetheless,
ophthalmology and became the standard treatise
two important contributions to modern
of the eye for several centuries in Islam and
11
ophthalmology were made.
First, Arabic
Christendom.
The text describes over a
medical literature contained the first illustrations
hundred different diseases of the eye organized
of eye anatomy, with the earliest surviving
by anatomical location and combined Grecodrawing appearing in Hunayn’s Ten Treatises on
Roman knowledge with novel observations.12
The Greco-Roman attitude to ophthalmology
the Eye.14 The optic chiasm and brain were
was poor, with only five works on
illustrated in Ali ibn Isa’s Memorandum Book
ophthalmology in the 800 years between
for Oculists.11 This was passed on to the
Herophilus and Alexander, all of these lost and
European Renaissance, including Vesalius,
none by a specialist. Moreover, the writings of
whose figures resemble the Arabic (Figure 1).14
Galen referred to ophthalmologists in a
Second, modern day terms for eye parts are
derogatory manner. In contrast, during the 500
derived from Arabic terms and not from Greek.
years of the Islamic golden age, thirty textbooks
For instance, the medieval Latin translation of
Figure 1. Hunayn’s figure of the eye, left, is the first known anatomical illustration, originally illustrated
ca. 850 and shown here in translated form by Meyerhof (Wood, 1936). Vesalius (1514-1565) was greatly
influenced by Arabic anatomy of the eye in his figure, right (Sorsby, 1933).
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the Arabic word, qarniyah, became a part of the
standard Leipzig anatomical nomenclature as
cornea. In contrast, Galen used the Greek word,
kerotoeides, which is not used today to describe
the cornea.13
Optics
Ibn al-Haytham, known as Alhazen, rejected
Hellenistic theories of vision postulating that
vision resulted from rays emitted from the eye
(Euclid), or transmission of a form from the
object to the eye (Aristotle).
Alhazen’s
remarkable insight was that an image of the
object is formed due to the emission or reflection
of light from the object to the eye.4 He worked
out his theory sufficiently to create the
foundation for use of lenses to correct vision.
However, this possibility was recognized only
after the transmission of his discovery to Europe,
where two centuries later Roger Bacon suggests
the use of lenses for vision correction.14
Cataract
The first authentic document on the treatment of
cataracts was by the Roman, Celsius, who
described entering a sharp needle into the eye to
downwardly displace the lens from the pupil,
breaking it up into many fragments if needed.14
This technique, known as couching, was
commonly employed in the Arabic lands, with
the major complications being infection and
glaucoma. Although the success rate was only 4
in 10, it found wide acceptance because the
alternative was blindness.3 Ammar, born in the
late tenth century, invented the suction method
for cataract extraction, by which a glass tube is
introduced through a corneal incision for
evacuation of the lens by suction (Figure 2).15
Unlike other contributions from the Arabic lands,
the suction technique was only popular in the
eastern part of the empire, and thus failed to
reach Christian Europe, where couching
continued until the technique was separately
described by Daviel in 1748.14
External Diseases of the Eye
Chalazions were described as collections of a
gross humor that gathers in the lid.
If
conservative topical treatments failed, it was
incised with a round-headed lancet, scraped out

with the spoon at the end of the sound, closed
with a suture, and irrigated.11 Today’s treatment
is similarly incision and curettage.16 Styes were
described as an abscess at the root of an eyelash.
Treatment was rubbing with very hot bread.11
Modern treatment is likewise hot compress.16
Original surgical techniques dealt with treating
the sequelae of trachoma, a leading cause of
blindness.
Trichiasis was treated through
extraction of the inverted hairs and cauterization
of the roots using a needle that was heated redhot. Trachomatous pannus was recognized as
the superficial vascularization of the conjunctiva
and treated surgically by raising the pannus with
a number of very small hooks and excising the
raised film with very thin scissors or cataract
needle (Figure 3). Pterygium was described as
the encroachment of the conjunctiva on the
cornea and was removed using a similar
technique as the removal of pannus.11
The Reflected Light
The Renaissance in Europe was the result of the
normal development of science coming from the
Islamic Orient, passing through the multilingual
communities of Southern Italy and Spain, and
finally reaching Western and Central Europe.9
Constantinus Africanus, an Italian monk born in
Carthage in 1018, translated numerous books
into Latin. The translations into Latin occurred
at the same time as the Crusades. The crusades
both aggravated relations between Christendom
and Islam and provided opportunities for
Europeans to learn different Arabic technologies
and practices.7
Systematic medical texts, such as Rhazes’
Kitab al-Mansuri and Ali ibn Isa’s Memorandum
Book for Oculists, carried both classical and
Arabic knowledge of ophthalmology and
medicine to Christian Europe.
Used by
European physicians for centuries, these works
had permanent influences on the formation of
Western ophthalmologic theories, practices and
terminology. Rhazes’ writings were part of the
curriculum in Western medical schools until the
nineteenth century.1 An analysis of De Oculis, a
Latin textbook about eye diseases written by
Peter Hispanus (Pope John XXI) in the thirteenth
century, concluded that the text depended on

treatises from Hunayn, Rhazes, Galen and Plato
alike.17
Although
Arabic
medicine
and
ophthalmology were founded on the work of
other cultures, and although several of its
brightest minds were not Muslim but Nestorian
Christian, the golden age of Islam was
responsible for numerous advances in
ophthalmology that remain with us today. The
common language of Arabic within Islamic lands
allowed discussion of ideas and development of
manuscripts by an international community of
scholars. Medical knowledge was improved by
the systemization of information and testing
theory with clinical observation. Curiosity and
knowledge, as well as acceptance of other
cultures, allowed early Islam to rapidly develop
scholarly knowledge in all fields, including
ophthalmology.
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Feature Article
AIDS and Guyana
Victor Ng
Since its first discovery in the early 1980s, the mystery of the Human Immunodeficiency Virus (HIV) has continued to
elude health care workers. While the standard of living has increased in developed nations with the advent of new
medication, the treatment offered to patients in undeveloped countries is still primitive. In Guyana, a country of about
700,000 people, it is roughly estimated that 3% of the population has Acquire Immunodeficiency Syndrome (AIDS).
However, many cases go unreported as a result of poor governmental statistics collection and lack of testing facilities.
A large number of infections occur in the mining regions in the interior of Guyana where many of the miners are
young men who engage in promiscuous engagements with local women. Furthermore, the prevalence of malaria in the
interior of Guyana has lead to HIV-malaria, leading to a greater number of both malaria and HIV cases. Throughout
the last 10 years, many Non-Governmental Organizations (NGOs) have been established throughout Guyana to offer
educational workshops on prevention and counselling services. However, the lack of capital has been a major obstacle.
While Guyana does receive developmental aid from developed countries, it is insufficient to substantially improve the
AIDS epidemic under Guyana’s current health care delivery system.

Guyana: The AIDS Epidemic
From the great plagues of Europe to the Small Pox
Pandemics of the modern era, disease and pestilence has
never been far away. Throughout the ages, Medical
practitioners have tried many different methods to combat
illness and disease from animal magnetism to
polypharmacy. In the modern era, it is no different as
modern medicine continues to seek out new ways to
promote healing. However, despite humanity’s best efforts,
some diseases are still unconquerable, among these is
AIDS.
Since its discovery in the early 1980s, the HIV virus
has spread to every country of the world including Guyana
in South America. Although Guyana is a relatively small
country with a population of only about 700 000 people, it
has the 2nd highest HIV prevalence rate in the Western
Hemisphere after Haiti. An estimated 3% of the population
currently suffers from AIDS, although the incidence rate
may be higher as many cases go unreported.

Mining represent 25% of Guyana’s gross national product
(GNP) in the mid 1990s.1 The mining industry has had a
profound effect on the people of Guyana. While most of
the population lives along the coast, most of the mines are
in the interior. As a result, many men leave their homes
and families to work in the interior for long periods. This
puts a serious strain on the families. Furthermore, the once
tranquil villages of the interior have been transformed into
supply depots catering to the needs of thousands of
migrant miners. The government station of Kamarang is a
small village in the interior. Since the early 1970s, this
calm administrative centre with a religious mission has
been transformed into a “tawdy tinsel town” of grog shops,
brothels and discos.1 Many young Amerindian women
have become prostitutes, promoting the spread of sexually
transmitted diseases such as HIV. The HIV virus is not
only spread among the Amerindian villages, but also to the
rest of the country by men who return to their families
after their work contract is done.

Guyana: The Beginning
The first ten AIDS cases were identified in Guyana in
1987, all being homosexual males, followed by five
females the next year. In the early years of the epidemic,
ignorance of the disease led doctors and nurses at the
Georgetown Public Hospital to abandon patients because
of fears that they would contract the disease themselves.
Pan-American Health Organization (PAHO) Programme
Assistant Dereck Springer described the situation:
“Nobody was responsible in terms of creating a safe
environment, persons were left unattended, not
recommended for medical care, nurses were reluctant to
provide nursing care, and families abandoned their sick
relatives. Even persons at home were isolated.”

Center for Disease Control Study on HIV prevalence in
a Gold Mining Camp
The high HIV prevalence rate in the interior of Guyana has
been the subject of discussion of one study by Palmer et al.
(2002) which focused on a mining camp 400km inland
from the capital, Georgetown.2 The men at this camp
worked 12 hours per day for 6-8 weeks before returning
home for a 2 week break.
Of the 216 men between the ages of 18-35 at the
labour camp, all but 4 men were tested for HIV. The HIV
testing was done on site by Determine (Dainabot, Tokyo,
Japan) rapid Immunochromatographic test for the
qualitative detection of HIV strains 1 and 2. In previous
fieldwork, this test was reported to yield 100% sensitivity
and specificity. In any case, a confirmation HIV test was
also done by enzyme-linked immunosorbent assay

Guyana: A Mining Nation
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(ELISA) with western blot (Abbott, Abbott Park, Illinois)
on all sera. The study reported that 6.5% of the men tested
positive for HIV and both the field test and confirmatory
test were 100% in agreement of these findings.2 This high
prevalence was troubling because it created a reservoir for
the HIV virus. This situation was exacerbated by the fact
that the health care system in the interior communities was
poorly equipped to deal the disease.
Malaria – HIV Co-infection
Since 1986, malaria prevalence has also risen in Guyana
and has become a serious health problem. There are over
30 000 clinical cases of malaria every year in the interior.2
P. Falciparum, the more dangerous species of the parasite
has re-established itself in areas from which it had been
previously eradicated. It is thought that the extensive
mining and natural resources exploration coupled with
poor health care services in the interior has led to this
resurgence.3 Furthermore, in some areas, P. Falciparum
has developed a resistance to chloroquine and fansidar,
two common anti-malarial medications. This is especially
dangerous since the victim can die within 24 hours of
symptomatic high fever and chills. Remote villages in the
interior do not have easy access to health centres and it
often takes hours just to get to the nearest health centre,
which are often not well equipped with medications.
High malaria prevalence in areas where HIV is present
is especially alarming. Immune T-cells and B-cells
function as the body’s defence system against infectious
diseases such as malaria. However, these lines of defences
are weakened during the first stages of HIV infection
rendering the body vulnerable to infections such as malaria.
Conversely, malaria could also exacerbate HIV infections
because the immune system could be overwhelmed dealing
with multiple infections.
In a study done by French and Gilks (2000), it was
shown that malaria infections were more frequent
individuals with compromised immune systems. The
researchers looked at three different categories of
individuals according to their CD4 T-cell counts. The
groups were as follows: 1) >500 2) 200-499 3) <200.
French and Gilks (2000) found that 4.5% of those with
CD4 T-cells >500 were infected with malaria compared
with 7.3% with CD4 200-499 and 11.5% with CD4<200.
Thus, an increase in malaria infection is observed in HIV
infected adults, suggesting an important correlation
between malaria and HIV.4
During the early stages of the AIDS epidemic, it can
be argued that non-governmental organizations played as
great if not a greater role in battling the disease than
governmental
departments.
Non-governmental
organization sprang up in all regions of the country
offering a variety of services from counselling to education.
In the year 2000, many of the non-governmental
organizations decided to combine their resources and
began a national crusade against HIV/AIDS and sexually
transmitted infections (STI). As a result, the Guyana
HIV/AIDS/STI Youth Project was born. This 5-year

program is funded by the United States Agency for
International Development (USAID) and will work to
educate people about the disease, as well as collecting data
to assess the knowledge Guyanese have about the disease
and their perceptions of the disease. This project also
works to interview focus groups such as sports clubs to
understand their view of the disease. Furthermore, the
project also interviews prominent members of
communities to understand the specific needs of
communities as well as draw on their leadership capacity
to motivate the community to wage the war against
HIV/AIDS and sexually transmitted infections.
The organizations that make up the Guyana
HIV/AIDS/STI Youth Project are all reputable
organizations with a history of their own. Each of them is
very active in their community in their field of work
whether it is counselling, education or medical care.
One of the more prominent NGO’s is Youth
Challenge Guyana (YCG) which is a part of the Youth
Challenge International alliance that includes partners in
Canada, Australia, and Costa Rica. Traditional, this
organization has worked on infrastructure development
and health promotion issues with a number of local and
international volunteers. Lately, Youth Challenge Guyana
has transformed itself to move away from infrastructure
projects and focuses on three streams: governance,
women’s issues and HIV/AIDS work. The HIV/AIDS
stream of work will be YCG’s contribution to the youth
project. International and local volunteers will travel into
different regions of Guyana to collect statistical data on
HIV/AIDS as well as provide educational workshops.
Although the NGO’s have the good intentions of helping
to ease the suffering of AIDS, the lack of resources has
truly hampered the efforts. In most countries, NGOs’
purpose is to support and complement the services offered
by the government. However, in the case of Guyana, the
poor state of the country’s health care infrastructure has
made many NGO’s primary care providers rather
supportive care providers. Although these organizations
have a depth of experience in aid work, they simply do not
have the manpower or financial resources to provide
adequate care to everybody. To the best of their abilities,
the non-governmental organizations can only offer indirect
methods such as counselling and workshops in the hope
that people will learn to protect themselves from
contracting HIV. As the HIV incidence rate increases, the
NGOs can only watch helplessly, hoping that the
international community will contribute aid. In the end,
only proper medical services and pharmaceuticals can slow
down this epidemic.
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Feature Aritcle
An Exploration of Anaesthesia through Antiquity
Jeremy Keller
“To avoid pain, in surgical operations, is a chimera…”
-Velpeau (1839)

The struggle to alleviate pain is not a new one.
The modern day science of anesthesia provides
this remarkable ability with great success. The
present era began in 1846 with the reported use
of ether as an anesthetic during surgery. The
field blossomed quickly and the field of surgery
grew exponentially. However, the history of
anesthesia does not begin here; an exploration
through antiquity is required to gain a true
understanding of the foundations of this
impressive science.
Throughout history and across civilizations,
the use of herbal remedies as medicines is well
documented.
Even though the anesthetic
capabilities of some of these methods is
debatable, it is worthwhile to explore the history
of the science of anesthesia. Herbal remedies as
analgesics and sedatives have a rich history.
Indeed, before ether, chloroform and nitrous
oxide there was hemlock, mandrake and dwale.
Physical attempts at anesthesia were also
frequently employed, including a literal blow to
the head.
Although they were often
unsatisfactory these methods withstood the test
of time in the pre-modern era. Finally, several
breakthroughs in anesthesia occurred as
civilization marched onward towards the modern
era. Attempts at sedation took many forms in
ancient times. It is these antiquated methods of
anesthesia that are the subject of investigation in
this paper.
The chimera is a mythical beast whose body
is composed of parts of natural animals. The
French surgeon Velpeau describes a chimera of
pain and surgery. He argues that they are
combined into one entity that is impossible to
separate. In the modern era of anesthesia pain is
separated from surgery with great ease.

However, prior to modern anesthesia humankind
still partook in surgical interventions. The
problem of pain during surgery has victimized
humans throughout the ages. The history of
anesthesia will provide an interesting and
impressive account of how this problem was
addressed.
Before discussing the history of anesthesia it
is necessary to explore the state of surgery in the
pre-modern era.
Surgery in ancient times
included amputation, caesarian section, treatment
of hernias, hemorrhoids, tumours and tooth
extraction1 as well as attempts to cure epilepsy,
serious headaches, insanity, and depression
fractures of the skull.2 It was not unusual for a
surgeon to approach a patient with several strong
men to literally hold the patient down. A good
surgeon is one who can perform quickly and one
who has strong nerves to withstand the screams
of the patient. The concept of surgery without
anesthesia is expected to cause some shock to
those who practice modern medicine. However,
the testimony of patients screaming during an
operation and the intense psychological distress
caused to patients awaiting surgery establishes
that the problem of pain was very real.2 It is
therefore highly likely that for as long as patients
were subjected to surgery people have searched
for methods of anesthesia.
Medicinal plants have been used throughout
the ages to treat many diseases.3 Medicinal
plants alone or in combination were often
utilized as anesthetics. Dioscorides, a Greek
physician in the first century AD recorded
hundreds of plant preparations for use in
medicine. Pliny the elder, a Roman of the same
era as Dioscorides recorded the use of opium and
henbane.4 These therapeutic plants were well
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known in antiquity and there are many records of
their use.1
The first description of a preparation used for
anesthesia is found in the 9th or 10th centuries AD
where the spongia somnifera or the soporific
sponge is first mentioned in the context of
anesthesia.5 This concoction was made with the
following ingredients: mandrake, opium,
hemlock and henbane. The plant extracts were
dissolved in water and soaked in a sponge. The
sponge was then left to dry in the sun. When
needed the sponge was placed in warm water and
then placed under the patient’s nostrils to be
inhaled, putting him to sleep. Once the surgery
was complete the patient would inhale vinegar
fumes and awaken.5
Mandrake or Mandragora was a popular
agent with many references throughout the ages.2
Its particularly curious physical characteristic
bifid root resembled the form of man, which
undoubtedly added to the mystique surrounding
the plant.6
The medicinal activity of the
mandrake was well known to many ancient
civilizations including the Egyptians, Greeks,
Assyrians, Babylonians, Hindus and Chinese.
Babylonians are believed to be the first users of
mandrake in pain relief more than 2000 years
B.C..2 The Greeks described its use mixed with
wine and given prior to surgery to avoid pain.
There is no doubt as to potency of the mandrake
root and its use during surgical procedures of
ancient times is well documented.1 Pliny went
as far as claiming that anesthesia can be induced
by smelling the juice.7 However, it was also
identified as a narcotic and necessarily a poison
when taken in large amounts. Dosing was also a
problem as the potency of the plant was variable
based on season and geographic location. This
caused it to fall out of favour.8
The opium poppy is the oldest, most familiar
and most effective of all the ancient drugs.
Opium's use in pain control can be traced back to
the Roman Empire.1 However, its regular use
for anesthesia is only observed in the Middle
Ages. Opium is a well-known potent narcotic
and pain reliever. Dosing was again a problem
since in high doses the opium will cause central
nervous system depression and death.1 As with

mandrake the variable effects of the opium
poppy made it difficult to consistently use as an
anesthetic.
Dwale was a liquid mixture that the patient
was required to drink prior to surgery. Recipes
for dwale were found dating back to the 12th
century AD. Dwale was composed of bile of a
boar, lettuce, vinegar, bryony root, hemlock,
opium and henbane. All of these were mixed
together in wine and drunk by the patient to
render him asleep before surgery. To arouse the
patient afterwards, vinegar was used just as it
was in the case of the spongia somnifera.9 Bile,
lettuce, vinegar and bryony root can be discarded
as ineffectual ingredients in the realm of
anesthesia and will not be discussed. While
opium has already been dealt with, henbane and
hemlock are both important plants in the history
of anesthesia.
Henbane or Hyoscyamus and hemlock were
not referred to nearly as much as mandrake or
opium. Henbane was a lesser-known sleep
inducer. It was generally used as a local
anesthetic in treatment of toothache.1 However,
it too has deadly consequences if ingested in
high amounts and was considered a dangerous
medication. Hemlock was the poison ingested
by Socrates that caused his death. It was a wellknown drug and obviously quite dangerous. It
was also described in the 15th century as a
method of inducing sleep before surgery.1 Both
of these were strong poisons and were not
frequently used.
At this stage in the discussion it is important
to note that potent analgesics, sleep inducers and
anesthetics were known and used by people
throughout antiquity. Problems arose for several
reasons including method of administration, lack
of dosing control and most of all the ever-present
danger of fatal overdose. These methods all fell
out of favour and patients still endured pain
during surgery.
The discussion must turn now to one of the
oldest and most popular anesthetics, alcohol.
Alcohol has always been a vital part of the
struggle against pain. It was likely the spur that
caused people to attempt to alleviate pain
through ingestion of medicines.2 Often, other
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herbal remedies are mixed in with alcohol and
administered for pain relief, a fact that certainly
improved the potency of these ancient
medicines.1
For example, the often used
laudanum, which was very popular and was one
of the only known consistent pain relievers of
antiquity, was simply opium mixed with alcohol.
Although alcohol alone is not sufficient to be
deemed an anesthetic in the true sense it does
have a valuable place in the history of medicine.2
The investigation into anesthesia through
antiquity shifts to a discussion of physical
mechanisms. Herbal remedies were discovered
to be either ineffectual or too dangerous. In an
attempt to control pain patients were literally
clubbed on the head prior to surgery. In ancient
Egypt men who dispensed this treatment became
highly skilled in the technique. The blow had to
be strong enough to knock the patient out but not
too strong as to kill him. While this method was
crude and unsatisfactory, it was used throughout
history as it was better than providing nothing.2
Local pressure proximal to the site of surgery
was found to help control pain. By using a
tourniquet that placed pressure on both the
vessels and the nerves, it was found that pain
could be numbed. This method was found to
cause significant pain itself as well as tissue
injury, which increased the risk of infection.2
This method can be traced back to ancient Egypt,
2500 BC, where evidence has been found in the
form of pictures. These pictures show pressure
being placed on the brachial plexus during
surgery on the hand1. This was a very crude
method of anesthesia that did not provide much
benefit to the patient.
The carotid artery translated from the Greek
means artery of sleep. It was found that by
choking both arteries, a person could be rendered
unconscious. One could imagine that this was a
truly ineffective method since the patient would
regain consciousness soon after the pressure was
removed.2
The exploration thus far has discovered many
options for anesthesia throughout antiquity but
none of these are viable, reproducible or
effective options. The attention shall now be

turned to more contemporary methods with
significantly more promise.
Joseph Priestly is credited with the invention
of the first modern anesthetic, nitrous oxide or
laughing gas, in 1773. This gas is still used in
the modern day as an anesthetic.10 Unfortunately,
during Priestly’s era doctors were not
courageous enough to make use of the new
discovery for fear of its potential danger and
despite the positive outcomes of his
experiments.10 It took another pioneer in the
form of Sir Humphry Davy to bring nitrous
oxide into popular use.2 Davy showed that
nitrous oxide was a safe and breathable gas.7 He
further went on to show that nitrous oxide could
render a person unconscious and went as far as to
write that it was capable of removing physical
pain, even during surgery.7 No surgeon made
use of the newfound anesthetic and so nitrous
oxide was destined for rediscovery at a later date.
Henry Hill Hickman was another man who
came close to a breakthrough discovery. His
idea of suspended animation involved
introducing sufficient inhalant so that painless
sleep could be induced. His initial experiment in
the 1820s involved depriving an animal subject
of air and providing carbon dioxide alone,
essentially anesthesia by asphyxiation. He noted
that without oxygen an animal would soon be
unconscious and would remain so throughout the
surgery. As a further benefit the subject did not
bleed as much and healed much faster.7 In
retrospect this was not much different from the
carotid
artery
compression
discussed
previously.2 This discovery truly provided an
alternative to pain during surgery. Hickman
attempted to present his results with the animal
subjects in the hopes of gaining recognition and
eventually attempting the procedure on humans.
However, his theory on suspended animation
was ignored completely and this promising
discovery died with him.2
It is commonly accepted that 1846 was truly
the birth of modern anesthesia with the use of
ether in surgery. However, ether was discovered
in the 14th century by Raymond Lully, who
synthesized it from sulfuric acid and alcohol. He
named it sweet vitriol. The power of his
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discovery eluded him and the discovery
remained dormant until the 16th century when
Valerius Cordus rediscovered it.10
Cordus
recorded the method of synthesis and his
contemporary, Paracelsus, documented its
analgesic effects on chickens.
Paracelsus
determined that it quieted all suffering and
relieved all pain.2 At this point in history,
approximately three hundred years before
Morton’s landmark discovery the effects of ether
were recorded for all to appreciate. As with Day
and Hickman, this discovery too was buried and
ether was forced to wait for its famous
unveiling.10
Mechanisms of pain control found their way
into the culture of their time. Their existence
was common knowledge and they provided plot
mechanisms to both Marlowe and Shakespeare.8
However, these plants did not provide adequate
anesthesia.
The practice of surgery was
continuing to flourish and the need for pain
control was great.
It is worthwhile here to discuss what is truly
meant by anesthesia. The exploration of the
history of this science unveiled the possibility of
providing some pain relief and methods of
rendering a person unconscious but it cannot
truly be declared that the ancients were in fact
practicing anesthesia. A general anesthetic not
only puts a patient to sleep but also keeps him
asleep throughout the operation.2 The medicinal
herbs discussed in this paper had the capacity of
causing some degree of unconsciousness yet
these did not replace the physical means of
clubbing and physically restraining a patient.
One must ask the question, how effective could
the spongia somnifera or dwale be if a patient
can be roused by simply inhaling vinegar.
Furthermore, a utilizable drug must be
reproducible and consistent in its effects. Since
the potency of the plants was variable with the
season and geographic area, it was impossible to
establish a single effective and reliable method
of providing anesthetic coverage during surgery.8

The discovery of anesthesia by inhalation,
nitrous oxide, carbon dioxide and ether, provided
a great benefit and it is only at this stage in
history that people truly began practicing
anesthesia. A gas can be administered until the
patient is unconscious. No longer were people
tied to the variable potency of the ingredients or
to the innate variability of the patient’s
metabolism and overall health. It is at this stage
in history that the foundation for modern
anesthesia is built.
It has been over 150 years since the
Velpeau’s chimera has been abolished. The
ability to remove pain from surgery is one of the
great marvels of modern medicine.
By
investigating the history leading up to this great
discovery one may gain an appreciation of the
great trouble that pain has caused humanity.
Those whose experiments whether they were
successes or failures deserve praise since they
furthered humanities understanding of the
science of anesthesiology and in doing so helped
solve the problem of pain during surgery.
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Feature Article
Anti Smoking Initiatives in Nazi Germany: Research and Public Policy
Nathaniel Dostrovsky
In 1939, German scientist Franz H. Muller published the world’s first epidemiological, case-control study showing a
link between tobacco smoking and lung cancer. Another more rigorous epidemiological study by Eberhard Schairer
and Erich Schoniger in 1943 further supported this link. The Nazi regime was very supportive of anti-smoking
initiatives. In addition to funding research, the government posted propaganda, passed legislation and offered medical
assistance in an effort to encourage Germans not to smoke. This anti-smoking campaign was part of a public health
initiative that included restrictions on alcohol and exposure to occupational contaminants as well as an emphasis on
good nutrition. A number of reasons have been suggested for the government’s desire to improve health-related
behaviour. These include economic and strategic - medical care and lost productivity from sick workers was
expensive, and Germany needed its soldiers to be healthy. Another is idealogical - the Nazi government viewed
alcohol, workplace pollutants, and especially tobacco as genetic poison to the pure German race. After Germany’s
defeat, the research linking smoking and lung cancer went virtually unnoticed by academics in the rest of the world,
perhaps due to the connection between the anti-smoking campaign and Nazi ideology.

Introduction
The causal link between tobacco smoke and lung
cancer is well established, and studies from the
1950s by British and American scientists such as
Sir Richard Doll, A.B. Hill, Cuyler Hammond
and Ernest Wynder are generally credited with
this discovery.1 Yet, the link was identified by
German researchers a decade earlier, but their
studies received little attention after World War
II.
The German research helped spawn antismoking initiatives, a centre piece of a public
health campaign that also targeted alcohol,
nutrition, and occupational carcinogens. The
rationale for improving public health included
economic, military, and most importantly,
ideological motives. Nazi ideology, specifically
racial hygiene, is a major reason why the
research linking tobacco and lung cancer went
virtually unnoticed after the war.
Research Linking Tobacco Smoke and Lung
Cancer in Nazi Germany
Until the sharp increase in incidence in the early
20th century, lung cancer was very rare. German
autopsy records show that it represented 1% of
cancer deaths in 1878, 10% in 1918 and 14% by
1927.1 An even larger increase in tobacco
consumption occurred in the latter decades of the
19th Century, with inventions such as safety

matches and industrial-scale cigarette rolling
machines.2 Despite the temporal correlation,
doctors and researchers didn’t initially recognize
the link, attributing the cause of the excess lung
cancer to automobile exhaust, road tar, and the
influenza pandemic of 1919.
Among the first to postulate a link between
tobacco smoke and lung cancer was the German
clinician Schonherr in 1928 who noted that many
of his female lung cancer patients were exposed
to “2nd-hand” smoke.3 Other doctors, such as
Fritz Lickint in 1929, noted increased frequency
of smoking in patients with lung cancer.
Scientists working during the Nazi regime
built on this earlier research. In 1939, Franz H.
Muller
published
the
world’s
first
epidemiological, case-control study showing a
link between tobacco smoking and lung cancer.
He compared the tobacco consumption of 86
men with lung cancer to 86 healthy men
(controls) of the same age.4 Patients with lung
cancer were more likely to be heavy smokers
than the control group and likewise the control
group were more likely to be moderate or nonsmokers than the lung cancer group.
This link was supported by a more
rigorous study by Eberhard Schairer and Erich
Schoniger in 1943. Questionnaires, asking about
amount and duration of smoking, were sent to
relatives of 195 patients who had died of lung
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cancer, relatives of 555 patients who died of
other cancers (mostly stomach and colon), and to
healthy controls.4 In their analysis, Schairer and
Schoniger attempted to account for confounding
variables such as occupational exposure to dust.
They concluded that “there is a high probability
in support of the contention that lung cancer
develops much more frequently in heavy
smokers and is much rarer among non-smokers
than expected.”4 Later analysis showed their
results to be statistically significant with
p<0.0000001.3
These studies were financed by a Nazi
regime very supportive of anti-smoking
initiatives. At a large conference about the
effects of alcohol and tobacco in March 1939,
Hans Reiter, head of the Reich Health office,
“charged all the medical societies of Germany
with the responsibility for determining
scientifically the degree to which tobacco caused
disease.”3
The Nazi government’s support of research
into the health effects of tobacco extended to the
very top of their government. Adolf Hitler
donated 100 000 Reichmarks (RM) of his
personal finances in 1941 to help fund the
establishment of the ‘Scientific Institute for the
Research into the Hazards of Tobacco’ in the
city of Jena.5 This institute funded the study by
Shairer and Shoniger, as well as other research
into the health impacts of smoking including
‘nervous disorders’, gastrointestinal function,
and
tobacco's effect
on the body’s
potassium:calcium ratio.
Anti-Smoking Initiatives in Nazi Germany
Such research provided scientific rationale for
the government’s anti-smoking initiative which
included propoganda, education, legislation and
economic measures. The government’s antismoking advertisements often used role models,
most notably Adolf Hitler, an ardent antismoking activist. One advertisement read:
Brother national socialist, do you know
that your Fuhrer is against smoking and
thinks that every German is responsible
to the whole people for all his deeds and

omissions, and does not have the right to
damage his body with drugs?3
The education ministry banned smoking in
schools and ordered education about the dangers
of tobacco to be included in school curricula.6
Anti-smoking propaganda was also disseminated
through the Hitler Youth, League of German
Girls, and Federation of German Women. A
popular slogan aimed at women was “Die
deutsche Frau raucht nicht!” (“The German
woman does not smoke!”).7 Restaurants and
cafés were forbidden to sell cigarettes to women.
Smoking among women was further restricted by
denying tobacco-rationing coupons to women
younger than 25.
Restrictions were also put on cigarette
advertising – they couldn’t imply that smoking
had any hygienic value or associate it with
masculine or feminine imagery.3 Smoking was
banned in many public places, including military
barracks, government offices, workplaces and
trains.
Specific groups of men were also
prohibited from smoking including uniformed
soldiers and anyone under 18.6
In addition to restricting smoking and its
advertising, the Nazi government implemented
medical programs to help people quit. These
included counselling, provision of nicotine gum,
and use of silver nitrate mouthwash which made
cigarettes distasteful.6 The government also
researched ways of producing nicotine-free
tobacco, and by 1940 it comprised 5% of the
German tobacco harvest.6
The Nazi government also used economic
means to limit tobacco consumption. In June
1940, the government ordered that cigarette
rations for soldiers be limited to six a day6 and
raised taxes on cigarettes to 80% in 1941.
The Nazi government’s anti-smoking
campaign was part of a broader public health
initiative that emphasized preventative medicine.
In an attempt to limit alcohol consumption, the
Nazi government used similar strategies to their
anti-smoking campaign.
Advertisements
claimed that alcohol “was sapping the strength of
the German people.”6
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Government authorities promoted a diet high
in fruits and vegetables, while encouraging a
reduction in fatty foods such as meat and
whipped cream.8 A concerted effort was made to
encourage bakeries to make whole wheat bread
instead of white and laws were passed that
limited the use of carcinogenic additives, such as
dyes, in food.
Regulations were also put on occupational
exposure to toxins such as limiting the use of
asbestos in factories.7
Just as the research into the dangers of
tobacco-smoking in Nazi Germany was ahead of
the rest of the world, so too were these public
anti-smoking initiatives. The government’s
multi-pronged combination of advertising,
legislation, medical therapy and economic
measures is similar to the strategy used in current
anti-smoking programs.
Rationale for the Public Health Initiative
A number of reasons have been proposed for the
government’s desire to improve health-related
behaviour, including economic, strategic and
ideologic. Throughout the 1930s, lung cancer
had risen to be the second most common cause
of cancer death in German men.2 By 1944, it was
the most common. This rapid increase had
tremendous economic impact: it was a large
expense for the German healthcare system and
health insurance companies, and workers'
morbidity and mortality affected the bottom line
of companies. In 1941, the Nazi government's
accounting division estimated that smoking was
costing the economy approximately RM 4 billion
annually.6 To put this in perspective, Germany's
entire military budget as it prepared for war in
1938 was only RM 16 billion. The government
had a strong economic impetus to reduce tobacco
consumption. Similarly, the rise in morbidity and
mortality from lung cancer was a concern to the
military, which needed soldiers to fight. There
was also concern that smoking tobacco would
affect the German soldiers' stamina and military
prowess.7
Another important reason for the German
government’s public health campaign involves
Nazi ideology, specifically racial hygiene. This

was a central tenet of Nazism, involving the
maintenance of a 'pure' Aryan race. The racial
hygienists attempted to accomplish this goal
through three main avenues:
Racial hygienists distinguished 'positive',
'negative' and 'preventive' racial hygiene,
encompassing
encouragement
of
breeding among the 'fit' (eg. by marital
loans and prizes for large families),
limitation of breeding among the 'unfit'
(especially by sterilization), and
prevention of exposure to genotoxic
hazards.2
Racial hygiene helps explain the Nazi
government’s public health policies that
attempted to ban or decrease use of many
potential mutagens including food dyes, asbestos,
and especially tobacco smoke. In 1939, the
Reich Health office commissioned studies
investigating the effects of smoking on
chromosome damage.3
After 1941, most of Germany’s research into
the health effects of smoking involved the
Institute for Struggle Against Tobacco Hazards
in Jena. It was founded and directed by Dr. Karl
Astel, Dean of the University of Jena, head of
both the Office for Racial Affairs and the Office
for Public Health and Social Affairs for the state
of Thuringia, a high ranking SS officer, and a
leading racial hygienist.5 His rationale for antitobacco research is evident through his belief
that “We cannot change our genes, but at least
we can safeguard them from future damage.”2
Astel was also involved in other aspects of the
Nazi’s racial hygiene campaign including
organizing the euthanasia programs that
murdered over 200 000 mentally and physically
disabled and was involved in organizing Hitler’s
‘final solution’ to murder all Jews.2
Why the Anti-Smoking Research Went
Unnoticed After World War II
After Germany’s defeat, the research showing a
link between smoking and lung cancer went
virtually unnoticed by most academics.
Logistics would have contributed to this:
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German scientific journals were not sent abroad
during the war.2
Another more important reason was that the
research was done in Nazi Germany. Even
though both Muller's and Shairer and Shoniger's
studies were purely epidemiological, many
associated all research from Nazi Germany with
the atrocious human experiments carried out.
The scientific community ignored much of the
research, because, as biochemist James Watson
explained, some thought "that good work simply
could not have been done by Nazi scientists.”2
Muller's 1939 paper wasn't completely
ignored and was occasionally referenced in the
1950s, even in the influential papers by British
and American authors such as Doll and Wynder,
whose studies are generally credited with
demonstrating the link between smoking and
lung cancer.6 Yet, Shairer and Shoniger's study,
which was methodologically and statistically
superior, was cited only three times in the 1960s,
and only once in the 1970s.2 The study also went
unnoticed in Germany, and failed to be
mentioned in a German bibliography about the
links between tobacco and cancer published in
1953.
This may have been because the study was
conducted at the Institute for Struggle Against
Tobacco Hazards, whose director had
involvement in the Nazi sterilisation, euthanasia
and murder of the Jews. Some other scientists
connected with the Institute engaged in horrific
human studies.2
Muller's study was completed before the
conception of the Institute, and so lacks the same
stigma. It also lacks Nazi ideology. For
example, "race", a common theme in many
medical studies from Nazi Germany, was not
mentioned at all.6 Furthermore, Muller refers to
work by Jewish authors in his study. Perhaps
this is why it received some minimal attention
after the war, compared to almost none for the
paper by Shairer and Shoniger.
The Effect of the Nazi Government’s AntiSmoking Policies
Despite the Nazi government's anti-smoking
initiatives, German tobacco consumption

continued to rise throughout the 1930s. One
reason for this increase may have been that
smoking was a form of passive resistance against
the authoritarian Nazi government.3 In the latter
stages of the war, tobacco consumption did drop
considerably, but rationing and economic
problems were likely the major factor.
At a glance, it appears that the Nazi
government’s anti-smoking initiatives were a
failure. Yet, the rise in smoking throughout the
1930s was due to growth in the German
economy, and it is possible that the Nazi
government's opposition kept this increase lower
than it would have been otherwise. Furthermore,
in 1990, lung cancer mortality among German
women was one fourth that of American
women.6 As much of the anti-smoking policies
were aimed at women, it is possible that the Nazi
government’s public health initiative is partly
responsible for this reduction.
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Feature Article
From Marjorie to Leonard: Leaping the Clinical Hurdle of Insulin in 1922
Aaron R. Mocon, Meds 2008
In the study of no other non-infectious disease has there been closer collaboration
between laboratory and clinical investigators than in that of diabetes.1
Leprosy has long had a reputation for being one of the most feared of all human diseases. In Canada today the disease
is a rarity and the few existing cases are considered little threat to public health; however, this was not always the case.
In the mid- to- late nineteenth century an endemic leprosy was found to exist among the Acadian Population of New
Brunswick, a discovery which caused much concern within the nation’s medical and legislative communities of the
time. In this outbreak, which occurred prior to the discovery of the leprosy bacillus, the physicians involved with the
situation were deeply divided as to the nature of the disease: was it hereditary or was it contagious? Their decision
would prove fateful for the victims of the disease in this area. Furthermore, issues of race and class would become
central in the discussion surrounding the appearance of leprosy in this population.

When J.J.R. Macleod wrote this statement in the
February 1922 edition of The Canadian Medical
Association Journal (CMAJ), he was referring to
the contributions of numerous groups of
scientists and physicians over many years,
including his own Toronto-based team, to the
study and treatment of diabetes mellitus.
Macleod, a professor of physiology at the
University of Toronto and assistant dean of the
Faculty of Medicine, was the primary
investigator who supplied the laboratory space,
advice and medical science community clout that
ultimately allowed F.G. Banting, C.H. Best and
J.B. Collip to isolate the pancreatic hormone
insulin and to be the first to use it to successfully
treat diabetes mellitus. Macleod’s commentary
prefaced Banting, Best and Collip’s preliminary
report published in the same issue of the journal
entitled “Pancreatic Extracts in the Treatment of
Diabetes Mellitus.” This was the team’s first
publication, which, although preliminary,
indicated that their pancreatic extract (later
named insulin) was able to control the clinical
manifestations of diabetes mellitus in humans
and in their opinion left “no doubt…that
[insulin] was a therapeutic measure of
unquestionable value.”2 The impact of insulin
can be regarded as one of the most dramatic
events in the history of the treatment of disease
and in 1923, the Nobel Prize was awarded for the
discovery of insulin at Toronto.

In early November of 1920, Dr. Banting
arrived in Toronto to meet Dr. Macleod after
being directed there by Prof. Miller of the
University of Western Ontario in London,
Ontario. Upon reading volume XXXI, number 5
of “Surgery, Gynecology and Obstetrics” (1920),
Banting, a struggling physician in London, was
struck by an idea of how to make a pancreatic
extract that contained the mysterious substance
or internal secretion, which was hypothesized to
control the metabolism of carbohydrates in
blood.3 He was sent to Macleod, a specialist in
diabetes, with the hope that he would give advice
and laboratory resources. After two turndowns,
Banting’s persistence was able to convince
Macleod to provide him with eight weeks of lab
space, experimental dogs and a bright young
physiologist named C.H. Best to partially
compensate for Banting’s lack of medical
science research skills. In May of 1921, Banting
and Best began what would be a tedious and
tumultuous conquest to ligate the pancreatic
ducts of dogs, wait for their pancreases to
degenerate and isolate isletin, a working term for
what was later called insulin. Upon injection into
depancreatized dogs, it was hoped that the
extract would counteract the clinical features of
diabetes. On July 30th, 1921 Banting and Best
found that injecting their extract into a diabetic
dog’s veins was able to transiently reduce the
blood and urine sugar levels and relieve the
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dog’s diabetic comatose state ― their first
promising results.3
Since 1887, when Von Mehring and
Minkowski discovered that depancreatizing an
animal renders it diabetic, many efforts had been
attempted to devise methods for extracting the
principle ingredient of the gland that mediated its
anti-diabetic effects. However, no method was
sufficiently robust to produce large enough
quantities needed to sustain a diabetic animal
once treatment had started while at the same time
being pure enough to eliminate unwanted
toxicity reactions.4 In an issue of the CMAJ, an
editorial by Macleod recognizes Knowlton and
Starling, Kleiner, Murlin, E.L. Scott and
Paulesco as the investigators that provided the
most notable evidence of an internal secretion
before the Toronto team had done. He notes,
however,
that
their
“results…have
been…insufficiently constant and significant to
justify more intensive research with the object of
securing preparations of greater potency that
could be used for the treatment of diabetes in
man.”5 Banting wanted to produce the elusive
sufficiently constant results and Macleod
apparently believed that he might be able to
succeed.
Aware of the progress that Banting and Best
had accomplished in dogs and perhaps
foreseeing the potential of clinical implications,
Macleod expanded the Toronto team, at the
request of Banting, to include the biochemist and
endocrinologist J.B. Collip in mid-December
1921. At this point, Macleod had shifted the
focus of his other research interests and
instructed his whole staff to work to purify
insulin (the Toronto team had now used the term
insulin for their extract, coined years earlier by
Sir A.E. Schafer).6 It was Collip’s principle task
to work on Banting and Best’s newly discovered
extract in order to refine its purity and increase
its yield through the use of more sophisticated
biochemical techniques. The priority was to
produce enough pure insulin for use in human
testing ― the hurdle that so many other
researchers had failed to leap.
It was merely six months later, on January 11,
1922, a refined version of the extract used in the

summer was injected into 14-year-old Leonard
Thomson in Ward H of the Toronto General
Hospital (TGH).2 Many significant events
occurred within this time period. Most notably,
the extract was able to prolong the life of a
depancreatized dog named Marjorie (referred to
in lab note books as dog #33) for 70 days
beginning in the last week of November until it
was sacrificed. These long-term results were a
significant and unprecedented achievement and it
was the formula for this extract that was chosen
by Macleod to be used in Leonard Thomson,
heralding the first clinical trial of insulin.7
Interestingly though, the extract injected into
Leonard Thomson, was of Banting and Best’s
formula that they had been using on Marjorie
since November, a month before Collip began
working on the project. In fact, Collip’s extracts
were only starting to be used on January 23,
1922, which was 12 days after the first clinical
trial of insulin in Leonard.8 Perhaps the mixed
experimental results were sufficient to convince
Macleod that Banting and Best’s extract was
refined and safe enough to be injected into a
human. Insulin’s first patient, Leonard Thomson
was 14 years old when he was admitted to TGH
on December 2nd, 1921 as “poorly nourished,
pale, weigh[ing] 65 pounds, hair falling out,
odour of acetone on [his] breath…abdomen large
and tympanic…dull, talked rather slowly [and]
quite willing to lie about all day.”2 He had been
diagnosed with a case of severe juvenile diabetes
with ketosis and according to Macleod, Banting,
Best and the rest of the Toronto group, his
“careful dietetic regulation [(the prevailing
treatment for diabetes at the time)] failed to
influence the course of the disease. [B]y January
11th his clinical condition [was]…definitely
worse.”2 Banting et al., made it evident in their
1922 CMAJ publication from which these
excepts are taken that it was Thomson’s
unpromising and grave circumstance that
prompted them to inject what was described as a
“thick brown muck” into the boy’s buttocks –
this muck, as described by Walter Campbell, the
chief clinician at TGH at the time, was 15 cc. of
beef pancreas extract made by Banting and
Best.9
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The effect of this first clinical test with
Banting and Best’s extract was not spectacular.
In the Banting et al. CMAJ paper, it is described
with one sentence:
The extracts given on January 11th were
not as concentrated as those used at a
later date, and, other than a slightly
lowered sugar excretion and a 25% fall
in the blood sugar level, no clinical
benefit was evidenced.2

clinical testing. The result was that for the first
time in recorded history, an extract of pancreas
had been unambiguously successful in having a
distinct antidiabetic effect on a human. Now,
millions of people worldwide who suffer and
would surely die from diabetes mellitus are
offered life and the hope of fulfilling their goals
and achieving happiness.
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Feature Article
Laennec and Auscultation
Milli Gupta
René-Théophile-Hyacinthe Laënnec invented the stethoscope in 1816 while trying to examine a young female thought
to have a heart problem, improving the diagnosis of disease and establishing objectivity in clinical medicine. This
invention came while physicians were struggling to correlate post-mortem pathology with clinical symptoms. Until
1816, symptomatology was the only means to diagnosis. The stethoscope not only connected post-mortem findings
with clinical findings but also helped identify illnesses that were asymptomatic. Laennec’s invention furthered the
study of physiology, and he used it to study the lung and heart. This paper discusses both his life and his pivotal
contribution to medicine.

Biography
René-Théophile-Hyacinthe Laennec was born on
February 17, 1781 at Quimper, Brittany, the first
born in a respectable family. After his mother’s
death from tuberculosis in 1786, he and his
brother were sent to live with relatives and
eventually ended up with Guillaume-Francois
Laennec, a physician at Nantes, a second father
to them, and a positive influence in René’s life.2

Figure 1: René-Théophile-Hyacinthe Laennec1
Through his uncle, René received the finest
education during the revolution, and got a job as
a medical aide in the army at the age of 14. He
learned clinical work, surgical dressing,

dissections and patient care. By 1799, after 34
months of service, René had decided on a career
in medicine. However, the revolution had closed
the medical faculty in Nantes, bringing René to
Paris for his medical education.3
On coming to Paris, he enrolled in the École
de Sante, a school which received a huge boost
in surgical studies from Napoleon. He was able
to sharpen his clinical skills and broaden his
knowledge by studying with some of the best:
Jean Nicolas Corvisart des Marets, later
Napoleon’s personal physician, and Jean-Noel
Halle, professor of hygiene and a mentor.3 It was
Laennec’s work with Corvisart that would have
implications on his study of the chest and
invention of the stethoscope.
Around this time, Laennec became interested
in the new science of pathological anatomy. He
wanted to connect presenting symptoms with
physiological and pathological processes.4 He is
reputed to have written roughly 400 case reports
during his first few years in Paris, including
important information on peritonitis, amenorrhea
and liver disease. 1 He eventually transferred to
École Pratique de Dissection in 1802.
In 1803, he received first prize in surgery and
runner up in medicine from the Grandes Écoles
of Paris. He was the first to win two awards in
one year, an acknowledgement of his skill as a
surgeon. Hoping to make more money and use
his own organization of pathological anatomy,
Laennec started his own anatomy class at the age
of 22. He was also working as a ghostwriter on
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many medical texts, but stopped when
remuneration was scarce.5
In July 1804 he successfully defended his
thesis on Hippocrates and his support of
pathological anatomy. This successful defense
made him part of the Societe de l'Ecole, to whose
journals he made many contributions. He was
still active as editor, contributor and reviewer in
the ‘Journal de medecine’, in which he had been
publishing as a student.
Laennec managed to accomplish much at a
young age, and had hoped that his research,
impressive publications and prizes would garner
him a position - but this was not so. He had little
political influence as a devout catholic and proud
royalist at the time when Napoleon was taking
over. It wouldn’t be until 1816 before that dream
would be realized.
Following his graduation he pursued work in
many different specialties, such as parasitology,
pathological anatomy, nosology (classification of
disease) and philology (study of ancient texts
and authors). He also wrote a two-part treatise on
pathological anatomy that was never published.
The classification system from this treatise is
important because his future work relied on this
framework. He tried to distinguish between
benign and malignant tissue growth without
describing the process behind their production.3
In 1810, he applied for the chair of
Hippocratic medicine, but the chair was
dissolved in 1811 and he focused on clinical
medicine instead. He also found that most of his
income came from the care of patients. However
by then, he was showing signs of tuberculosis
infection, believed to have been acquired through
a needle-stick injury during an autopsy in 1803
(he did not acknowledge his illness until the end).
He also felt a change of work style would do him
good.
He carried on his practice in Paris for a few
years and took care of such prominent figures as
Napoleon’s uncle before accepting a position at
the Necker Hospital in Paris in 1816. His most
important contribution to medicine, inventing the
stethoscope, would be made there.
In 1819, Laënnec published the first edition
of his book, entitled De l’Auscultation Médiate.

Two years later it was reorganized, translated
into English, and published by John Forbes
under the title A Treatise on Disease of the
Chest.2 These books described in exquisite detail
many lung diseases, especially tuberculosis. A
second edition with many additions was printed
in 1826.

Figure 2: Laennec’s stethoscopes6
A few months after the book’s release in
1819, he returned to his native Brittany due to
failing health. His health improved and his
recognition grew. He became a professor of
medicine at the College de France and was put in
charge of Hopital Charite in 1822. In 1824, he
was made Chevalier of the Legion of Honor of
France and was married. His health deteriorated
in April 1826 and he returned to Brittany, to pass
away in August. His physician may have used
Laennec’s own invention to diagnose him, but
kept the diagnosis from him until the end.3
Auscultation
As Laennec and others moved toward correlating
post-mortem findings with clinical disease1,
physical examination became an exciting new
area of clinical medicine. Given that Laennec’s
mother, uncle, brother and friend Bayle
succumbed to tuberculosis, he did considerable
investigations in chest medicine. During his
early days with Corvisart, he learnt of percussion,
which was being re-introduced into medical
practice. Percussion was initially introduced by
Leopold Auenbrugger in 1761, who applied the
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technique to examine a wine barrel towards the
thorax1, surmising that a normal thorax would
resonate, but one filled with secretions would
sound low-pitched.
Corvisart used his physical exam findings of
percussion to predict postmortem findings before
the patient died. He then applied this to the heart
and could detect an enlarged heart. He could also
discern a thrill, which led him to believe “the
palpitations of the heart are sometimes so intense
that the sound of the heart can be heard beating
against the chest wall”.5
Direct auscultation (placing the ear on the
chest wall) was another technique (Figure 3).
This was known to Hippocrates and extensively
used in ancient Greece. However, it was hard to
perform this act on obese or heavily endowed
females as it was socially unacceptable and
unhygienic, and sounds would often be muffled
and hard to interpret.
It was only a matter of time before the
stethoscope would have been invented. Many
glorified tales exist of how Laennec came to
create it, but the consensus is that in 1816, he
saw a young female presenting with generalized
symptoms of heart disease. He was
uncomfortable with direct auscultation, so he
rolled up a paper notebook, applied one end to
the chest, and listened to the heart. He felt that
he could hear the heart more clearly than if he
had used direct auscultation. He coined a famous
double entendre “J’entends,” meaning “I hear
and I understand” and named his instrument the
stethoscope, from the Greek “to explore the
chest”.5 He subsequently used his invention to
identify many pathological lesions within the
heart and the lungs.

Figure 3: Laennec at the bedside
performing direct auscultation6
Laennec needed a very good ear and wide
vocabulary to create a classification system for
his findings. He described what he heard by
creating a common vocabulary to correlate
anatomy and pathophysiology for others to use
and understand. To describe what he heard,
Laennec relied on imagination and the common
sounds in nature. Examples include animal
voices and pitch, music, and urban life.4
In identifying what findings he considered to
be a sign of the disease in question, Laennec
used the basic concepts underlying sensitivity
and specificity.5 Findings with high specificity
(being present with just one disease) were
deemed “pathognomonique,” while findings that
were of low sensitivity (present in only some
cases of a disease) were deemed less reliable. As
an example, pericarditis can occur without
friction rub, therefore making it not sensitive.
Pulmonary Signs
Although it was cardiac disease that led to the
invention of the stethoscope, Laennec’s legacy
arises from his work on the lung. Laennec set up
the first categorization of these findings. His
classification style relied on defining disease by
its post-mortem characteristics. For instance, in
his time, tuberculosis was defined by presenting
symptoms. Laennec defined tuberculosis by the
presence of lung caverns (tubercles) on autopsy.4
He used the stethoscope to identify these lesions
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and to diagnose patients earlier, not waiting for
late symptoms to give the official diagnosis.
Through percussion and auscultation,
Laennec identified the pathophysiology of the
cavitary lesions. He believed there was a change
in tuberculous ‘matter’ from grey to yellow,
which then liquefied (caseation) and expelled
through the airways, leaving a cavity (often
calcified) at autopsy.5 He was the first to use his
stethoscope to identify tuberculosis in patients
who had no signs or symptoms (latent
tuberculosis), but had anatomic defects.
Laennec initially believed in a direct, one-toone relationship between the sound heard and the
pathology a patient presented with.
He
considered pectoriloquy, a change in the
patient’s voice heard with a stethoscope, to be
indicative of tubercles.4 Even if the patient did
not present with the symptoms, if pectoriloquy
was heard, the patient undeniably had
tuberculosis.5 However, he soon realized that all
cavities may result in pectoriloquy, but not the
converse. By 1817 he thought that bronchiectasis
(dilation of the airways) and the second stage of
pneumonia (hepatization) also resulted in a
similar
sound.
To
maintain
his
“pathognomonique,” rule, he changed the name
of the sound in the latter two lesions to
bronchophony.5 He was initially resistant to this,
and so this revision only appeared in the 1826
edition of his book.
Similarly, he claimed egophony was a variant
of pectoriloquy but sounded like the bleating of a
goat, and believed this to be synonymous with
acute pleural effusion, refusing to be challenged.
Ironically, he admitted having troubles
differentiating between the two.5 He also
believed rales (bubbling or silent respiration)
was pathognomonic for bronchitis (1816-17),
metallic clinking for pneumothorax with small
quantity of fluid, and decreased breath sounds
for emphysema (1818). He acknowledged the
various sounds of rales, but attributed this to
differing sputum color, quantity and texture.5
His invention also helped him put physiology
into practice.5 The first time he heard “puerile
respiration”, he thought it was a physiologic
response to increased oxygen demand in adults,

and a normal variant in children. He later
realized it was also a sign for asthma, but there
was no post-mortem lesion to associate with this.
He relied on physiology to explain the clinical
presentation of shortness of breath: constriction
of the bronchiolar muscles was separate from
costal and diaphragmatic movements, leading to
decreased air entering the bronchioles and
reduced oxygen delivery.
Patients had to
increase their breathing rates to increase oxygen
flow. In those without clinical signs of asthma,
hyperventilation secondary to ‘white coat effect’
led to these findings.
Conclusion
The stethoscope made it possible to reveal
physical changes before the patient died. The
discoveries by auscultation of the thorax led to a
frenzied search for pathognomonic signs in other
parts of the body. The stethoscope allowed
physicians to detect asymptomatic lesions and
introduced objectivity to clinical medicine, but it
shifted the focus of medicine away from the sick
person.
Although active in establishing objective
signs of disease, Laennec believed that patient’s
symptoms were just as important when it came
to diagnosis. Even when the stethoscope did not
tell him anything, he continued to believe in the
possibility of the disease, and paid his patient
due respect. The work that Laennec did was
indisputably amazing and accurate for his times.
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Feature Article
Lovesickness: The Most Common Form of Heart Disease
Nancy Dzaja
“My mouth doth water, and my breast doth swell,
My tongue doth itch, my thoughts in labour be;”1
As Astrophil pines for his Stella in Sir Philip Sidney's sonnet, he describes the physical symptoms of his infatuation
which point to a rampant case of lovesickness. In addition to its common presence in works of literature, lovesickness
has been described as an actual medical entity with a specific etiology, pathogenesis, and treatment. Amazingly, many
of the described symptoms of lovesickness are consistent across time and place, including fever, agitation, loss of
appetite, headache, rapid breathing, and palpitations. On the other hand, other aspects of the disease and its care differ
tremendously depending on the cultural context. Lovesickness (also known as lover’s malady, mal de ojo, mal amor,
amor heroes, inordinate love, or philocaptio) had a variety of proposed etiologies. In the Middle Ages it was often
attributed to love philters and demons, while the ancient Nahua of Mexico thought it had to do with the evil eye. The
disease had serious consequences: failure to treat an afflicted patient could result in losing one’s genitalia, death, or
eternal damnation. Treatments were creative and varied widely, from herbal remedies to the prescription of sexual
intercourse, to drinking water that had been boiled in the desired person’s underwear. Lovesickness is a disease that
permeates medical literature since the time of Hippocrates, and may still have a place in modern medicine in the form
of somatoform disorder, bipolar disorder, or erotomania.

Introduction
In a case description, the physician Erasistratus
(4th century BC) is called to the bedside of Prince
Antiochus, who is extremely ill. On examination,
the prince is weak, emaciated, and near death,
and no one understands why. As Erasistratus
feels Antiochus’ wrist, he realizes that the
prince’s pulse quickens and he becomes flushed
when his stepmother Stratonice enters the room.
Erasistratus realizes that Antiochus is suffering
from lovesickness, and tells King Seleucus, who
gives his wife to his son.2 Similar stories are
attributed to Hippocrates and Galen. Indeed,
lovesickness is a disease that permeates medical
literature and the ability to diagnose it was the
sign of a great physician.2 Descriptions of the
disease have changed extensively over hundreds
of years and it may exist today in the guise of
psychiatric disorders.
Signs and Symptoms
The signs and symptoms of lovesickness (also
known as lover’s malady, mal de ojo, mal amor,
amor heroes, inordinate love, or philocaptio) are
often consistent regardless of time or culture.
Lovesickness involves fixation on a person: the

afflicted individual has obsessive thoughts about
the object of their fixation.3 Insomnia, loss of
appetite, hollowing of the eyes, anorexia, pallor,
rapid pulse, and jaundice are consistently
described.3,4,5,6
Other symptoms are more specific to the
time or place in which they were described. For
example, the Islamic physician Rhazes (850-923
AD) described a unique syndrome. In the early
stages, the patient’s eyesight would become
weak, the tongue would dry up and pustules
would grow on it.5 A dusty substance, and marks
like dog bites would appear on the patient’s back,
calves, and face. If untreated, the person would
eventually wander through cemeteries at night
and howl like a wolf.
One of the manifestations in medieval Spain
was the “Frog/Diana syndrome,” caused by
excessive desire of a person, and led to a person
viewing something unpleasant and repulsive as
beautiful and desirable.6
Some
medieval
writings
connect
lovesickness and bipolar disease. Depressive
symptoms of weeping, insomnia, and loss of
appetite were accompanied by manic symptoms
in many.4 Rapid mood swings between
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inappropriate laughter and depression were
common.6 Ferrand described a situation where
patients “have a look about them that suggests
they see something pleasing, or else are hearing
it, or longing for it…one moment they laugh, a
moment later they turn sad and weep, now they
jest, and a short time later are sorrowful, pensive,
and solitary.”5 Toohey maintained that the
depressive type was more of a cliché with the
manic form more common, and patients often
becoming violent.7 Similarly, Hippocrates
described violent symptoms with melancholy
madness, which may have been related to
lovesickness.5 He described how some women
are prone to this condition, which causes them to
become insane, homicidal, and produces a desire
to asphyxiate themselves. This is akin to the
violent impulses that may occur in people during
a psychotic manic episode.
The Nahua of Mexico describe unique
findings, including grabbing posts as substitutes
for the desired person, the formation of blisters
on the face, and a red eye with a yellowish
mucus discharge.8 In extreme cases, the disease
interrupted the circulation, causing blood to
freeze in the heart. Lovesickness could also
result in the disappearance of the genitals.
Although the major symptoms of lovesickness
are fairly consistent, the disease also had a lot of
variability in its atypical presentations.
Etiology and Pathogenesis
Physicians of Hippocrates’ era believed that
maintaining a balance of the four humors (blood,
phlegm, choler, and melancholy) was essential to
maintaining health.5,10 Disturbances of the
melancholy humor led to psychological
problems and somatic side effects, resulting in
symptoms of lovesickness. The early Christian
writers did not clearly distinguish between
illnesses of the body and illnesses of the spirit,5
believing that lovesickness was a disease of the
senses that could also corrupt the soul.
Medieval medical writings had a more
clearly defined pathogenesis for the disease. The
first stage occurs when the object of desire
causes overheating of the “vital spirit.”4 The vital
spirit inflames the middle ventricle of the brain,

which was where the faculty of estimation (or
the virtus aestimativa) is located, resulting in
dryness in the faculty of imagination (virtus
imaginative). Consequently, the image of the
beloved becomes imprinted in the patient’s
memory, causing obsession, decreased ability to
reason, and abnormal behaviour.6
Hereditary causes were considered possible
during the Renaissance. The child of a parent
who suffered from lovesickness was at greater
risk unless this predisposition was countered by
other factors including a good education,
excellent discipline, or an orderly lifestyle.5 It
was also believed that most people who
developed the illness had a susceptibility to it:
young children, the very old, eunuchs, and the
impotent were considered essentially immune.5
Lovesickness befell men and women equally
in the ancient Nahua. The disease did not
necessarily occur in the person who was
experiencing the desire: it had to do with which
person was the weakest.8 The stronger person
had more heat power in their eyes, and could
cause harm to others by looking directly at them.
For example, a woman might see a man she liked
and make him ill by looking directly into his
eyes. For this reason, lovesickness was
considered a form of mal ojo, or evil eye.
Magical and Demonic Causes
In the Middle Ages, use of magic in the matters
of love was fairly popular. For example, some
believed that hair from a hyena’s muzzle was a
love charm when placed on a woman’s lips.11
Similarly, it was thought that if a woman kept
the Eucharistic host in her mouth while kissing
her beloved, she could make him fall in love
with her permanently. In the 13th and 14th
centuries, academics began writing about “visual
species;” objects that mediated between the
physical world and the mind. Visual species
could cause lovesickness by imprinting images
into the imagination from a distance. It followed
that incantations and magic could also generate
species in the mind and cause changes that
affected the body. Consequently, magic was a
possible cause of lovesickness. Temptation by
demons was could also cause the disease since it
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was thought that the Devil had a partiality for
inflicting sexually-related diseases on people.12
By the 15th century, lovesickness became
associated with the occult and the disease was
listed as a widespread form of witchcraft in
manuals for witch hunters.11 During the
Renaissance, potions and philters were also
considered to be possible causes of the disease.11
Lovesickness in Women versus Men
The sex of the patient was also a risk factor. In
medieval times, lovesickness tended to be a male
disease, especially since medical writings came
from monasteries where the illness was
negatively regarded.13 Eventually, lovesickness
became regarded as a form of courtly love,
where a man worships and idolizes a woman as
perfect even while she scornfully rejects him.
This form of love was considered ennobling and
chaste. In the Renaissance the illness was
interpreted as a shameful and debasing sexual,
and not a mental disease, and so it became
attributed to women.13 According to medical
treatises, women enjoyed intercourse more than
men, were more impulsive, and were not rational
enough to resist their desires.5 Medical writers
believed lovesickness could be caused by a
distended clitoris, or by satyriasis (pain caused
by a voracious desire for sexual intercourse).5 An
illness known as uterine fury may also have been
linked to lovesickness: in this disease, the
woman has an inordinate interest in sex and
experiences painless burning sensations in her
genitals.5 Uterine fury was usually a disease of
overly sensuous, greedy, and gluttonous women.
Treatment
Treatment options varied depending on the
cultural values and medical beliefs of the time.
Greek and Roman physicians often prescribed
sexual intercourse for the illness.
Galen
maintained that men should make love for the
sake of staying healthy, even if they derived no
pleasure from it.3 Similarly, the Iranian physician
Avicenna recommended sexual intercourse, but
only if law and religion allowed it.5 If this was
not possible, physicians would attempt to distract
their patients with baths, sleep, and exercise.

They also hired old women to belittle the object
of the patient’s affection.
During the medieval period, many people
perceived sexual activity in general as capable of
corrupting the soul. Consequently, most
therapies during this time revolved around
distraction. Herbal remedies helped rid the body
of destructive humors.6 Distracting the patient
could be done in a number of ways, including
sending the patient on a trip or inflicting pain.6
Some believed that scaring the patient into good
behaviour was the most effective cure: patients
were told that sexual activity could lead to
blindness, gout, accelerated aging, kidney failure,
pulmonary disease, genital sores, baldness,
infection, the conception of monstrous children,
and even eternal damnation.6 Perhaps the most
dramatic of treatments in this time period
involved attempting to change the patient’s
perception of his beloved from adoration to
disgust. This was done in many creative ways,
such as forcing the patient to stare at a cloth
soaked in the woman’s urine or menstrual blood,
or burning her stool in front of the patient.6
Cures during the Renaissance tended to be
more invasive, with blood letting being a popular
choice.5 If a distended clitoris was the origin of
the problem, then cutting it could bring about
recovery.5 Pharmacological treatments included
opium to treat the associated insomnia, and
hemlock to reduce sexual desire.
Because the Nahua of Mexico believed that
the root of the illness was excessive heat from a
person’s eye, most treatments involved the use of
cold water.8 Some examples include drinking
water from abandoned wells, drinking the saliva
or urine from the desired person, or drinking
water that had been boiled in the person’s
underwear. Having the patient gaze directly into
the eyes of the person to eventually satisfy their
desire was another method.
Lovesickness in Modern Medicine
Lovesickness has been a common medical entity
for hundreds of years, and yet it has no mention
in modern medical texts. It is possible that the
disease exists today under a different title. Many
symptoms of lovesickness are similar to
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symptoms of modern psychiatric disorders,
including obsession, rapid mood swings, loss of
appetite, insomnia, and compulsions. In a recent
study, Marazziti et al looked at serotonin levels
in people who had recently fallen in love and
patients with obsessive-compulsive disorder.
They found that both groups had lower than
normal levels of serotonin, suggesting shared
psychological elements.14 Many of the symptoms
of lovesickness have to do with alternating
between depression and mania, so perhaps
lovesickness
in
modern
medicine
is
encompassed in bipolar disorder. One study used
functional MRI scanning to show that very
specific areas of the brain were activated in
patients who were in love,15 and perhaps a
pathological stimulus in these areas of the brain
could lead to lovesickness. Tallis makes the
point that some of the therapy used for
lovesickness over a thousand years ago is similar
to modern cognitive behavioural therapy, such as
Avicenna’s encouragement of distracting the
patient from his fixation using physical exercise,
trips, and so on.16 Finally, lovesickness may be a
somatoform disorder, where physical symptoms
exist that are not part of another medical
condition or mental disorder. These patients may
have psychological conflicts that are translated
into somatic problems.
Conclusion
Lovesickness was a common disease that
persisted throughout centuries and may still
endure today. The supposed etiological factors
and treatments changed as cultural beliefs
evolved and as the understanding of science
developed. Many of the symptoms and signs
remained constant regardless of what point in
time or in what culture you examine them; this
adds to the authenticity of the disease. Many
aspects of the disease can be explained by
elements of modern psychiatric disorders, which
makes it likely that there are still many patients
suffering from lovesickness even today.
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Feature Article
Paracelsus the Innovator: A Challenge to Galenism from
On the Miner’s Sickeness and Other Miners’ Diseases
Emily R. Kelly
Phillipus Aurelius Theophrastus Bombastus Von Hohenheim, called Paracelsus, occupies a curious place in the history
of medical innovators: on the one hand celebrated for his emphasis on empirical observation, and on the other reviled
as a hot-headed and arrogant mystic. His works show great devotion to the Light of Nature, a property of the world
which caused it to reveal its God-given healing secrets to the discerning and knowledgeable physician. This emphasis
on experience was radical in the days when scholastic study of the works of Hippocrates and Galen was the basis of
medical practice. Paracelsus rejected the authority of Galen but lacked the tools of the scientific method to replace
Galen’s teachings with empirical knowledge. Instead, Paracelsus devised a highly creative and interwoven mystical
system of macrocosm and microcosm - God had devised the stars, spirits and the natural world in a pattern which was
repeated in man’s sidereal, spiritual and physical bodies. The wise physician could study the natural world, waiting to
reveal its healing clues. This paper will evaluate Paracelsus the innovator based on one of his most influential and
important writings, Von der Bergsucht und Anderen Bergkrankheiten, (On the Miners’ Sickness and Other Miners’
Diseases), written in 1534. An in-depth look at Paracelsus’ theories of pathogenesis, cure, and prevention of miner’s
diseases will show that Paracelsus was a positive innovator in the history of medicine in his role as a reformer of
medical therapies, as proponent of preventive medicine, and as advocate of learning through experience.

Introduction
While some are remembered for important
contributions to medicine, and others as icons of
their time, Paracelsus is most remembered for a
lively and infamous temper. Phillipus Aurelius
Theophrastus Von Hohenheim, called Paracelsus,
was probably not a pleasant man. Paracelsus had
a prolific output, and his follower Huser of Basel
collected and edited these works (1589-91).
Huser had difficulty separating Paracelsus’ life
and works from colourful legend.1,2 Paracelsus
was deeply concerned with healing the outcast
and sick, and with reforming a stagnant and
bastardized Galenic medicine, but was grandiose,
self-assured, with poor political judgement and a
wicked temper.2,3
Sixteenth century medicine was the product
of medieval scholasticism filtered through
Eastern commentators.2 Galen, interpreted by
Avicenna, was the medical authority of the day,
while the Church ruled over diseases of
supernatural origin.4 Medical knowledge was
complete with Hippocrates and Galen, and
although
these
early
physicians
had
experimented, this was no longer done. Medieval
observations were limited to those which
reinforced pre-existing theories. Dissections

were rare, crude, and viewed as immoral.
Scholastic medical ideas were based on Galen’s
theory of four humours: phlegm, blood, yellow
bile and black bile representing the elemental
influences of cold, dryness, warmth and moisture.
Disease resulted from an imbalance in these
humours, and was treated with a “cure by
opposition” approach using complicated
concoctions of herbs and unsavoury animal
products, or bleeding and purging.1,2 Insanity
was viewed as a supernatural affliction stemming
from demonic activity.4,5 A rebel from the
beginning, Paracelsus burst onto the scene with
his own elemental system, the idea of like curing
like6,7, an increased emphasis on simple herb and
mineral remedies 6,7, and natural origins of
insanity.5
Theophrastus was born in Einsiedeln,
Switzerland in 1493. His father, William of
Hohenheim, was a local physician, from whom
he presumably learned the basics of medicine.
His name Paracelsus, a Latin creation perhaps
meaning “equal of Celsus,” a classical physician,
was taken on during his university days.2 His
early education is mysterious: he may have
obtained a medical degree at the University of
Ferrara. He spent some years practicing in the
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Fuggers mines at Hutenberg and Schwaz,
possibly penning an early version of Von der
Bergsucht und Anderen Bergkrankheiten, (On
the Miners’ Sickness and Other Miners’
Diseases). He worked as an army surgeon before
arriving at Straussburg in 1526. The great
turning point in his career came in 1527 when he
was appointed as city-physician to Basel. He
lectured at the university in vernacular German,
an innovative insult to the scholastic sensibilities
of the time, and gave lectures criticizing
Galenism, demanding reform in medicine. He
publicly burned a copy of Avicenna’s Codex at a
student gathering. After two years in Basel, he
had so many enemies that he was forced to flee,
spending years wandering and studying in
various degrees of poverty. He wrote prolifically
on syphilis, plague, and surgery, completing his
fundamental books, Paragranium and Opus
Paramirium, in 1531. He returned to the mines at
Hall and Schwaz in 1532-1533, refining his
knowledge of mining and chemistry. He died in
relative comfort in Salzburg in 1541.2,6,7
Paracelsus took ideas from ancient writers,
neo-Platonists and alchemists, synthesizing them
to create his own new metaphysics and
cosmologies.1 He believed that when God
created the universe’s astral, spiritual and
physical realms, he echoed the human being’s
astral, spiritual and physical bodies.1 Nature was
a macrocosm, ordered into different groups and
stages of being, reflecting a human’s different
and ordered components. The components were
Paracelsus’ new elements: salt, the principle of
stability; mercury, the principle of volatility; and
sulphur, the principle of combustibility. The
stomach was the Archeus, a sort of alchemist that
sorted out and arranged the salt, mercury and
sulphur in the patient’s food and air.1,6,7
A physician was gifted by God with the
ability to read the Light of Nature1, a property
which revealed secret patterns of Nature’s
macrocosm which could be harnessed to heal
disease. This is probably Paracelsus’ greatest
scientific achievement: knowledge is to be
sought through the observation of Nature.
However, Paracelsus was a medieval man, not an
empiricist. Without the tools of hypothesis and

experiment, he was forced to substitute his own
metaphysical theories for those that he had
rejected. This is evident in his four pillars of the
practice of medicine: Philosophy, the study of
the Light of Nature, Astronomy, Alchemy, the
earliest branch of chemistry, and Virtue,
theological understanding and right practice.1
The Von der Bergsucht
The Von der Bergsucht und Anderen
Bergkrankheiten may have written as early as
152510, though others favour 1534. It was
published posthumously by Samuel Architectus
in 1567, and was not widely read until a century
later.10 It is based on years of up-close
observation of the workers made by Paracelsus
in local mines, who favoured experience over
theoretical talk. As Paracelsus puts it:
It is no longer meet to speak with the
learned men and the philosophers, but
with experienced men; for it is the
manner and the innate custom of any
experienced man not to confront another
experienced man with talk…Experience
is so constituted, that an understanding
of its works makes itself known to
everyone without much gab.11
The Von der Bergsucht is divided into three
books, each subdivided into four tractates. The
first book deals with diseases of miners, the
second with diseases of smelters and metal
workers, and the third with disease caused by
mercury, which Paracelsus considered unique
enough to be treated separately. The four
tractates introduce the disease and elements in
question, and discuss pathogenesis, signs of the
disease, and finally, the disease’s cure.
The First Book
Paracelsus, always humble, begins the first book,
with an observation that no previous scholar has
attempted such a classification.10 He then
explains the basics of how sicknesses of the
lungs are generated in the second tractate. Air is
the food of the lungs, and is digested there.10 Air
can be polluted through contact with the stars,
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whose alchemical furnaces cause air to become
separated into its separate elements which are
harmful to human health.10 These elements are
mercury, which causes disease by coagulating
from smoke, sulphur, which can be roasted by
fire onto the lungs, and salt, which precipitates
into the lungs. Altogether, these imbalanced
elements cannot be properly digested by the
lungs and form tartarus10, a sort of mucus that
induces disease. Paracelsus draws a distinction
between the lung diseases that all people suffer,
and those unique to miners. Those suffered by
above-ground dwellers are caused by the
poisoning of surface air by the celestial stars.
Those suffered by miners, however, result from
the digestion of subterranean air that is poisoned
by subterranean stars. By this Paracelsus meant
the minerals themselves, forming constellations
under the earth in the same manner as proper
stars do in the sky.10 Thus, astronomy, the
second pillar of Paracelsus’ medicine, informs
philosophy, his first pillar of medicine.
The third tractate concerns the recognition of
miners’ diseases. He stated that physicians are
ordained by God to protect men from the
dangerous but necessary work of mining.10
Paracelsus understands himself as a divinely
ordained servant. He recognized the importance
of shortness of breath due to excessive cold, and
acidity and hoarseness due to excessive
sulphur.10 Paracelsus expounds the importance of
observing disease to be able to accurately
identify these signs.10 He then poses two ideas of
enduring worth to the progress of medicine: a
recognition of acute versus chronic forms of
poisoning, which he attributes to ingestion of the
body instead of the spirit of a mineral. Eating
arsenic produces instant death, but a vapour
coming off the mineral produces a slower disease
with the symptoms similar to pulmonary fibrosis,
neoplasia, or emphysema.10 The other idea is his
formulation of what would become known as the
homeopathic principle. As Paracelsus puts it:
Now our physic (cure) is in mercury,
sulphur and salt, and our poison is
also in these three things, for they both
exist
together10…For
instance:

whatever causes jaundice, also cures
jaundice. It is thus: good and evil are
in the same thing, the jaundice arises
from the evil, and when the good is
separated from the evil, the arcanum
(cure) against jaundice is there.10
The final tractate concerns itself with cures
for miners’ diseases. The first cures are
preventative, beings recipes for prophylaxis
against ore vapours.10 A diet rich in salt and
deficient in spices is prescribed for the same
reason.10 Once the disease has taken hold,
Paracelsus divides his cures into natural cures
and arcana cures. Natural cures include sweating
and the use of cyclamen roots.10 Arcana cures
take advantage of the astrological and elemental
correspondences that caused the disease in order
to cure the disease. The poisons are divided into
arsenic, antimony and alkali sub-types, and each
has its own mineral cure designed to produce
sweating within the effected organs to wash off
the polluting tartarus.10
Discussion
In treatment, Paracelsus rejects the Galenic
model by rejecting the theory of bodily humours
and by rejecting cure by opposition. Paracelsus’
pathogeneses are not internal humoural
imbalances, but external poisons that have
accumulated inside the body. This is much closer
to our understanding of the modern pathogen. Of
course, Paracelsus is reluctant to leave the older
imbalance model behind entirely, as his
dissertations imbalances of air, fire, water, and
earth indicate. Paracelsus is also the first to
suggest that the cause of disease may also be its
cure - the homeopathic principle and the idea
that one substance may contain both good and
evil within it, which has played such an
important part in the history of medicine.
Paracelsus’ pharmacy is also of interest to
history. He is an early, if certainly not the first,
proponent of a return to simple herbal remedies.
More importantly, he is the first to introduce
mineral remedies effectively. These would
become increasingly popular, entering England’s
materia medica in the next century.
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Paracelsus was also a strong advocate of
what we might today call “lifestyle
management”. He clearly understood that certain
occupations carry their own specific risks, hence
an entire book devoted to the diseases of miners
and refiners. Of particular interest is his
emphasis on the prevention of disease,
something whose importance is sometimes
forgotten in today’s medicine. Lifestyle control
plays some part in this: Paracelsus recommends
specific diets and sweatbaths for miners.
Paracelsus shows a rudimentary understanding
of primary and secondary prevention of disease
by discussing those therapies that keep the
patient from becoming weak and susceptible to
mine vapours in the first place, and those that
drive out infections before they take hold.
Finally, there is Paracelsus’ emphasis on
experience, and where his sermons reach their
most bombastic heights. He was nothing less
than fanatically passionate about rejecting book
learning and going out to the patients and local
healers to understand disease. In the Von der
Bergsucht he says:
This experience should defend itself and
the results which should move every
unbeliever to believe in physic should be
examined. For the results are so clear,
that they are not in need of any
disputation… However, each one should
retain his own experience; for who can
or wants to fathom the end of
medicine?10
Paracelsus anticipates the secular and empirical
trends that would soon sweep medicine as the
Renaissance took hold. However, he cannot
make the leap away from the medieval
scholasticism in which he was raised; he does
not have any guides or tools with which to do so.
He cannot be properly understood as a demystifier of medical knowledge.11 His own
mystical systems are complex and frequently
self-incompatible. For all his arrogant confidence
in his own mystical ideas however, Paracelsus
remained a stubborn proponent of experienced
facts, and as the above quotation shows, he

remained open to the idea that his own
understanding might someday be surpassed by
others’ experiences.
Conclusion
So was Paracelsus a positive innovator? It
depends on the measure. The Von der Bergsucht
is the first handbook of occupational disease, and
one of the first therapeutic texts to endorse a
homeopathic ideal. Paracelsus’ descriptions of
the physiognomy of mercury poisoning are quite
accurate. On a practical level, Paracelsus’ Von
der Bergsucht is a mixed success. Some of his
herbal and mineral cures may have worked, and
some undoubtedly did not. His observation that a
substance might be helpful or harmful depending
on context is a valuable one. However, to focus
entirely on the practical therapeutic value of
Paracelsus’ cures is to miss out on his greatest
contribution to the history of medicine. This is a
catalogue of diseases not heretofore recognized
by medical authorities- the idea that the
ancients might have missed a few things is
radical and valuable. Furthermore, Paracelsus’
physiognomic data on the miners’ diseases more
than any others (save perhaps his studies on
syphilis) were based on real, objective
observation. Openness to new ideas and close
observation and relationship with the patient,
was an ideal of Hippocrates, and is something
still highly prized in medicine today. It is also an
innovation of which Paracelsus was one of the
earliest proponents. For this reason, Von der
Bergsucht und Anderen Bergkrankheiten,
demonstrates the Paracelsus was indeed a
positive innovator in the history of medicine.
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Feature Article
Race, Contagion, and Discrimination: Endemic Leprosy
in 19th Century New Brunswick
Joanne Hamilton, Meds 2005
Leprosy has long had a reputation for being one of the most feared of all human diseases. In Canada today the disease
is a rarity and the few existing cases are considered little threat to public health; however, this was not always the case.
In the mid- to- late nineteenth century an endemic leprosy was found to exist among the Acadian Population of New
Brunswick, a discovery which caused much concern within the nation’s medical and legislative communities of the
time. In this outbreak, which occurred prior to the discovery of the leprosy bacillus, the physicians involved with the
situation were deeply divided as to the nature of the disease: was it hereditary or was it contagious? Their decision
would prove fateful for the victims of the disease in this area. Furthermore, issues of race and class would become
central in the discussion surrounding the appearance of leprosy in this population.

Introduction
In Canada today leprosy is a rare disease that is
diagnosed exclusively those who acquired the
infection outside of Canada’s borders.1 However,
this was not always the case. In the nineteenth
century endemic leprosy was found to exist in
Maritime Canada, particularly among the
Acadians of northeast New Brunswick. The
appearance of leprosy on Canadian soil posed
several challenges for the medical and legislative
community of eastern Canada, and brought
Canadian physicians into the debate regarding
the nature of this particularly loathsome disease.
Consequently, the medical community of eastern
Canada made some significant steps toward
understanding the transmission and pathogenesis
of this disease. However, an examination of the
era of endemic leprosy in New Brunswick also
demonstrates the extent to which concepts of
race and class influenced nineteenth century
medical thinking.
It is impossible to know exactly when the
first cases of leprosy appeared in the Acadian
population of New Brunswick or how it was
introduced to this population. The first generally
accepted case of leprosy in the Acadian
population occurred in a woman named Ursule
Benoit who began exhibiting symptoms of the
disease around 1815. Other than her illness,
which claimed her life in 1828, there was
nothing particularly unusual about Mrs. Benoit.
There were no reports of leprosy in her parents’

or her husband’s families prior her illness;
however, after she became ill the disease
appeared in two of her sisters and in her
husband.2 By the 1840’s several small Acadian
towns surrounding Chaleur Bay, New Brunswick,
all had cases of leprosy among their townspeople.
The cases were clustered within several families,
and in most cases the afflicted families were in
some way related to Ursule Benoit and her
family.3 In 1844, the parish priest of Tracadie,
one of the affected towns, began to suspect that
the disease amongst his parishioners was leprosy,
and notified the local health authorities and
urged them to investigate the illness.4 In 1844
the New Brunswick Legislature sent an
investigative Commission to the region to
confirm or disprove the existence of the leprosy.
This Commission reported that they found
eighteen confirmed cases of leprosy and several
other highly suspicious cases. The investigators
unanimously agreed that the illness was
contagious and advocated for the creation of a
lazaretto to separate the sick from the healthy.3
In response to the report, in April 1844 the New
Brunswick Legislature passed legislation which
authorized the construction of a lazaretto, and
gave the Board of Health the authority to
forcibly remove leprous individuals from their
homes and transport them to the facility.
From 1844 to 1849, leprous individuals from
the Acadian communities around Chaleur Bay
were sent to a lazaretto which was built on
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Sheldrake Island, a small island in the mouth of
the Miramichi River.3 Those confined there were
expected to be self-sufficient for all of their basic
needs such as cooking and cleaning. With the
poor living conditions, and deprived from the
support of friends and family, most leprosy
victims deteriorated within months of their
arrival on the island. During the Sheldrake
Island years, the Acadian sufferers of leprosy
were given no formal medical treatment. In
1849, thanks in large due to the lobbying efforts
of the local Catholic Church, the Board of Health
agreed to close the Sheldrake Island lazaretto and
to transfer the surviving individuals to a lazaretto
which would be built in Tracadie. In its five year
history thirty-seven people had lived on
Sheldrake Island; five vanished after escaping
the island, fifteen died, and another seventeen
were transferred to the new facility in Tracadie.3
The Tracadie Lazaretto, while certainly not
without flaws, would over the next century prove
to be a vast improvement over the Sheldrake
Island lazaretto. However, in its early years there
was little improvement in quality of life for those
confined there. In 1850’s the population of the
lazaretto grew and the mortality rate remained
high. The situation was exacerbated by the lack
of formal medical care inside the facility. In
1861, again as a result of the efforts of local
parish priest, a permanent physician was finally
found for the lazaretto. From 1861 to 1864, Dr.
James Nicholson served as resident physician at
Tracadie before dying at an early age of
tuberculosis. In 1865 Dr. Alfred Corbett Smith, a
twenty-five year old graduate of Harvard
Medical School, was hired to replace Dr.
Nicholson; he would remain at the lazaretto until
this death in 1909. In 1868, ‘Les Hospitalieres
de Saint-Joseph’ a Montreal-based order of
cloistered nuns agreed to establish a religious
community and nursing hospital at Tracadie.3
The presence of the nursing sisters, who would
stay with the various incarnations of the lazaretto
until it finally closed in 1965, was pivotal in
transforming the quality of patient care within
this facility.2 With the arrival of first six
‘Hospitalieres’ in 1868 the facility for the first

time functioned as a hospital rather than a
medically enforced detention centre.
At the time of the leprosy outbreak in the
Acadian population of New Brunswick the
origins of the disease was a hotly debated topic
in the medical circles of Europe and North
America. With the discovery of leprosy in New
Brunswick this debate became a local concern.
In their 1844 report to the government of New
Brunswick the medical commission led by Dr.
Alexander Key stated that they unanimously
agreed that leprosy was a contagious disease.3
This conviction paved the way for the legislation
that would create the Sheldrake Island lazaretto.
In spite of this, one of the other authors of the
report, Dr. A.H. Skene, seemed somewhat less
certain of the contagious nature of the illness. In
a report which he submitted to the Montreal
Medical Gazette just a few months later, he
states that those who are vulnerable to the
disease are so by virtue of “hereditary taint, and
by contagion” and he goes on to demonstrate his
conviction by providing genealogical tables
linking the disease to the relatives of Ursule
Benoit.5 In 1847, New Brunswick legislature
appointed a committee of doctors to investigate
the heredity-versus-contagion debate. This
committee led by Drs. Robert Bayard and
William Wilson, conducted a thorough
investigation of all of the known cases concluded
that the illness was non-contagious and
transmitted by hereditary means.6 To support
their argument the authors pointed out the
genealogy of the illness, and they also recounted
the numerous reports of healthy spouses who had
slept in the same bed as their leprous husband or
wife for years without contracting the disease.6
Nevertheless, they did qualify their conviction
by stating that a small number, perhaps one
percent of the population, with no known
hereditary connection to the disease may be able
to contact the illness through casual contact with
a leprosy sufferer.6 The significance of this
report, aside from the surprisingly accurate
description of the immunological basis of
leprosy, was that in their conclusions they
foreshadowed the modern approach to leprosy
management by almost a century. They
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recommended that the lazaretto be abolished as,
“It coerces the leper, and removes him from his
family, without any regard to his feelings”.6 In
the place of a lazaretto, they suggested that the
leper should be given a small monetary
appropriation and be allowed to be cared for at
home. None of the recommendations of this
seminal, albeit theoretically flawed, report were
followed by the New Brunswick government.
The legislature ultimately decided that the
medical evidence was inconclusive, and
therefore, they could not risk the health of the
general public by closing the lazaretto.3
As the heredity versus contagion debate
continued within the medical community there
was one aspect of the transmission of the illness
that was quite generally agreed upon—that
certain peoples, or races to use the term of the
time, were more vulnerable to leprosy, either by
virtue of some inherited factor or by means of
the their lifestyle. Although it was acknowledged
that leprosy had once plagued the European
population it was felt that most European ‘races’
were no longer vulnerable to the leprosy by
virtue of their civilized habits.7 Foreign places
and their ‘inferior’ peoples, on the other hand
were felt to be a reservoir of leprosy and other
diseases that afflict those uncivilized in mind,
body and soul.7 Race and class were frequently
used by English speaking medical and
governmental authorities and to a lesser degree
by French Canadian religious authorities to
explain the existence of a foreign or even
‘tropical’ disease in the Acadian population. The
Acadian people were considered to be racially
different from the English-speaking of New
Brunswick and even from the French-speaking
population of Quebec. One Quebec-born priest
wrote that his parishioners were “Acadian fools
who live in disorder…being a racial mixture of
Indian, Negro, French, Spanish and even Italian
with all of the natural and intellectual defects of
their origins.”3
Dr. A.C. Smith, the longstanding physician
of Tracadie Lazaretto, would become known as
Canada’s foremost expert on the subject of
leprosy. Although he was known to be a man of
considerable good-will, he was steadfast in his

convictions that leprosy, while contagious to a
degree, preferentially infected inferior classes
and races, such as the Acadians.3 In 1891,
reflecting on the New Brunswick experience, he
wrote: “Leprosy never appears in the better class
of our French population”.3 In the 1890’s, after
investigating several cases of leprosy among
Icelandic immigrants in Western Canada, he
reassured authorities that leprosy would not be
able to make headway among hard-working
people such as these.3 Here the condemnation of
the Acadians is implicitly obvious. There are
several reputable reports of the existence of
endemic leprosy on Cape Breton Island in the
late nineteenth century. In 1889, Smith traveled
to the island where he confirmed the existence of
leprosy and brought one man to Tracadie;
however, he did not propose the creation of a
lazaretto in Cape Breton, nor did he formally
publish his findings.3 Later, in 1904, Smith
admitted that he had not disclosed his finding at
the request of the Nova Scotia government after
it was discovered that some of the descendants of
the Cape Breton leprosy victims had achieved
prominence within business and government.3 In
addition to assuring a low profile to the Cape
Breton cases, Dr. Smith also never made any
racial or class generalizations regarding the
presence of leprosy among these English
speaking Scottish immigrants. To Dr. Smith the
appearance of leprosy in those of superior racial
stock was to be regarded as an unfortunate act of
nature rather than as a condemnation of the
intrinsic worth of the population.
Conclusion
The era of endemic leprosy in New Brunswick
was significant to Canadian medical history on
several levels. In terms of the elucidation of the
nature of leprosy Dr. A.H. Skene proposed a
theory that incorporated both features that we
now understand to be prerequisites for the
development of leprosy, an infectious particle
and a susceptible host, in his paper published a
full thirty years before Hansen first observed the
leprosy bacillus. Drs. W. Wilson and R. Bayard
advocated a humane treatment strategy for the
treatment of leprosy sufferers which included the
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abolishment of leprosaria; a strategy which
would not be utilized for another century after
their proposal. Finally, the history of leprosy
among the Acadians of New Brunswick is
significant as it illustrates the racialized thinking
which was so accepted in the Western medical
paradigm of the nineteenth century, with
‘inferior’ peoples acquiring ‘inferior’ diseases.
While acting well within the acceptable
standards of their time, the medical community
openly contributed to the discrimination of the
Acadians suffering from leprosy, who were felt
to have acquired leprosy by virtue of their racial
inferiority. Looking at this case with modern
eyes, the discriminatory attitude of our Canadian
physician forefathers is startling. However, this
was not an isolated or particularly unusual case
as throughout history and even up to our modern
times there are many examples illustrating the
role of the medical community in contributing to
the oppression of an already vulnerable
population.
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Feature Article
The Birth of Caesarean Section
Milli Gupta
Caesarean section has been performed for many centuries and is considered to be one of the oldest operations in the
history of medicine. References to cesarean section date back to ancient Hindu, Egyptian, Roman and Grecian folklore.
For example, in Greek mythology, Apollo removed Asclepius, originator of religious medicine, from his dying
mother's abdomen. Even the socio-economic structure of Jewish society accommodated such surgery. According to the
Mishnah (140 B.C.), twins born by this method could not receive the right for primogeniture (obtain office or inherit
property). Up until (and including) the 15th century, cases documented suggest that caesarean sections were performed
only when the mother was dying or dead, in an attempt to save the unborn child or bury it separately (as was the
religious custom). It was not meant to save the mother’s life. It was not until the 19th century that steps to improve the
chances of survival of the mother were successfully made. This included the usage of anesthesia (allowed surgeons to
take the time to operate with precision), surgical asepsis (carbolic acid introduced by Joseph Lister) better equipment
(low obstetrical forceps reduced number of craniotomies performed and vaginal tears) and uterine sutures (used to
treat the vaginal tears/fistulas resulting from traumatic childbirth). Following these changes, surgeons were able to
focus on improving incisions made to the uterus. Advocated by British obstetrician Munro Kerr, between 1880 and
1925, transverse incisions of the lower aspect of the uterus were found to reduce infections and uterine ruptures in
pregnancy, increasing survival rates. This still remains as the most common method today. This is in contrast to the
vertical incisions made classically.

Origins of the name: Caesarean operation to
caesarean section
Caesarean section involves the delivery of the
baby through an abdominal cut. Initially,
“caesarean section” was referred to as “caesarean
operation”. There is rampant debate over how
the name “caesarean operation” came to be.
Many theorize that the name came from Julius
Caesar, who supposedly was born by this
method.1 This, however, is unlikely because it is
known that Caesar’s mother, Aurelia, was still
alive when he invaded Britain, and it is unlikely
that she could have survived such a surgery
given the crude technique and amount of
knowledge of the female anatomy and
physiology known at that time.2
Also, it is
believed that at the time of his existence, the
surgery was mostly done on dead or dying
women. A possibility as to why his name is
associated is that during his reign he ordered the
use of this procedure to procure the child from a
dying mother.3
Romans described caesarean birth until the
last century B.C as “a caeso matris utero”,
which means, “to cut an infant of its mother’s
womb”.4 Another possible source is from the
King of Rome, Numa Pompilius, who codified

Roman Law in 715 B.C.5 Lex Regia, which later
became known as Lex Caesarea (under the rule
of the Caesars) made it mandatory to remove the
child from its dying mother, even if there was no
chance of its own survival. This was done in part
to ensure separate burial for both mother and
child.1 Also, the state was interested in raising
its population size, and did not wish to loose any
person unnecessarily.3
Pliny (28-70 AD) in Book VII of ‘Natural
History’ suggested that the term might come
from the Latin verb ‘caedare’ which means ‘to
cut’, implying delivery by cutting.2 Children
born by this method were called ‘caesones’,
which is another possible origin.4
As for the change from caesarean operation to
section, the first person to use the now common
phrase was Jacques Guillimeau, who in 1598
used ‘section’ in his book of midwifery.3
Historical references
The oldest authentic record of a living child is
that of Gorgias, a famous orator of Sicily, 508
B.C.5 References to caesarean section appear in
ancient Egyptian, Hindu, Grecian and Roman
folklore. Religious laws of Egypt in 3000 BC
and of India in 1500 BC required abdominal
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delivery of the child from its dead mother.6
Greek and Roman mythology have tales of this
surgery, and it is believed that Asclepius, the god
of medicine, was removed by a cut from his

dying mother’s (Coronis’) womb by Apollo
(Figure 1).7 Bacchus, the god of wine, was also
delivered this way, with Jupiter taking on the
role of Apollo.1

Figure 1: The extraction of Asclepius from the abdomen of his mother, Coronis, by his father,
Apollo. Woodcut from the 1549 edition of Alessandro Beneditti's De Re Medica.3

Ancient Chinese texts portray this as being done
on living women.3 The story of King Sol’s wife,
as recounted by Machnezie (1927) also
suggested that she delivered a son by this method
and survived.1 These references to women
surviving is odd considering that many of the
operations (done in the earlier part of its history)
were carried out after the woman had died, or it
was late in the pregnancy/labor and done when
the health of the child was at risk.6 Perhaps this
operation was successfully done on living
subjects a lot earlier than is actually
documented.2
Caesarean section was an integral part of life
and accommodations were made within religious,
literary and societal texts. The Jewish book of
Law, the Talmud (400AD) states that women do
not need to observe the usual days of purification
following this type of delivery. In Mishnah
(Jewish text from 140 BC), twins born by this
method had restrictions placed on their
birthright:
“… in the case of twins, neither the first
child which shall be brought into the

world by the cut in the abdomen, nor the
second, can receive the right of
primogeniture, either as regards the
office of priest or succession to
property”6
Many great works of literature also refer to this
operation. In Shakespeare’s ‘Macbeth’ for
example, Macbeth is horrified to realize that
Macduff was ‘from his mother’s womb untimely
ripped’, therefore making him susceptible to
death by Macduff’s hands (Macbeth could not be
killed by “one of woman born”. Since Macduff
was not ‘born’ in the sense of the word, he could
kill Macbeth). Shakespeare also refers to
caesarean sections in “Cymbeline”.5
Religious influence
Islam before 1500 was against the procedure and
stated that any child born by this method was an
offspring of the devil and therefore should be
killed immediately.2 Now of course such is not
the case.
On the other hand, Christianity was positive
towards this operation, being more concerned
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with saving souls.1 Specifically, in the Middle
Ages, the Roman Catholic Church encouraged
the use of caesarean section to save the child and
wanted to offer their souls a chance of salvation
through baptism.1 The mother, on the other hand,
was not a concern since the church prohibited
usage of abortion, fetal dismemberment and
craniotomy to save the mother.6 Other church
councils did not decree anything positive for the
mother either, but allowed for operating on a
dead pregnant woman to save the child and allow
baptism. In 1280, the church councils of Cologne
made it mandatory to do this surgery. The
Republic of Venice in 1608 actually laid down
severe penalties for any doctor that failed to
make an attempt to save a child in this way.6
The need to baptize and therefore save the soul
of the child was so prevalent and important,
especially in France, that Peu in his “Practiques
des Accouchements” states that:
“… immediate opening of the abdomen
as soon as the mother is assuredly dead
and within the space of time taken to say
one “Ave maria”, and as soon as the
child is visible, pouring water over it
and adding to the usual words of
baptism, “si tu as vie” 8
Similarly, in the United States, during the
Franciscan mission period (1769-1833), it
became the responsibility of the missionary
priest to do the operation on dying women. They
were actually taught pertinent maternal anatomy,
the actual procedure and given instruments to aid
in their task.4
Earliest documented cases
Even though references in ancient texts indicate
this surgery was performed on live subjects, it
was during the 1500’s that debates issued over
the possibility of doing this on live women.
Francois Roussett in 1582, was the first
physician to endorse the operation on living
women.5 In fact, he was the one to record Jacob
Nufer’s story (below), and use it as proof that
such surgery should be considered for live
women.2 Except for the Trautmann case (below),

even though the authors were not the ones that
performed those surgeries, many were penned
down and used for debating purposes.5
Trautmann performed the first generally
accepted and authenticated case in the presence
of two midwives in Wittenberg, Germany in
1610. The patient died 25 days after the
procedure and the uterine wall was found to have
already healed.2
Jacob Nufer, in 1500, performed the first
documented, successful operation on a living
woman.1 He was not a doctor, but rather a Swiss
sow-gelder. The story goes that the wife was
pregnant for the first time, and was having severe
labor pains. The skills of the 13 midwives
involved were not leading to the subsequent
delivery of the child. There did not seem to be
much hope and so the husband wanted to
perform caesarean section. She was willing,
unfortunately, the municipal authorities were not
willing to allow it. Only after the second request
did the mayor consent, and then Jacob “…laid
his wife on a table, incised the abdominal wall
(with a razor), then the uterus and after which he
quickly extracted the child. Several sutures were
placed in the abdominal wall”.5 The wound
healed and she lived to bear several children,
even twins, vaginally, with no complications.
This documentation suggests that this is the first
successful vaginal delivery after a caesarean
birth. The cesarean baby lived to be 77.3
However, some historians do not accept the
validity of this case because it was not reported
until 1582, 82 years after the procedure was done.
This delay suggests publication of this case was
based on hearsay.1 Adding to that, had this been
really done, it is expected that such news would
have spread far and wide long before 82 years.2
Some caesarean sections happened to occur
under interesting and unique circumstances. For
example, pregnant women were gored by the
horns of animals such as bulls or cows, resulting
in the birth of the child. Earliest case
documented was in 1647 Holland, where the
wife of a farmer in Zaandam was tossed by a bull
in the ninth month of pregnancy and:

UWOMJ 78(1)2008 P81

“… sustained an incision into the
abdominal wall, which stretched from
one ischium to the other, and through
the pubic bone in the shape of a crescent.
She had another wound through skin and
peritoneum into the uterus, twelve finger
breadths in length, from which the child
issued.”
The woman died 36 hours later, and the child
escaped unscathed.9
Refinements in the medical profession and
caesarean sections
Improvements in many aspects that helped to
enhance the medical profession had an impact on
the mortality and precision of caesarean sections.
According to Boley5, three major reasons can be
attributed to the death of these women: using the
surgery only when the woman was close to dying,
high rates of infection (lack of sanitation) and
lack of uterine sutures. Many improvements with
instruments (high vs. low forceps) and
procedures employed (including other than
caesarean sections) to remove the baby all
further enhanced and strengthened arguments for
using caesarean sections, and eventually lead to
the current style of surgery.
Anesthesia
In 1846, at Massachusetts General Hospital,
dentist William T.G. Morton used diethyl ether
to desensitize the face to remove a tumor.
However, there was opposition to its use in
obstetrics because of biblical injunction that
women should suffer while giving birth in
compensation for Eve's sin.3 This argument was
weakened when Queen Victoria, the head of the
Church of England, had chloroform administered
for the births of two of her children (Leopold in
1853 and Beatrice in 1857). Subsequently,
anesthesia in childbirth became accepted and
practical in cases of cesarean section.3
The use of anesthetics gave surgeons the time
to operate with precision, clean the peritoneal
cavity properly, record the details of their
procedures, and learn from their experiences.
Women were spared from feeling the cuts made,

and were less susceptible to shock, which was
becoming a leading cause of post-operative
mortality and morbidity.3
Procedures other than caesarean sections
Using anesthesia shifted the argument for
caesarean section versus relying on craniotomy.
Craniotomy had been practiced for hundreds,
perhaps even thousands, of years.3 It has been
performed on both live and dead fetuses. This
procedure involved the destruction of the fetal
skull (by instruments such as the crotchet) and
the extraction of the entire fetus vaginally.
Figure 2 shows how this was done. Unlike
caesarean section, it entailed lower risks to the
mother.3 Another reason craniotomy was popular
was because it was believed that the fetus felt no
pain during this procedure.2 Closer to 1855 Sir
James Y. Simpson showed otherwise and this
seemed to have an effect on the number of such
procedures done.2

Figure 2: Craniotomy
Another method to deliver the baby involved
forceps (figure 3). Initially, high forceps were
used, which reduced the number of deaths that
would have occurred via craniotomy. However,
it ended up creating severe tears (fistulas) in the

UWOMJ 78(1)2008 P82

that cannot be separated, …in such
emergencies, if the woman is strong and
of good habit of body, caesarean
operation is certainly advisable and
ought to be performed; because the
mother and child have no other chance
to be saved, and it is better to have
recourse to an operation which has
sometimes succeeded than leave them
both to inevitable death…”6
Figure 3: Forceps used in the
1700s, French in origin
vaginal wall and perineum of the mother,
affecting maternal morbidity and mortality.3 The
fetus could also be injured if the forceps used to
pull the baby were pressed too tightly. Harold
Williams (1879) of Boston researched the
number of cases and mortality with these
forceps, and he concluded they were more lethal
than caesarean sections.2 An improvement with
this method was the use of low forceps, which
did not cause as many vaginal tears.3 These
forceps are still used today.
Neither craniotomy nor obstetrical forceps
were of any help when severe pelvic distortion or
contraction existed, and that is when caesarean
sections were especially useful.3 One of the first
men to suggest factors when caesarean sections
should and should not be used was William
Smellie (1752). He was a British physician who
suggested that women should not be operated on
when they were weak and in poor condition. If
they were in such a situation then it was best that
the operation was delayed until she died, after
which it should be immediately performed to
save the child. He suggested that it should only
be done in:
“… laborious and preternatural labors,
on account of the narrowness or
distortion of the pelvis into which it is
sometimes impossible to introduce the
hand; or from large excresences and
glandular swellings that fill up the
vagina and cannot be removed…or
adhesions in that part and at the os uteri

Uterine sutures
In the 16th century, obstetricians opposed
performing surgery on live patients because
maternal mortality was incredibly high.5 As well,
during most of the 19th century (1787 to 1876),
no successful caesarean operation had been
performed in Paris.3 This was attributed to the
wrong belief that the natural rhythmic
contraction and relaxation of the uterus
prevented the use of sutures. Therefore, after the
baby was removed, incisions in the uterus were
left open. Due to this, women died from
hemorrhage and infection. As well, in those
days, sutures had to be removed, and it was
impossible to remove them from the uterine wall
after the abdomen had been closed.5 The first
man to close a uterine incision with sutures was
Lebas, a French surgeon in 1769. However, the
usage of sutures did not become popular until the
Sanger method (below) resulted in reduced
mortality rates.
Antiseptic
It is interesting to note that the early documented
cases with successful births took place under
unusual circumstances, and far away from
hospitals (Bull horn goring and Jacob Nufer).
Most of the surgeries in remote areas lacked
medical staff and facilities. As well, because they
lacked a medical community, time was not
wasted on professional consultations. Instead it
was being used to take action earlier. This meant
that surgery was being performed earlier, when
the fetus was not under much distress and the
mother was not close to dying. Treating both
parties at an earlier time increased their survival
rates.3 Since operations got performed on kitchen
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tables, beds and any other facilities but the
hospitals, infection rates were low (sanitation
was not practiced in hospitals) and survival rates
were higher.
Hospitals during those times were notorious
for being ‘infection beds’, especially because the
surgeons came in wearing street clothes and did
not clean their hands in between patients. As a
matter of fact, it was estimated that if a woman
performed surgery on herself or was gored by a
bull, she had a 50% chance of survival,
compared with 10% survival rate if she were
being taken care of by a New York surgeon!10 In
the mid-1860s, the British surgeon Joseph Lister
introduced an antiseptic method using carbolic
acid.3 Introducing this method however helped
reduce the number of deaths due to infection
(seen as being the most common cause for
women mortality), and allowed physicians to
focus on their technique and style of operating.3
Time of intervention
As cesarean section became safer, obstetricians
increasingly argued against delaying surgery.
Rather than waiting for hours of unsuccessful
labor, physicians like Franz von Winckel in
Germany, Thomas Radford in England and
Robert Harris in the United States opted for early
intervention.3 Higher rate of survival were likely
with early intervention. Such arguments
eventually led to greater numbers of operations
occurring earlier, and the data collected showed
lower mortality.3
Porro Operation
The Porro operation, or the ‘radical caesarean
section’, is defined as a surgery where the uterus
is completely removed (hysterectomy). This left
the woman unable to have any more children,
which in itself had profound effects on emotional
well being of the woman. Dr Joseph Cavallini
had suggested this surgery as early as 1768, but
attempts to perform this surgery then had
been unsuccessful.2 In 1876, Eduardo Porro
successfully performed this surgery. With the
widespread usage of this surgery, presence of
antiseptic protocols, and intervening earlier,
mortality rates showed a marked decrease.2

Sanger operation
In 1882, Max Sanger used uterine sutures (silver
and silk wire) to sew up the cuts made in the
peritoneum. This was just as successful in
reducing mortality rates as the Porro operation,
and it did not involve removal of the uterus.
Development of the silver wire stitches to treat
vaginal tears (fistulas that resulted from
traumatic delivery) was done by 19th century
American gynecologist J. Marion Sims.3 Sanger
operation was just as effective as the Porro
method, and thus a lot of physicians moved to
using this, for the woman’s benefit.
Where to incise?
As confidence in the outcome of their procedures
increased, doctors turned their attention to where
to incise the uterus. Various styles (longitudinal,
oblique, etc.) were debated for a century (17701880). Between 1880-1925, obstetricians
experimented with transverse incisions in the
lower segment of the uterus. The first person to
suggest this type of incision was Robert Wallace
Johnson (1786) in his book “A New Systems of
Midwifery”.1 He suggested this because of low
bleeding that occurred with such a cut. Kehrer in
1881 successfully performed this type of
incision.6
Munro Kerr, a British obstetrician, highly
advocated the Kehrer method during the 1920’s.2
He believed that such an incision had low
bleeding, low infection rate and low uterine
rupture from subsequent pregnancies (because
the scar would make the region stronger).6
A further modification -- vaginal cesarean
section -- helped avoid peritonitis in patients
who were already suffering from certain
infections.3 However, with the discovery of
penicillin in 1928 by Alexander Fleming, this
method was eventually eliminated from
practice.3
Most incisions today either involve
transverse incision of lower segment (Kerr
technique) or classical/vertical incision, which is
a cut made through the abdomen and front wall
of uterus. The latter has high blood loss and
increased incidence of infection.6. However, if it
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is an emergency C-section, a pre-term fetus, or a
tumor that obscures the lower segment, then
vertical incision is used.6
Conclusion
Caesarean section has enjoyed a very long
history and has been continuously refined by
society. At one time such a procedure was only
used on deathbeds. But now it is heavily being
considered as elective or first line when it comes
to delivery of a child (especially in South
American countries like Brazil). Before where
the child’s health and well being was put first,
now the mother’s health and cosmetic outlook is
considered just as seriously. The art and style of
caesarean section has developed despite many
problems, and has grown with civilization as
human nature has throughout these centuries.
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Feature Article
The Birth of Defibrillation: A Slow March Towards Treating Sudden Death
Stephen M. Chihrin
Recent years have seen the rapid fine-tuning of external cardiac defibrillation for the treatment of cardiac arrest.
However, this rapid advancement conceals the slow march of physiologists over several centuries to address this life
threatening state. Frequently, accounts of defibrillation research begin with the turn of the 20th century. However, the
birth of the field was rooted millennia earlier, and became the object of scientific investigation a full 150 years before
Einthoven received the Nobel Prize for his work developing the electrocardiograph. Early accounts of resuscitation
demonstrated an understanding of the necessity of respiration for life, as well as the correlation of respiratory and
cardiac function. The eminent danger posed by ventricular fibrillation was noted by the Egyptians as early as 3500 BC,
when it was observed that “When the heart trembles, has little power and sinks, the disease is advancing and death is
near.” However, it was the discovery of electricity that proved critical to research into heart function, and ultimately,
defibrillation. In the mid 18th century, Luigi Galvani made the classic observation that an electrical impulse could
cause a frog’s leg to twitch “as though it were seized with tetanus at the very moment when the sparks were
discharged.” The excitement generated from Galvani’s experiments led to the almost instantaneous application of
electricity to the treatment of cardiac arrest. However, it would take a number of innovative physicians, in roles
spanning from basic researchers to public educators, to bring defibrillation from a baseless practice attempted out of
desperation, to a scientifically validated, reliable, and widely available procedure. It is the intent of this report to
highlight a number of these innovative individuals, and to detail the research that provides a foundation for the rapid
advancements in cardiac care seen today.

and put his mouth upon his mouth, and
his eyes upon his eyes, and his hands
upon his hands: and stretched himself
upon the child; and the flesh of the child
waxed warm .... And the child sneezed
seven times, and the child opened his
eyes.” (2 Kings 4:32-35).

Introduction
Recent years have seen the rapid fine-tuning of
external cardiac defibrillation for the treatment
of cardiac arrest. The recent announcement of
the Phillips HeartStart Home Defibrillator as one
of Fortune Magazine’s “25 Best Products of
2004”1 can be seen not only as a testament to
medicine’s growing response to one of society’s
greatest health risks, but also as the culmination
of several centuries of discovery in cardiac
electrophysiology.
While our ability to respond effectively to
sudden death has greatly improved in recent
years, it comes as no surprise that the desire to
do so is as old as antiquity itself. Reviving
someone apparently dead was no doubt a
dramatic tale in any time, and countless instances
of it are found in mythology and ancient texts.
One of the earliest and most widespread written
depictions of resuscitation can be found in the
Bible, where Elisha was detailed on more than
one occasion to raise the dead:

While techniques to aid in true cardiac arrest did
not emerge until the 18th century, knowledge of
ventricular fibrillation – the most common cause
of sudden cardiac death – existed more than
3500 years ago. At that time, it was written in
the Ebers Papyrus that “When the heart trembles,
has little power and sinks, the disease is
advancing and death is near…”.2 The link
between trembling (fibrillation), little power
(poor circulation), and death, was again
described by Vesalius as “worm-like” motions of
the heart. Vesalius added to this description in
1543, by also noting the correlation between
respiration and cardiac function:

“And when Elisha was come into the
house, behold, the child was dead ....
And he went up, and lay upon the child,

“…Indeed, with a slight breath in the
case of this living animal the lung will
swell to the full extent of the thoracic
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cavity, and the heart become strong and
exhibits a wondrous variety of motions….
And as I … take care that the lung is
inflated at intervals, the motion of the
heart and arteries does not stop…”. 3
Electricity
It was the discovery of electricity that proved
critical to research into heart function, and
ultimately, defibrillation. In the mid 18th century,
Luigi Galvani began experimenting with
electricity, and made the classic observation in
that an electrical impulse could cause a frog’s leg
to twitch “as though it were seized with tetanus
at the very moment when the sparks were
discharged”.4
This account of “animal
electricity” quickly caught the interest of
seemingly every scientist in Europe. And while
it undoubtedly put great survival pressure on the
common frog, the discovery ultimately spawned
the field of electrophysiology.
Early Discoveries
The excitement generated from Galvani’s
experiments, and the countless experiments that
followed, led to the almost instantaneous
application of electricity to the treatment of
cardiac arrest. While it wouldn’t be until Prevost
and Battelli’s work in the turn of the 20th century
that true defibrillation would be depicted
scientifically,5 the first case report describing
successful resuscitation using electrical shock
was made in 1774, when a young woman fell out
a second-storey window and was believed by all
accounts to be dead.6 After approximately
twenty minutes, a doctor was summoned, who
after exhausting all conventional techniques,
attempted to apply electricity “to various parts of
the body in vain; but upon transmitting a few
shocks through the thorax, he perceived a small
pulsation’ in a few minutes the child began to
breathe with great difficulty, and after some time
she vomited.” This account, and many others,
were recorded in the register of Royal Humane
Society of London, an organization established
the very same year to promote resuscitation as a
means of saving otherwise healthy people –

victims most often of falls, drowning, mining
accidents, and lightning.6
While doctors across Europe began using
electricity as experimental treatment for sudden
death, the first report of scientific investigation
into this practice was not conducted until a year
after the first recorded “save”. In 1775, Dr. Peter
Abilgaard published his observations on shock
and countershock – a full 124 years before
Provost and Battelli’s documentation of
ventricular fibrillation and defibrillation.
Abilgaard observed that electrical stimuli could,
when applied anywhere across the body of a hen,
in particular the head, render his animal
specimen lifeless, and when applied again across
the thorax, restarted the heart:
“With a shock to the head, the animal
was rendered lifeless, and arose with a
second shock to the chest; however, after
the experiment was repeated rather often,
the hen was completely stunned, walked
with some difficulty, and did not eat for
a day and night; then later it was very
well and even laid an egg.”7
Surprisingly, given the importance of
Abilgaard’s observations, few references were
made to it in the literature of the time.
A True Beginning
While the study by Abilgaard and the numerous
case reports from the Royal Humane Society
suggested an early beginning to cardiac arrest
research, it was not until the beginning of the
19th century that work began in earnest. The
mechanism of cardiac arrest began to be
elucidated by Ludwig and Hoffa, who in 1850
were the first to physiologically describe
fibrillation in animals, while also noting that
electrical shocks can reliably induce the
phenomenon.6 By 1851, chloroform had gained
considerable popularity in operating theatres
across the world, and numerous cases of sudden
death left surgeons hesitant to use the
anesthetic.8 Dr. Steiner was one of the first to
investigate chloroform and ether induced cardiac
arrest, and published accounts of successful
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ventricular pacing in 10 dogs, 14 cats, 6 rabbits,
and 1 donkey. Unfortunately, his one attempt at
resuscitating a human patient was unsuccessful.9
Work on fibrillation continued by many
physiologists in the later half of the 19th century,
aided by advances in knowledge of cardiac
function and in technology to observe it. John
McWilliam
made
several
significant
observations about ventricular fibrillation
through a series of reports in 188710 and was one
of the first to insist that that ventricular
fibrillation must occur in humankind. Until this
point, and in fact for a number of years after,
ventricular fibrillation had only been clearly
observed in animals, leading many to believe it
simply did not occur in mankind.6 McWilliam,
however,
demonstrated
that
ventricular
fibrillation occurs with greater frequency and
severity in larger mammal species, and suggested
quite reasonably that the reason ventricular
fibrillation had not been clearly identified
humankind was simply that most cases of
cardiac arrest occurred out of hospital, where
response time exceeded fibrillation duration.10
Around the same time, two other
physiologists were studying fibrillation and
made some significant discoveries. The focus of
Prevost and Battelli’s report was not unlike the
conclusions made by McWilliam: the heart’s
ventricles could be made to fibrillate with a
small amount – as little as 40 Volts – of
electricity delivered across the chest wall.5 What
was not the focus of this report, but would
become the focus of countless reports in the next
hundred years was the casual observation – in a
footnote – that a second, larger shock (between
240 and 4800 Volts) could often defibrillate the
heart. While it is likely that Prevost and Battelli
realized the importance of their observation for
the animals they studied, they must not have
been aware of McWilliams suggestion that
ventricular fibrillation is likely a major cause of
sudden cardiac arrest in mankind.11 Thus, with
what could be the understatement of their
professional careers, Prevost and Battelli helped
electrophysiology conclude the 19th century with
a solid background in ventricular fibrillation and

defibrillation – in animals only – setting the
stage for rapid advancement in the 20th century.
Development of Defibrillation
While cardiac arrest due to early application of
anesthesia prompted research early in the 19th
century, the advent of public electricity in the
early 20th century prompted further development
of the field of cardiac electrophysiology.
Spurred by a growing number of employee
accidents, in 1926 the Consolidated Electric
Company of New York City funded a
collaboration at John Hopkins between Orthello
Langworthy and Donald Hooker, both physicians,
and William Kouwenhoven, an electrical
engineer.6 By 1933 the trio had published a
summary of their initial research, expanding
upon the findings made 30 years earlier made by
Prevost and Battelli. Specifically, the group
noted that for defibrillation to be successful, the
shock must be applied within a few minutes of
arrest if no other intervention is made: 99% of
cardiac arrests defibrillated after 30 seconds
were successfully resuscitated, but after one, two
and four minutes the success rates dropped to 90,
27, and zero percent, respectively.8 They also
noted that open- and closed-chest cardiac
massage could extend this window, an
observation that ultimately lead to the chest
compressions used in CPR today.
Around the same time that Kouwenhoven
and colleagues were developing clinically usable
defibrillation techniques, a man who would later
be cited as one of the most influential individuals
in cardiac resuscitation was completing his
internship. During his internship in Cleveland,
Ohio, Claude Beck witnessed a number of
cardiac arrests during surgery, and stood back
with amazement as the surgeon would request
that the local fire department be summoned to
administer oxygen in an attempt at resuscitation,
leaving him feeling, quite fairly, that “we were
not doing our best for the patient”. 8 He went on
to construct his own defibrillator and developed
the first in-house cardiac resuscitation team – the
precursor to the crash cart team.8 In 1947 Beck
achieved the first clearly documented
defibrillation, in a young boy undergoing surgery
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for a congenital form of funnel chest. Upon
noticing ventricular fibrillation, Beck maintained
manual heart massage for over 30 minutes before
he had an electrocardiograph confirmation and
then delivered a shock directly to the heart. The
first shock was unsuccessful, procaine was
administered
to
improve
the
heart’s
susceptibility to electricity, and upon a second
shock normal sinus rhythm was restored.

Figure 1: Electrocardiogram recorded by Dr.
Claude Beck detailing the first documented
successful defibrillation of a human. The three
tracings demonstrate: a) ventricular fibrillation,
b) ventricular fibrillation still present after first
shock, c) supraventricular tachycardia following
procaine administration and successful second
shock.12
Beck went on to fine-tune his device, and in the
interest of promoting defibrillation, promising to
“furnish this apparatus to anyone who would like
to have it for the cost of the various parts”.8 In
1950 Beck began to educate others in his
protocol, establishing a course that trained
surgeons, anesthetists, nurses, and dentists from
around the world in his protocol, forming the
basis of today’s CPR and ACLS courses.6,8 By
1961, the advantages of closed chest cardiac and
external defibrillation, first suggested by
Kouwenhoven 30 years before, were proven
clinically by Dr. Paul Zoll.8 Beck capitalized on
the development of external defibrillation as an
opportunity to expand his training to the lay
public, establishing the Resuscitators of America
program to train members of the public in CPR
using the now ubiquitous CPR mannequins.

Research continued from the early models
designed by Kouwenhoven, Beck and Zoll,
refining the amount and type of electricity, the
method of delivery, as well as improvements in
safety and automation. The advances in cardiac
treatment witnessed in just this last generation
are substantial, and reveal a history of scientific
research spanning over 300 years, and a history
of curiosity in the heart’s operation spanning
over 3000 years. What will be the future of
cardiac resuscitation? The Phillips HeartStart
Home Defibrillator is likely just the beginning.
When Abilgaard conducted his initial research
into “countershock” in 1775, science and society
were not ready to appreciate the importance of
his work in the context of improving patient care.
Perhaps with time we too will find modern
research deemed insignificant today shedding
light on significant issues of tomorrow.
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Feature Article
Triumph Over Pain: The Curiously Contentious History of Ether
Daniel J. Kim
Surgery in the early nineteenth century posed serious challenges to both the surgeon and the patient due to unbearable
pain. However surgical textbooks of the day scarcely mentioned this pain; accompanying illustrations showed patients
lying quietly, apparently unconcerned in the midst of gruesome and painful procedures. All this changed on October
16, 1846. William T.G. Morton, a Boston area dentist, administered ether to a patient with a large vascular
malformation in his neck. John Collins Warren, a senior surgeon at the Massachusetts General Hospital, painlessly
excised the tumor in an operating theater filled with hospital staff. Morton’s demonstration revolutionized the way
surgery was practiced, but the credit for the discovery of surgical anesthesia is certainly not his alone. Several
individuals challenged Morton’s attempts to claim sole credit, including Horace Wells, Charles T. Jackson, and
Crawford W. Long. Long, a physician from Georgia, was actually the first to perform an anesthetized operation using
ether in March 1842, but failed to publish his results until several years after Morton’s demonstration. Morton learned
of inhalation anesthesia at a failed demonstration by Wells, his former dental partner, who in turn noted the analgesic
qualities of nitrous oxide at a public lecture in 1844. Jackson, a former mentor to Morton, supplied the critically
important advice of using pure sulfuric ether, rather than impure commercial concoctions. Hope of financial gain led
to acrimonious legal battles erupted between Morton, Wells, and Jackson. Ironically none received any financial
reward, and all met untimely and tragic deaths.

Introduction
Surgery before the mid nineteenth century is
difficult to comprehend today – patients suffered
unbearable only relieved by a speedy
conclusion.1 The necessity of anesthetic agents
was not lost on surgeons, but there was a lack of
systematic research. Opiates were administered
gratuitously, alcohol intoxication, hypnotism,
and sometimes even a blow to the chin was
used.2 Unfortunately none worked reliably, and
surgical textbooks of the day scarcely mentioned
pain. Illustrations showed patients lying quietly,
apparently unconcerned in the midst of gruesome
and painful procedures.1 All this changed on
October 16, 1846 thanks to a resourceful but
profiteering dentist.
Discovery
William T.G. Morton began his dental career at
the Baltimore College of Dental Surgery.
Without finishing his degree, he studied with
Horace Wells, a Hartford dentist, in 1841. The
two became partners during 1842 and 1843, but
this proved unsuccessful and Morton set up his
own practice in Boston. He attended several
classes at Harvard Medical School in 1844 and
studied briefly with Charles T. Jackson, an

internationally famous physician, chemist, and
geologist. He quit his extracurricular academic
interests to focus on his practice when it began to
flourish.3
Morton specialized in prosthetic dentistry,
considering it essential to extract all tooth
material from the jaw before fitting a prosthesis.
Although skilled, his technique was laborious
and painful, discouraging many potential clients.
He realized that he was losing business, so he
looked for a way to make extractions painless.4
At this time, dentistry was a trade, not a
profession, and many kept their special
techniques secret. It is no surprise that Morton
was so cautious in his search.5 He took interest
in ether because Charles Jackson had suggested
its local application might deaden the pain of
extractions. Results were inconsistent, and his
interest turned to ether vapor. His experiments
in the summer of 1846 were on household pets,
then on himself and his assistants. His results
were unreliable, and Morton sought Jackson’s
help. Jackson suggested that Morton could
improve his results if he used chemically
purified sulfuric ether rather than less pure
commercial products.3 After additional tests on
himself and his assistants, Morton felt confident
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enough to administer ether to a patient. On the
evening of September 30, 1846, Eben Frost came
in with an intensely painful tooth and begged
Morton to hypnotize him, a standard but
ineffective pain reliever. Morton claimed that he
could offer something far more effective, and
Frost agreed to ether. After inhaling the ether
through a handkerchief, Morton painlessly
extracted the tooth and Frost had no recollection
of the extraction.5
After this success, Morton inquired about the
possibility of patenting a new process using
sulfuric ether. He received an uncertain response,
but was assured that a definitive answer could be
provided by consulting the law.3 Morton then
approached John Collins Warren, head of the
surgical staff at the Massachusetts General
Hospital (MGH), about a public demonstration.
Hoping for a patent and fearing piracy, he
refused to disclose his exact preparation. Warren
had ethical misgivings because the preparation’s
identity and safety were unknown. Despite
misgivings, Warren had an invitation sent to
Morton written by one of the junior house
officers, perhaps reflecting Warren’s skepticism
and reservations.1
Morton’s demonstration was scheduled for
October 16, 1846. The operating theater was full
and skepticism was pervasive. Morton was late
because of several last minute changes to the
inhaler.5 Warren was impatient and decided to
proceed. “As Dr. Morton has not arrived, I
presume he is otherwise engaged,” he remarked
to the audience implying that Morton was too
fearful of failure to show up.6 Morton rushed in
with his newly configured inhaler and applied
the ether vapor to the patient, who was soon
asleep. The theater watched in silent anticipation
as Warren started his incision over a vascular
tumor in the patient’s neck. To everyone’s
surprise, the patient didn’t startle, scream, or
give any indication of pain. As Warren ligated
the deep vessels, the patient started moving his
limbs and uttering nonsensical expressions.
Warren doubted the success of the operation
until he had full confirmation from the patient
that he had had no pain. He then turned towards

the amazed audience and famously remarked,
“Gentlemen, this is no humbug”.3
Origins
The origins of inhalation anesthesia predate
Morton’s interest. After nitrous oxide was shown
to be relatively safe in the early 19th century,
traveling chemistry professors lectured on gases
and demonstrated their exhilarating effects.
Nitrous oxide was quite popular because
intoxicated individuals spoke foolishly and
would sometimes laugh uncontrollably. It
became fashionable to inhale nitrous oxide at
lectures and social gatherings.3 In many social
circles, ether replaced nitrous oxide because of
the ease of obtaining, storing, and administering
it. Ether frolics, where participants would
become drunk from ether vapor, became popular,
particularly among students.7
Morton wasn’t the first to demonstrate ether
as an anesthetic - Crawford Long, a well-trained
physician practicing in the small town of
Jefferson, Georgia, was. His offices were a
clubroom for the town’s young intellectuals, and
meetings often turned into ether frolics. Long
enjoyed inhaling ether and often discovered new
bruises on himself and his friends afterward.
They had no recollection of pain or the causes of
these bruises, and Long concluded that ether
could eliminate pain. He put his observations
into practice on March 30, 1842, when a boy
named James Venable approached him
requesting removal of two small neck masses.
Long explained his observations to Venable, as
he knew that Venable enjoyed inhaling ether.3
After getting consent, Long painlessly removed
one of the sebaceous cysts. Although thrilled
with his achievement, he only gave ether for
seven minor operations over the next four years
and didn’t publish the report of his cases until
1849. Regardless of his lack of influence, Long
had the innovation and courage to experiment
with ether as a surgical anesthetic.5
Horace Wells also had an important impact
on the development of anesthesia. On December
10, 1844, he and his wife attended a lecture in
Hartford, Connecticut by Gardner Colton, a
traveling professor. Colton demonstrated with
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laughing gas, but Wells noticed that a participant
suffered a severe gash to his knees without
reacting to the pain. He reasoned that nitrous
oxide might be able to alleviate the pain
associated with dental procedures. After asking
Colton to produce some nitrous oxide for him,
Wells inhaled it and had one of his own wisdom
teeth extracted.5 Upon waking he exclaimed, “I
felt it no more than the prick of a pin. This is the
most wonderful discovery of our time”.2 In the
following month, Wells performed about fifteen
painless dental procedures with nitrous oxide and
felt confident enough to demonstrate it publicly.
John Warren invited Wells to demonstrate a
dental extraction on a student in January 1845.
Unfortunately, the gasbag was withdrawn too
soon, the anesthesia was incomplete, and the
student screamed in pain. This proved disastrous,
and the surgeons took no further interest in Wells
or his methods. This demonstration had a strong
and lasting impression on Morton, launching his
clandestine quest for an effective and reliable
anesthetic agent.5
Fallout
Morton’s success with ether continued after his
original demonstration. The following day he
aided in the removal of an adipose tumor from a
woman’s arm. The patent commissioning office
confirmed that etherization could be patented.
Unhappily, the patent commissioner was a friend
of Thomas Jackson’s, and had been persuaded by
Jackson to consider a joint discovery. Although
Jackson was a distinguished academic, he had an
unsavory tendency to take credit for other
people’s inventions, especially when they had
financial promise. Jackson’s friend at the patent
office persuaded Morton to include Jackson’s
name, and the patent was issued on November
12, 1846.3
During this time, Morton had been prohibited
from using ether at MGH because he had kept
his preparation a secret, calling it Letheon, Greek
for forgetfulness. John Warren and other senior
surgeons at MGH were concerned about using a
preparation whose composition and safety were
unknown. He finally revealed it to be nothing
more than sulfuric ether on November 6. The

next day Morton administered ether in two major
operations both of which were complete
successes, and the MGH surgeons were fully
persuaded of the importance and effectiveness of
this discovery. Morton enjoyed the endorsement
of the MGH staff in his mission to collect fees
and regulate the use of ether anesthesia.5
As ether anesthesia became more accepted,
Jackson wrote two letters to a friend in Paris
claiming that he discovered ether anesthesia and
introduced it into surgery, and that it had been
thoroughly tested and accepted at MGH. These
letters were presented to the Académie des
Sciences, and the European scientific community
accepted Jackson’s claims. Morton learned of
Jackson’s letters and collected evidence to refute
his claims, but Jackson’s connections in Europe
had more influence. He continued to enjoy the
support of his international friends from Paris
and London.3
Horace Wells also challenged Morton’s
claims. After Wells’ failure with nitrous oxide at
MGH, he returned to Hartford and became so
seriously ill that his practice was ruined. In
December 1846, his friends advised him to
publish a statement in the Hartford Courant. He
claimed that he should have rights to the
discovery based on the fact that his nitrous oxide
experiments used the same principles as
Morton’s ether discovery.3
Morton’s patent was soon ignored all over
America and Europe, as surgeons used a sponge
instead of Morton’s specialized inhaler. The
United States Army and Navy broke his patent
with their widespread use of ether during the
Mexican War in 1847. Morton’s efforts to
collect fees and regulate anesthesia failed and his
dental business was ruined.3 In 1849, Morton
petitioned Congress to recognize his claims and
to compensate him. After three appeals,
Congress finally agreed to reward Morton with a
$100,000 award in 1852. Jackson’s and Wells’
supporters objected, and Crawford Long was
persuaded to submit a claim in 1854. All the
proposed bills were rejected due to the excessive
number of claimants, and no one received any
reward.5
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Afterward
Of the four figures involved in the ether
controversy, only Crawford Long’s life wasn’t
destroyed by the desire to gain prestige and
monetary reward. After the Congressional
debates of 1854, he gave up and continued his
practice in Georgia until his death. As a hero of
the South, his successful use of ether is
commemorated by Doctor’s Day every March
30.5
Horace Wells’ attempts at recognition failed,
and he left his family unsupported in Hartford,
returning to New York City to resume
experiments. He became addicted to chloroform
and committed suicide after being incarcerated
for throwing sulfuric acid on prostitutes. Twelve
days later, the Paris Medical Society gave him
the honor of being first to use vapors or gases to
make surgery painless.5
Charles Jackson became an uncontrollable
megalomaniac. When he came across Morton’s
grave in 1873, Jackson developed a severe
psychotic illness. He was placed in an institution
for the insane outside of Boston and remained
there until his death in 1880. He was buried just
a short distance from Morton at Mount Auburn.5
Morton became obsessed with financial
reward and recognition for his contribution to
anesthesia. However, none of his schemes were
successful, and he was ruined by them. His
creditors ignored him; he lost his home, and was
censured by the American Medical Association.
In the summer of 1868, Morton journeyed to
New York City to refute a new publication by
Thomas Jackson claiming credit for ether
anesthesia, but Morton suffered heat stroke
during a heat wave.5

The discovery of ether anesthesia
revolutionized surgery and dentists had the most
important influence on this discovery. Many
surgeries that save or improve lives are now
readily possible. Although their motives may
have been suspect, it was their drive, courage,
and innovation that led to this important
discovery.
Because of the bitterness and
peculiarities of the ether controversy, it is fitting
that no individual receives credit. The Boston
Public Garden is home to the Ether Monument
commemorating the discovery of ether
anesthesia as a treatment rather than an
individual.8
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